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Abstract 
 
Postpartum ingestion of the afterbirth by the mother, or maternal placentophagy, is a common 
behavior among eutherian mammals, including non-human primates, with humans as a rare 
exception. Despite the conspicuous absence of placentophagy in the cross-cultural ethnographic 
record, the practice appears to be gaining popularity among a small but growing number of 
advocates in various industrialized contexts who claim that the practice provides benefits to the 
postpartum mother, namely the relief and prevention of postpartum blues and depressive 
symptoms, improved breast milk production, and enhanced bonding with their infant. Because 
the placenta serves as an endocrine organ throughout pregnancy and facilitates the exchange of 
nutrients between mother and fetus, placentophagy supporters suggest that the hormones and 
nutrients remaining in the placenta after parturition can be used to replenish these substances 
during the postpartum period, often through the ingestion of dehydrated and encapsulated 
placenta supplements.  
This dissertation addresses the claims of placentophagy advocates through a randomized, 
double blind, placebo controlled trial in which postpartum women (N=27) were given a 
supplement containing either their dehydrated and homogenized placenta (n=12), or a similarly 
prepared placebo (n=15). Questionnaire responses and biological samples were collected during 
pregnancy and at three postpartum meetings to address whether supplementation with placenta 
capsules improves postpartum affect, energy and recovery in comparison to a placebo 
supplement; whether there are differences within and between these two groups in concentration 
of prolactin, estradiol, and progesterone across meetings and whether these hormones are related 
to measures of postpartum affect, energy and recovery; and to identify the concentration of 
iv 
hormones, micronutrients, and environmental metals in dehydrated placenta capsules. The results 
suggest that participants receiving the placenta supplement experienced a postpartum decrease in 
depressive symptoms and fatigue that was not experienced by those taking the placebo 
supplement, but that hormonal differences were not related to these changes. Analysis of the 
placenta supplements also revealed modest concentrations of some micronutrients and hormones, 
as well as negligible concentrations of potentially harmful environmental metals.
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Chapter 1: Introduction 
 
Overview of the Topic 
The postpartum ingestion of the afterbirth by the mother, or maternal placentophagy, is a 
common behavior among eutherian mammals, including non-human primates (Kristal, 1980; 
Soyková-Pachnerová et al., 1954; Stewart, 1977). Of over 4,000 terrestrial mammalian species 
only camelids (camels, llamas, alpacas, vicunas and guanacos) and humans have been identified 
as species that do not regularly engage in this behavior (Kristal, 1980; Vaughan & Tibary, 2006).  
Despite the conspicuous absence of placentophagy in the cross-cultural record, the 
practice appears to be gaining popularity among a small but growing number of advocates in 
various industrialized contexts around the world (Bastien, 2004; Field, 1984; Friess, 2007; 
Janzsen, 1980; Selander, 2009; Selander et al., 2013; Stein, 2009; Young & Benyshek, 2010). An 
internet survey of 189 women living in industrialized countries who have engaged in this 
behavior after at least one birth showed that the overwhelming majority of women in the sample 
reported experiencing some benefit that they attributed to placentophagy, that their experience 
with placentophagy was overwhelmingly positive, and that they would ingest their placenta 
again after subsequent births (Selander et al., 2013). Although participants in this study 
constitute a self-selected sample, and therefore cannot be generalized to all placentophagic 
mothers, the results suggest that women who choose to engage in placentophagy do so because 
they believe it is in some way beneficial, and that most of these women perceive some positive 
effect as a result of the practice.  
 
Importance of Studying Placentophagy 
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During gestation, the placenta is responsible for the exchange of nutrients and gases 
between the mother and fetus, as well as the production and secretion of a number of hormones 
(Donnelley & Campling, 2008; Gude et al., 2008; Guibourdenche et al., 2009; Taylor & Lebovic, 
2007). Research using both experimental animal models and human subjects has suggested that 
some of these substances are retained by the placenta postpartum and might be bioavailable upon 
ingestion (Blank & Friesen, 1980; DiPirro & Kristal, 2004; Grota & Eik-Nes, 1967; Kong et al., 
2008; Kristal, 1991; Onuguluchi & Ghasi, 1996; Soyková-Pachnerová et al., 1954). This has led 
some researchers to suggest that placentophagy could provide a means for the mother to 
replenish hormones and nutrients lost during parturition, and that it may also play a role in 
improved postpartum recovery and mood (Apari & Rózsa, 2006; Janzsen, 1980; Selander, 2009). 
Proponents of placentophagy have adopted these ideas and argue that postpartum 
placental ingestion is a natural and beneficial part of the birth process and that it plays an 
important role in preventing or alleviating postpartum depressive symptoms and speeding 
recovery from childbirth, among other purported benefits (Apari & Rózsa, 2006; Bastien, 2004; 
Field, 1984; Friess, 2007; Janszen, 1980; Selander, 2009; Selander et al., 2013; Stein, 2009). 
This support and advocacy of placentophagy as a natural and beneficial practice, seems to have 
emerged out of the natural birth and natural health movement in the 1960s, where women who 
were concerned about the risks of unnecessary technological interventions in the birth process 
began opting for more natural births (e.g. midwife-attended out-of-hospital birth with minimal 
intervention) (Rooks 1996). Early accounts of placentophagy from this time identify similar 
birthing choices and express ideas that are aligned with those exhibited by women during the 
natural birth movement (Ober, 1960; Rooks, 1996). 
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Although many studies investigating the proximate mechanisms involved in 
placentophagy have been conducted using experimental rodent models (see Kristal et al., 2012 
for a review), research aimed at understanding the physiological and emotional effects of this 
behavior in humans, and the motivations behind women’s decisions to engage in this behavior, 
have been largely ignored in the scientific literature with the exception of only a few studies 
(Hammett & McNeile, 1917a; Hammett & McNeile, 1917b; Selander et al., 2013; Soyková-
Pachnerová, 1954; Young & Benyshek, 2010). Recently published studies have noted the limited 
number and limitations of the published literature on this topic, and have called for research that 
rigorously evaluates the efficacy and safety of the practice (Cole, 2014; Coyle et al., 2015; 
Marraccini & Gorman, 2015; Selander et al., 2013; Young & Benyshek, 2010; Young et al., 
2012).  
Although proponents tout the positive effects of placentophagy and attribute a host of 
benefits to the behavior, the implications of this practice for both maternal and infant health are 
largely unknown, and women are making the decision to ingest their placenta in the absence of 
evidence supporting the benefits or exposing the negative effects of placental ingestion. Because 
placentophagy is a practice that appears to be gaining popularity among mothers in industrialized 
contexts, evidenced by the increasing media attention the practice has garnered in the last few 
years in particular (Abrahamian, 2011; Dahl, 2007; Friess, 2007; McLaughlin, 2011; Stein, 
2009), it is important to assess not only the benefits claimed by advocates, but also the potential 
risks of this behavior. 
The aim of this dissertation project is to investigate the purported benefits of human 
placentophagy for postpartum mood and recovery from childbirth among a small number of 
women participating in this trend. This was done through a double-blind, placebo-controlled trial 
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in which psychometric questionnaires were administered and biological samples were collected 
to identify the psychological and physiological effects of ingesting placenta capsules postpartum. 
Additionally, samples of dehydrated placenta collected from each participant were analyzed to 
evaluate the hormonal, nutritional, and toxic element composition of placenta capsules in order 
to address questions about the concentration of beneficial substances in the capsules, as well as 
concerns about potential accumulation of harmful substances in the organ that may be present in 
the capsules taken by postpartum mothers. Results from this research are important in 
understanding the potential physiological, psychological, and emotional consequences of this 
behavior, and contribute to the placentophagy literature that can be used by postpartum mothers 
to better inform their decision to engage in placentophagy postpartum.  
 
Overview of the Dissertation 
This dissertation is comprised of 7 chapters, the Introduction, Literature Review, Research 
Questions and Design, Methods, Results, Discussion, and the Conclusion. A brief introduction is 
provided in the current introductory chapter, which is followed by a more detailed discussion of 
the topic in Chapter 2, the Literature Review. The Literature Review provides an overview of 
placentophagy among mammalian mothers, including primates, as well as the history of the 
practice among human mothers. The physiology and function of the placenta in human gestation 
is addressed in this chapter, in addition to a discussion of previous research on this topic, in both 
humans and animal studies, including observational and experimental animal models, in order to 
frame this dissertation study in the context of the current state of placentophagy research. The 
chapter concludes with an overview of postpartum maternal health and the role of placentophagy 
in this topic.  
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 Chapter 3, Study Design and Research Questions, outlines the research questions 
addressed by the dissertation project. It also provides an overview of the design of the research 
project in which the methods for the study, described in Chapter 4, are situated. Chapter 4 
provides a detailed description of the methodology employed in this research study. This 
includes information about participant recruitment and inclusion criteria, meeting schedule, data 
and sample collection procedures, supplement preparation and dosing, and randomization and 
blinding procedures. The assessment tools utilized in this study are also described in this chapter.  
 The Results of this study are discussed in Chapter 5. Here I discuss the way the 
assessment tools were scored and an overview of the statistical methods used is provided. The 
results presented here include demographic data for participants in both the treatment and control 
groups, within-subjects and between group comparisons of psychometric variables and hormonal 
measures, and relationships between psychometric and biological variables. The composition of 
hormones and environmental metals in dehydrated placenta prepared for encapsulation is 
reported here, and relationships between biomarkers in the placenta and saliva and plasma 
samples are addressed. Discussion and interpretation of these results, as well as limitations and 
recommendations for future placentophagy research are provided in Chapter 6, followed by a 
summary of the dissertation in the concluding chapter.  
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Chapter 2: Review of the Literature 
 
Overview of Placentophagy 
Maternal placentophagy is the consumption of the afterbirth and birth fluids in mammalian 
mothers immediately following parturition. Of over 4,000 terrestrial mammalian species (Wilson 
& Reeder, 2005), humans are among only a handful of species who do not routinely engage in 
this behavior, and are joined only by camels and their relatives (camelids) (Hrdy, 2009; Kristal, 
2009; Vaughn & Tibary, 2006; Young & Benyshek, 2010). The practice of maternal 
placentophagy among mammals is puzzling for several reasons: among non-human mothers, 
both the proximate and ultimate causes of the behavior are largely unknown, and conversely, the 
reason for the conspicuous absence of placentophagy among some mammals, such as humans 
who do not routinely engage in this behavior, remains unclear. Among non-human mammals, 
observations indicating a strong desire to consume this organ have been made in rats who more 
readily give up their pups than the placenta (Kristal, 1991), in macaques who pay more attention 
to the placenta than the neonate in the first hour after birth (Kemps & Timmermans 1982), and in 
cows who demonstrate a “violent craving for the placenta” (Soyková-Pachnerová et al., 1954). 
Although the behavior is ubiquitous among terrestrial mammalian species, including our closest 
primate relatives, postpartum human maternal placentophagy has not been recorded as a 
traditional practice in the ethnographic literature (Young & Benyshek, 2010).  
Despite its absence among humans, including natural fertility populations, a small but 
growing number of women, primarily in industrialized countries are ingesting the placenta 
postpartum in order to reap the many purported benefits of the practice. These include the 
prevention and relief of postpartum depression, fatigue, and improved lactation, among other 
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reported positive outcomes (see Selander et al., 2013). Although claims about the benefits that 
placentophagy provides have never been objectively evaluated, the practice appears to be 
increasing in popularity. As Selander and colleagues (2013) note, there was a four-fold increase 
in the reported number of PBi encapsulation clients between 2007 and 2011 and there has been 
growing media attention given to placentophagy in recent years (Selander et al., 2013).   
 
Mammalian Placental Physiology and Function 
Among all eutherian mammals, the placenta is a temporary organ that forms during pregnancy to 
perform specific support functions for fetal growth. There are three basic types of mammalian 
placentas demonstrating variation in the degree of invasiveness. From least to most invasive, 
these are: epitheliochorial, endotheliochorial, and haemochorial. Within each basic type, there is 
great morphological variation in size, shape, and structure based on the needs and gestation of 
each species (Loke, 2013). Placental type varies among primates with humans developing a 
haemochorial placenta, characterized by a discoid shape and deep penetration of the placenta into 
the uterine wall. In the haemochorial placenta, there is a thin cellular layer between maternal and 
fetal membranes in the intervillous space where projections from the placenta, called villi, are 
bathed in maternal blood, and where the exchange of substances between the mother and fetus 
occurs (Loke, 2013).  
The placenta is formed entirely from fetal cells after the fertilized egg implants in the 
uterine wall (Loke, 2013). After implantation, cells derived from the blastocyst, called 
trophoblasts, invade the endometrium (uterine lining) and connect with the uterine artery to 
secure a blood supply. The placenta has two distinct parts, the maternal and fetal sides, which are 
separated by a very thin layer of cells, the thickness of which decreases across pregnancy, while 
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placental size and surface area increase (Gude et al., 2008). The exchange of important 
substances between mother and fetus, such as nutrient and gas exchange from the mother to fetus 
and the delivery of waste products from the fetus to mother, occurs in the intervillous space. 
Here, substances cross the placenta in a number of ways: passive diffusion (e.g., oxygen and 
carbon dioxide), facilitated diffusion with the help of specific transporters (e.g., glucose via 
GLUT-1 transporter), active diffusion through ion channels operating at a concentration gradient 
(e.g., many amino acids via sodium ion channels), and osmosis (e.g., water, which after crossing 
the barrier is ingested into the fetal system from swallowing amniotic fluid) (Donnelly & 
Campling, 2009). The proper functioning of these mechanisms in the placenta is vital to adequate 
placental and fetal growth. 
The placenta becomes increasingly important across pregnancy in performing many 
functions necessary for fetal development. It functions as the fetus’s lungs, exchanging oxygen 
and carbon dioxide waste, as the kidneys, filtering and removing waste products from fetal 
circulation, as the gastrointestinal tract, transferring important nutrients to the fetus, and as an 
endocrine organ, synthesizing and orchestrating the function production and function of a 
number of hormones (Donnelly & Campling, 2009; Goodman, 2003; Petraglia et al., 2006). 
Alterations to placental size, surface area, vascularization, and the thickness of the cell layer 
between maternal and fetal contact can all impact the interaction between mother and fetus, and 
in turn, fetal growth and development both positively or negatively (Myatt & Roberts, 2006). 
Decreased surface area reduces the amount of space available for the blood to pass over, 
reducing the total amount of substances available for exchange. Reduced vascularization limits 
the amount of blood flow to the placenta and therefore, the amount of blood that will pass 
through the intervillous space (Burton et al., 2009). The thickness of the placental barrier limits 
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the ability of substances to cross the placenta, and as barrier thickness increases, so does the 
difficulty for certain substances to cross the “placental barrier,” reducing availability of the 
substance to the fetus (Donnelly & Campling, 2009).  
The concentration of available transporters also impacts the amount of nutrients that can 
be transported to the fetus, so that a decreased number of transporters will reduce availability of 
the nutrient it transports. Thus, disruptions to any of these processes can impair or alter placental 
and/or fetal growth, and disruption of some of these mechanisms has been identified in cases of 
intrauterine growth restriction (IUGR) and small for gestational age (SGA) fetuses (Myatt et al., 
2006), although animal research also suggests that decreased placental size is sometimes 
compensated with increased efficiency (Fowden et al., 2008). Placental size and function have 
also been shown to be altered based on signals from the environment, such as decreased 
nutrition, increased maternal stress, heat stress, and alterations in oxygen availability (Fowden et 
al., 2008), and the organ is thought to play a role in fetal programming of characteristics that  
have been hypothesized to enhance offspring survival to reproduction in stressed or resource 
poor environments, and which, under more favorable postnatal conditions, may otherwise lead to 
greater adult morbidity and mortality due to increased susceptibility to cardiometabolic 
disorders, including cardiovascular disease, type 2 diabetes, hypertension, and coronary heart 
disease (Myatt et al., 2006; Nellisen et al., 2011). Because the placenta is responsible for so 
many tasks vital to fetal development, it has the ability to impact lifetime health of the fetus. 
 
Reproductive Endocrine Function of the Human Placenta 
The embryo implants in the uterus approximately 8 to 10 days after fertilization and at this time 
secretes detectable levels of human chorionic gonadotropin (hCG), a hormone that is necessary 
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in sufficient quantities in order to sustain the pregnancy (Taylor & Lebovic, 2007). During the 
first trimester, the placenta assumes and coordinates the production of several hormones, some of 
which are produced at concentrations that far exceed the mother’s pre-pregnancy levels, and 
contribute to some of the symptoms typically associated with pregnancy, such as nausea, mood 
lability, and fatigue (Petraglia et al., 2006).  
By the end of the first trimester, the fetal-placental unit is established, and the fetus 
begins working with the placenta to control hormone production and secretion, and in the second 
trimester, concentrations of progesterone and estrogens increase rapidly and continue to climb 
across pregnancy (Gude et al., 2004; Petraglia et al., 2006; Taylor & Lebovic, 2007). 
Progesterone is required in order to sustain pregnancy, and is produced by the placenta using 
maternal cholesterol that is synthesized first into pregnenalone, and then progesterone 
(Goodman, 2003; Petraglia et al., 2006). This elevated progesterone suppresses both uterine 
contractions and immune function, with a likely role in preventing maternal rejection of the fetus 
(Talyor & Lebovic, 2007).  
Estrogens are another important steroid hormone whose concentration increases across 
pregnancy. The placenta produces these hormones from maternal and fetal androgen precursors, 
primarily fetal DHEA-S which is converted into estriol, and into DHEA, which is then converted 
to testosterone which is ultimately aromatized to estradiol, and androstenedione which is 
aromatized to estrone (Petraglia et al., 2006; Taylor & Lebovic, 2007). Maternal concentrations 
of estrogens increase dramatically across pregnancy, with estradiol and estrone increasing to 50 
times higher than pre-pregnancy levels, and estriol (a very weak estrogen) increasing 1000-fold 
(Taylor & Lebovic, 2007). Maternal androgens also increase during pregnancy, however, these 
increases are small in comparison to those seen with the female sex steroids, and levels of free 
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androgens are affected by the presence of sex hormone binding globulin (SHBG) which binds to 
these hormones rendering them inactive, and by their conversion into estrogens (Taylor & 
Lebovic, 2007).  
Levels of hormones that have been increasing dramatically across pregnancy, such as 
estrogens and progesterone, plummet with the expulsion of the placenta at birth. Within a few 
days, both progesterone and estrogen returns to levels experienced in the follicular phase (the 
phase immediately preceding ovulation) (Taylor & Lebovic, 2007). The dramatic declines in 
these hormones have been attributed to some of the symptoms experienced by postpartum 
mothers, namely postpartum blues and depression (Bloch et al., 2000).   
Two other hormones, oxytocin, which facilitates uterine contractions, and prolactin, 
which promotes lactation, play prominent roles in labor and preparation for lactation 
respectively. Oxytocin increases across pregnancy, and starting at 20 weeks gestation, but 
especially in the weeks preceding birth, there is growth in the concentration of oxytocin 
receptors in the uterus as well as increased responsiveness to the hormone (Goodman, 2003; 
Petraglia et al., 2006; Taylor & Lebovic, 2007). At parturition, oxytocin spikes in response to 
cervical dilation, and this release of oxytocin leads to increased uterine contraction which further 
dilates the cervix. This feedback process between oxytocin and cervical dilation continues until 
the infant and placenta are born (Goodman, 2003). Postpartum, oxytocin stimulates alveolar 
contractions that facilitate lactation (Goodman, 2003).  
Prolactin increases across pregnancy and is responsible (along with estrogen, 
progesterone, growth hormone, glucocorticoids, and human placental lactogen) for increasing the 
number and volume of mammary alveoli in preparation for lactation (Goodman, 2003; Taylor & 
Lebovic, 2007). At the start of labor, prolactin declines at a rate that is influenced greatly by the 
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presence or absence of breastfeeding. Lactation affects the time it takes for hormones to return to 
pre-pregnancy levels, and compared to women who do not breastfeed, lactating mothers 
experience increased levels of both oxytocin and prolactin, which are necessary for milk let-
down and production respectively, and return to pre-pregnancy levels more slowly (Goodman, 
2003; Petraglia et al., 2006). Prolactin also suppresses the release of gonadotropin releasing 
hormone (GnRH), which can lead to lactational amenorrhea in breastfeeding women (Taylor & 
Lebovic, 2007). 
 
Placentophagy in Mammals 
Postpartum placentophagy is ubiquitous among eutherian mammalian mothers with few 
documented exceptions, and the absence of placentophagy has only been noted in a handful of 
mammalian species, including camelids, humans, and some aquatic mammals (Kristal, 1980; 
Young & Benyshek, 2010). Several hypotheses have been proposed to explain the ubiquity of 
this behavior among postpartum mammalian mothers, however, no single explanation is 
sufficient to explain placentophagy across all mammalian species (Kristal, 1980; Menges, 2007). 
Kristal (1980) reviews each of the following explanations in detail, providing counterevidence 
that refutes each argument. One explanation is that placentophagy functions to clean the net site 
as a means of predator avoidance and disease prevention, however, apex predators, arboreal 
species, and non-nesting mammals are known to ingest the placenta postpartum. Additionally, 
the fluids associated with birth would be easily absorbed into the ground at the birthing site and 
would likely be detected by predators. Another explanation for the behavior suggests that 
mothers experience a shift toward a carnivorous diet at parturition, however, Kristal’s (1973) 
experimental research with rodents has shown that there is a preference for placenta over other 
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types of meat. Tinkelpaugh and Hartman (1930) also showed that rhesus macaques that were 
offered three different types of meat just before and after birth refused all types of meat, and they 
noted that generally other foods are refused by parturient female monkeys until the placenta has 
been consumed. A third explanation is that mammalian mothers experience a general hunger at 
parturition due to decreased food intake prior to birth, however, not all mammals reduce their 
dietary intake leading up to parturition, as noted in rats by Kristal and Wampler (1973). The final 
explanation that has been proposed to explain the behavior is that mammalian mothers 
experience specific hunger for a particular substance that is present in the placenta. This 
explanation however, does not account for rodents where a large number of virgin females will 
accept placenta, while some will refuse the organ up to parturition. If the physiological state 
needed to induce placentophagy in female rodents occurs at parturition, this does not explain 
placentophagy in virgin female rodents, as the physiological state required to induce this 
behavior (birth) is not present (Kristal, 1980). Although it is possible that the behavior arose 
through convergent evolution and each explanation could account for the emergence of 
placentophagy in different species, there is no single hypothesis that explains the behavior across 
all mammals. For a detailed discussion of these hypotheses and their counterevidence, see Kristal 
(1980).  
 Although the proximate and ultimate causes of the behavior among mammals remain 
unclear, placentophagy has been well-studied in rodents, and physiological effects of the 
behavior have been identified. Mark Kristal and colleagues at SUNY Buffalo have investigated 
placentophagy in rats and mice using experimental design to manipulate the behavior. Kristal 
and colleagues (1980) have identified several factors that influence placentophagy in rodents. 
They found that although virtually all mice and rats eat the placenta at delivery, nulliparous 
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females of some strains of mice are more likely to eat the placenta than other strains. Other 
researchers have investigated placentophagy in rodents and have similarly reported variation in 
the percentage of virgin individuals who will accept placenta, often noting that peripartum and 
parous individuals are more likely to be placentophagic. Examples include female Long-Evans 
rats (Rattus norvegicus) (Harding & Lonstein, 2014), biparental California Mouse (Peromyscus 
californicus) females and males (Perea-Rodriguez & Saltzman, 2014), biparental Phodopus 
campbelli dwarf hamster females and males (Gregg & Wynne-Edwards, 2005), and in 
uniparental Siberian hamster (Phodopus sungorus) females and males (Gregg & Wynne-
Edwards, 2006). These researchers suggest that placentophagy serves to increase contact 
between the mother and her neonates, which may enhance postpartum maternal (and, in the case 
of fathers, paternal) behavior.  
  Kristal and colleagues (Kristal, 1980) conducted experiments offering placenta to virgin 
rats during different phases of the estrous cycle and found that they would not eat placenta for 
the first time during proestrus (the phase immediately before estrus in which estrogen is 
elevated), indicating an aversion to novel substances during this time (Kristal, 1980). Despite 
aversions throughout the estrous cycle, Kristal notes that nearly all rats will eat the placenta at 
birth. Similar work was conducted by Melo and Gonzalez-Mariscal (2003) in rabbits where 
placenta and liver were offered to animals at different reproductive stages, including estrous, 
mid-pregnancy, 1 day pre-partum, parturition, 1 day postpartum, and 5 days postpartum, 
incidence of placentophagy was recorded. None of the rabbits ingested placenta during estrous, 
and few (less than 14%) accepted placenta during pregnancy or 1 day pre-partum, however, all 
of the mothers ingested the placenta at birth, and about half accepted donor placenta on days 1 
and 5 postpartum. The authors noted that liver was consumed in only about 10% of individuals at 
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all reproductive stages, and that placenta was ingested sooner and given more attention (i.e.., 
sniffing) than the liver. The authors conducted a follow-up experiment in the same study in 
which rabbits were offered placenta at 2 hour intervals leading up to birth, and from 30 minutes 
to 24 hours postpartum, this time using rabbit pellets as a control instead of liver. Results were 
reported for tests at 8 hours pre-partum, 2 hours pre-partum, 4 hours postpartum, 6 hours 
postpartum, and 8 hours postpartum. Again, they found that pre-partum instances of 
placentophagy were low, while all mothers ingested the placenta at birth. Similarly, the 
percentage of placentophagic mothers postpartum was high (ranging from 56% - 75% within the 
first 8 hours postpartum), however, unlike liver, few mothers refused pellets and ingested only 
placenta (Melo & Gonzalez-Mariscal, 2003).   
 Because hormonal changes are well-documented as playing a role in the onset of 
maternal behavior, Kristal (1980) conducted an experiment in which he offered placenta to rats 
across pregnancy and tracked the percentage of placentophagic individuals each day. He found 
increased incidence of placentophagy over time, but it never exceeded 50%, and no correlation 
was identified between hormone levels and the days on which the rats were most likely to accept 
the placenta for the first time. When Kristal tested the effects of estrogen on placentophagy by 
administering estrogen in levels sufficient to induce maternal behavior to rats whose 
reproductive organs had been removed, placentophagy was inhibited (Kristal 1980). 
 In addition to an influence of reproductive stage and status on willingness to ingest 
placenta, Kristal and colleagues (Kristal, 1980) noted that rats purchased from a breeding lab had 
higher rates of virgin (nulliparous) placentophagy than those born and raised in their own lab by 
about 25-40% (Kristal, 1980). After investigating this observation with a series of tests designed 
to induce stress in the homegrown rats, they discovered that rats that experienced at least one 
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stressful event were more likely to be placentophagic as virgins, than rats that had not 
experienced a stressful event (Kristal, 1980).  
Additional work by Kristal and colleagues has also identified an effect of the behavior 
involving pain reduction. Through a series of experiments in which rats were administered 
morphine to elevate their pain threshold (as in pregnancy), given either placenta or beef, and then 
exposed to pain stimuli, Kristal (1991) found that those who ingested placenta showed increased 
and longer lasting pain tolerance compared to those who ingested beef. This effect was not seen 
in rats that were not given morphine or in animals administered an opioid antagonist to block the 
effect of the morphine. These results indicate that while the placenta itself does not induce 
analgesic effects, it enhances opioid-mediated analgesia, and the substance that elicits this effect, 
which remains to be identified, has been dubbed “placental opioid enhancing factor” (POEF).   
Other experimental rodent data suggests that ingestion of placenta may alter postpartum 
hormone levels. Two studies conducted in rats indicate that consuming the placenta can affect 
postpartum concentrations of certain hormones in the serum (Blank & Friesen, 1980; Grota & 
Eik-Nes, 1967). Blank and Friesen (1980) found that when compared to rats in which 
placentophagy was prevented, those that ate the placenta had elevated prolactin levels on the first 
day postpartum and lower progesterone levels on the sixth and eighth days. Grota & Eik-Nes 
(1967) found that rats that were prevented from consuming the placenta exhibited decreased 
levels of progesterone on the fourth day of lactation compared to those allowed to consume the 
organ. Other studies looking at birth in biparental dwarf hamsters in which the father actively 
assists in the delivery and offspring care, noted that the father joins the mother in consuming the 
placenta (Gregg & Wynne-Edwards, 2005; Jones & Wynn-Edwards, 2000). This behavior was 
also investigated in male Siberian hamsters, who do not typically assist or attend births, and 
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placentophagy was noted only when the father was present during birth (Gregg & Wynne-
Edwards, 2006). Harding and Lonstein (2014) examined placentophagy in female rats who were 
present during the subsequent birth of a sibling litter and found that 58% of these weanling 
female rats ingested placenta during the birth. Although limited to only a few studies, this 
research suggests that placentophagy may contain substances that affect certain circulating 
hormone levels, and parental behavior. Although hormonal analysis was not included in an 
experimental placentophagy study in rabbits, González-Mariscal and colleagues (1998) found 
that removal of the placenta and pups from the mother postpartum resulted in decreased lactation 
compared to rabbits in the control group. This suggests that placentophagy may have positive 
effects on lactation, which is one of the claims made by advocates of the practice in human 
mothers (Selander et al., 2013).  
Although an evolutionary function of placentophagy among mammalian mothers has not 
been definitively identified, the presence of this behavior across mammalian species, as well as 
the enthusiasm with which the organ is consumed, sometimes at the expense of direct interaction 
with the neonate, suggests that it likely provides a fitness-enhancing benefit.  
 
Placentophagy in Non-Human Primates 
Unlike rodents, no experimental research has been conducted that specifically focuses on or 
manipulates placentophagy in primates, however, observational data on primate placentophagy 
has been collected in both wild and captive populations of various species, however due to the 
difficulty of witnessing a wild primate birth, more of these observations are in captive 
populations. As a result, all of the primate data are limited to observations, with no biological 
markers recorded and little information regarding specific behavioral differences between 
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placentophagic and non-placentophagic mothers. As such, these limited data should be 
interpreted cautiously. For a list of primate species in which placentophagy has been recorded, 
see Appendix A, Table 2.1 (adapted from Young et al., 2012). 
Although placentophagy occurs in all (non-human) primate species, it does not 
necessarily occur in every individual. For example, prevalence among captive rhesus macaques 
is about 83%, in baboons the prevalence in about 69%, and the number drops to 25% for 
chimpanzee. In those mothers that do ingest the placenta, some behavioral effects have been 
noted. A study with Java macaques reports that mothers pay more attention to the placenta than 
their newborn in the first hour after birth (Kemps & Timmermans, 1982), suggesting a strong 
desire to eat the placenta, even during the immediate postpartum period when the mother would 
be expected to be focused on the neonate. In another study with Java macaques, the author 
observed an alpha female who took a piece of the placenta from a lower ranking postpartum 
mother while she was engaged in placentophagy (Ratnayeke & Dittus, 1989). Japanese macaques 
who ingested placenta postpartum in one study were noted to increase oral behaviors of licking 
both the neonate, and the mother’s own limbs (Negayama et al., 1986), suggesting a relationship 
between placentophagy and an increase in this maternal licking behavior. Finally, much like the 
biparental dwarf hamsters, P. campbelli, tamarin fathers invest heavily in infant care, and in this 
species they share the placenta with the mother postpartum, sometimes even including juvenile 
offspring in the activity (Price, 1990; Pryce et al., 1988).  
 
Placentophagy in Humans  
Because humans are an exception among primates in that they do not routinely engage in 
postpartum maternal placentophagy, our ancestors must have engaged in this behavior in our 
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evolutionary past, and at some point in prehistory placentophagy was eradicated as a typical 
behavior in our species. When and why humans stopped practicing placentophagy is unclear, 
although hypotheses have been suggested ranging from strict cultural explanations of food 
taboos, to speculation that the behavior may have been dangerous or harmful in our ancestral 
environment (Young et al., 2012).  
 
The disappearance of placentophagy in humans. One suggested explanation for the 
absence of placentophagy in humans is that as a substance that is associated with childbirth, an 
event that is often categorized as “unclean,” the placenta is also considered to be “unclean” or 
even dangerous, and as a result has become taboo as a food in humans (Field, 1984). Davidson 
(1985) suggested that placenta rituals among humans may function to reduce anxiety through a 
sense of control over the future health and well-being of the mother, child, and community. This 
hypothesis is rooted in her observation of the widespread cross-cultural belief that treatment of 
the placenta can have real effects on the individuals with whom it is closely connected - the child 
and mother – who are vulnerable during this liminal state. If this is the case, the culturally-
appropriate treatment of the postpartum placenta in a ritualistic way would preclude its ingestion, 
making placentophagy decrease and eventually disappear in humans. The association of 
placentophagy with cannibalism was discussed by Ober (1979), a medical doctor who noted that 
the behavior may have been perceived as related to the “uncivilized” practices of human sacrifice 
and cannibalism, leading to its near-universal cultural rejection. Another explanation for its 
absence is that placentophagy offers no direct benefits to human mothers who are more likely 
than mothers of other mammalian species to be adequately nourished at parturition, rendering 
placentophagy an unnecessary (nutritional) behavior in humans (Friess, 2007).  
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Other explanations offering an evolutionarily-based argument for the absence of 
placentophagy in humans have been proposed as well. It is possible that an aversion to 
placentophagy is the result of a common human avoidance of foods that present visual or 
olfactory cues signaling the potential for the item to harbor pathogens (e.g., uncooked meat) 
(Young et al., 2012). It is also possible that placentophagy absence in humans is the result of 
genetic drift, where the practice would have been neutral in terms of effects on fitness and 
eventually disappeared as the result of a bottleneck in a small population that gave rise to future 
human groups (Young et al., 2012).  
Given that there are no documented exceptions to the absence of placentophagy among 
humans until recently, in either contemporary or natural fertility populations, it seems unlikely 
that any of the proposed explanations can account for the absence of the behavior in our species. 
Although ideas about “clean” and “unclean” foods and substances are prevalent across cultures, 
the few universal (or near-universal) taboos such as this that have been identified in humans, are 
associated with behaviors that impact our fitness (e.g., universal avoidance of feces (Rozin & 
Fallon, 1987), or incest taboos (Brown, 1991). Although it is possible that placentophagy is a 
neutral behavioral trait offering no nutritional benefit to well-nourished human mothers, or that 
the behavior was lost among humans to genetic drift, if this were the case, it is unlikely that the 
behavior would disappear in every human population, as neutral traits will persist in some 
individuals (Young et al., 2012).  
A 2012 paper proposes that placentophagy disappeared in our species as a result of the 
uniquely human practice seen in every human culture of the controlled use of fire (Young et al., 
2012).  The authors suggest that as the use of fire became widespread among human populations, 
the close contact of human mothers to vegetative fire smoke (VFS) across pregnancy introduced 
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harmful substances to the mother that may accumulate in the placenta throughout gestation, 
using cadmium as an example. Because cadmium and other toxic metals are taken up by plants 
from the soil, when these plants are burned in a fire, these harmful substances are released into 
the environment and people can be exposed via smoke inhalation and ingestion of fly ash 
(Faroon et al., 2008; Stefanidou et al., 2008). Based on observational studies in contemporary 
foraging populations and developing countries where women spend more time in close proximity 
to fires than do males, it is likely that females in our ancestral environment were exposed to 
greater quantities of VFS than males (Ezzati, 2001; Lee & Daly, 1999; Marlowe, 2009; von 
Schirnding, 2001; Wickeramsinghe, 2001). Although many harmful substances that are released 
in fire smoke cross the placental barrier during pregnancy, some substances, such as cadmium, 
are unable to pass the barrier and accumulate in the placenta throughout gestation (Clarkson et 
al., 1985; Iyengar & Rapp, 2001).   
If human females were exposed to harmful substances during pregnancy that 
accumulated in the placenta, it is possible that ingestion of the placenta postpartum could have 
had negative impacts on the health of the mother, the neonate, or both (Young et al., 2012). 
Through placentophagy, the mother could have become ill from the effects of acute exposure to 
the toxic substances in the organ, potentially decreasing survival or ability to care for her 
newborn in placentophagic women therefore reducing their fitness, or her reproductive fitness 
could be inhibited through endocrine disruption caused by heavy metal exposure (Henson & 
Chedrese, 2004; Piasek & Laskey, 1994; Young et al., 2012). The fitness of the newborn may 
also have been reduced through the ingestion of harmful substances that made their way into the 
breast milk as a consequence of placentophagy, causing illness in the neonate (Young et al., 
2012). This explanation suggests that placentophagy was either a beneficial or neutral behavioral 
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trait that became maladaptive as a result of our changing environment, and that any benefit 
placentophagy offered to our ancestors was outweighed by the fitness cost resulting from 
ingesting the toxin-laden organ postpartum (Young et al., 2012). 
Another hypothesis proposed by Kristal and colleagues (2012) offer an adaptive 
explanation for the disappearance of this behavior in our species. They explain that because a 
primary benefit of placentophagy in animal models is the effects of POEF for enhancing pain 
relief following ingestion of placental tissue (and amniotic fluid), the adaptive benefit of not 
ingesting placenta in human mothers is a lack of pain reduction. In humans, they argue, the 
additional social support and assistance for a parturient female that would be garnered through 
suppressing placentophagy outweighs the benefit provided by the behavior. This increased social 
support would translate into strengthened social bonds, transmission of important information 
related to birth, and additional maternal and neonatal care that would ultimately enhance infant 
survival (Kristal et al., 2012).  
Although the hypotheses that have been proposed to explain the absence of 
placentophagy in humans are supported by indirect evidence, no experimental research has been 
conducted to directly evaluate these claims, and these hypotheses remain to be tested.  
 
Placentophagy in the ethnographic literature. Although the belief is held by some that 
there are human populations who still routinely practice placentophagy, a 2010 review of the 
ethnographic literature on the behavior, which included a survey of ethnographic works on 179 
cultures in the electronic Human Relations Area Files (Yale University) revealed no primary 
source accounts of maternal placentophagy as a longstanding traditional practice in any culture 
(Young & Benyshek, 2010). Only one instance of maternal placentophagy was described in this 
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study. This was an account of the practice in an ethnographic work on the Chicano (Mexican-
American) culture in which an Anglo mother attended by a Chicana midwife ingested her roasted 
placenta following the birth, however this appeared to be consistent with the relatively recent 
appearance of placentophagy among women in industrialized countries (Keys, 1986).  
 A handful of accounts of non-maternal placentophagy were identified in which the 
placenta was given to someone other than the mother as a medicine or remedy for an ailment, or 
ingested for unidentified reasons. Placenta is administered in Traditional Chinese Medicine to 
treat a range of ailments and imbalances such as fatigue, infertility, or liver problems, however 
the recipient is typically not the mother who delivered the organ (Furth, 1999; Shizhen et al., 
2003; Yanchi, 1988). Another source indicated that in Vietnamese culture, the placenta is given 
orally to patients with tuberculosis to aid their recovery (De & Coughlin, 1951). A secondary 
source also noted that Vietnamese nurses and midwifes of Thai and Chinese descent reportedly 
ingested the placentas of their patients, however, no additional details were provided (Ober, 
1979). Another reported practice was among the Sea Islanders (Gullah) off of the coast of South 
Carolina, where babies who are born with a caul (described as the placenta covering the face, but 
typically understood as the amniotic sac covering the face at birth) are given a tea made from 
their placenta to prevent the ability for them to see spirits (Trott, 2003). A final description of 
non-maternal placentophagy was included for the Malekula of Oceania, in whom the father of a 
newborn is alleged to eat a pudding prepared from the placenta and blood of the newborn 
(Deacon & Wedgewood, 1934), however, this was a secondary account and must be interpreted 
with caution (Young & Benyshek, 2010). Additional second- and third-hand accounts of both 
maternal and non-maternal placentophagy have been reported, however they must be considered 
cautiously as their veracity is unclear. Jacques Gélis (1991) suggests that although humans today 
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find the placenta repulsive, human placentophagy was at one time widespread and more recently, 
was practiced by several human populations across the globe. He summarizes several reports of 
the alleged existence of placentophagy among European populations, starting with early records 
of the use of placenta by ancient apothecaries to treat ailments such as birth marks, freckles, and 
tumors. In 17th century France, ingesting placenta was thought to stimulate and support breast 
milk production, a belief that he states persisted among certain low income Italians until the early 
1900s. Accounts from France in the 18th century state that dried placenta was effective in the 
treatment of epilepsy and internal bleeding. Gélis also notes that the placenta was ingested by 
Europeans for the aphrodisiac effects of the organ, and to treat infertility. Outside of Europe, 
maternal placentophagy was reported in 16th century Brazilian mothers, an account that was 
corroborated by Engelmann in 1881, who claims that Brazilian mothers who birth alone would 
eat the placenta in secret, and would only burn or bury the organ if under observation by another. 
He also notes an observation from the 1700s of the Siberian Yakinde in whom the father would 
cook and eat the placenta with his friends and relatives (Gélis, 1991). 
Although it is suggested by some that there are cultures in which this behavior has 
persisted into the present, studies and accounts of placentophagy in the scientific and 
anthropological literature have failed to provide a single reliable, first-hand account of the 
practice in humans outside of the recent postpartum behavior. This suggests that placentophagy 
does not exist in any contemporary human population as a longstanding traditional practice.  
 
Therapeutic and medical uses of placenta. Besides ingestion of placenta for cultural or 
therapeutic purposes, the use of placenta in other forms and for other reasons has been noted. 
The use of placental extracts (both animal and human) is seen in a variety of commercially 
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available cosmetic and personal care products, including hair care products, lotions, ointments, 
and skin care products (Donovan et al., 2007; James-Todd et al., 2011; Muralidhar & Panda, 
1999; Tiwary, 1998). The use of placenta does not come without concerns, however, as it has 
been suggested that their use may be linked to the development of reproductive cancers and early 
onset of secondary sex characteristics in prepubescent females, resulting from exposure to 
estrogens and progestogens (Donovan et al., 2006; James-Todd et al., 2011; Tiwary, 1998). 
Beyond use in cosmetics, placenta and amniotic membranes have also been used in 
medical treatments, and recently, clinical research using placental tissue and placentally derived 
cells has increased with the potential for medicinal applications (Silini et al., 2015). Silini and 
colleagues (2015) provide a comprehensive review of the history and extent of the use of 
placenta and the amniotic membrane in medicine, including an overview of NIH-registered 
clinical trials involving these substances or cells derived from them. Amniotic membranes have 
been used since the early 1900s in the treatment of burns and skin wounds, and their use in this 
capacity has been found to reduce pain and infection, increase fluid retention, and improve 
recovery. Other clinical applications of amniotic membranes in the 20th century noted by Silini 
and colleagues (2015) include use in ophthalmologic treatments, vaginal reconstruction, and 
surgical procedures. More recently amniotic and placental cells have been isolated and used in 
treatments for a range of conditions, often with promising results. Examples of conditions being 
treated with placental or amniotic cells include autoimmune diseases like Crohn’s disease and 
rheumatoid arthritis, burns and skin wounds, ophthalmologic conditions, dental diseases, 
orthopedic injuries and conditions, pulmonary injuries and diseases, multiple sclerosis, type 2 
diabetes, and others (Silini et al., 2015).   
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The “emergence” of placentophagy in humans. Given that our closest primate relatives 
engage in placentophagy, some advocates of the practice among humans believe that in avoiding 
placentophagy, we are ignoring an important part of the birth process, and leaving ourselves 
vulnerable to postpartum affective disorders and poorer postpartum recovery. Suggestions 
regarding the potential benefits of placentophagy have been sporadically proposed in the 
scientific and popular literature since the early twentieth century, and advocacy of the practice 
began appearing in the scientific literature in the late 1960s and early 1970s (Ober, 1968; Ober, 
1973), with enthusiastic support increasing to the present (Apari & Rosza, 2006; Bastien, 2004; 
Field, 1985; Janszen, 1980; Selander, 2009; Selander et al., 2013; Stein, 2009).  
Although no studies explicitly focusing on the motivations for placentophagy have been 
conducted until recently, the timing and content of the literature regarding placentophagy 
suggests that ideas about the practice revolved around the appeal of engaging in a “natural” 
behavior, and that the recent emergence of the behavior in humans may have been influenced by 
-- or grown out of -- the natural birth and natural food movements (Boucher et al., 2009; Janszen, 
1980). The earliest documented account of placentophagy in this context occurred within a 
communal living situation and was attended by a midwife or lay birth attendant (Ober, 1973), 
suggesting that the individual practiced a lifestyle and birthing behavior that was counter to the 
physician-attended hospital birth that was typical at the time (Rooks, 1996). Additional 
discussion of placentophagy includes claims by supporters that it is a natural part of childbirth 
and that humans should ingest their placenta since all other mammals do, often suggesting that 
there are traditional cultures that still practice placentophagy today (Janszen, 1980; Field, 1985). 
These ideas are consistent with those held by advocates of alternative medicine and the organic 
and health food movements, who believe that humans are too far removed from our natural state, 
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and who support health and nutrition related practices that are considered more “natural” and 
consistent with our pre-industrial roots (Brissett & Lewis, 1978).  
Advocates of maternal placentophagy seemingly began by suggesting that the organ 
provides the mother with a rich source of postpartum nutrients that benefit the recovering mother 
(Janszen, 1980; Field, 1985), and have since evolved to propose a hormonal mechanism by 
which the numerous benefits could be provided (Bastien, 2004; Selander, 2009; Selander et al., 
2013). In addition to claims that placentophagy is natural and healthful for new mothers, 
proponents suggest that because the placenta functions as an endocrine organ during pregnancy, 
exposing the mother to increasing concentrations of hormones across gestation to which she 
becomes accustomed, and since those hormones are abruptly lost at parturition, the mother 
experiences hormonal withdrawal that can inflict a host of negative consequences on maternal 
health, namely postnatal mood lability and depression, and that placentophagy is the body’s way 
of supplementing the mother with the hormones needed until lactation facilitates the resumption 
of their endogenous production (Apari & Rosza, 2006). Advocates of placentophagy insist that 
this is not only a natural form of “medicine” but that it is superior to biomedical interventions 
because the hormonal profile of the placenta is tailored exactly to the body in which it 
developed.  
Despite a lack of evidence that humans have ever engaged in maternal placentophagy as a 
traditional practice, and virtually no research into the benefit or safety of placentophagy beyond 
a handful of studies in the early- to mid-20th century (Hammet & McNeile, 1917a; Hammet & 
McNeile, 1917b; Soykova-Pachnerova et al., 1953), ideas about the benefits of postpartum 
human placentophagy persist, and the behavior has gained popularity primarily in the United 
States, Europe, and Mexico (Young & Benyshek, 2010), with a host of reported benefits  and 
28 
anecdotal support (Bastien, 2004; Field, 1985; Selander, 2009; Stein, 2009). This support and 
advocacy of placentophagy as a natural practice with health and nutritional benefits, coupled 
with the rejection of biomedical interventions that are the norm in industrialized countries, has 
similarities to the natural health/food movement. This movement, which responded to increased 
concerns about the dangers of biomedical healthcare and questions about where and how our 
food is produced, is based in similar claims to those of placentophagy advocates that we have 
strayed too far from natural behaviors, and that optimal health requires less technological 
intervention and more natural and sustainable practices (Brissett & Lewis, 1978; Davis-Floyd, 
1992/2003).  
Throughout United States history, midwifery has been available as an option for birth 
assistance, however, the general attitude toward birthing with a midwife has changed (Rooks, 
1996). Research has shown that the demographic profile of women who give birth at home with 
midwives has changed since the 1960s, where the majority of midwifery clients have 
traditionally been women of lower socioeconomic status living in rural areas with less access to 
healthcare, and generally ethnic minorities (Rooks, 1996). A longitudinal study examining the 
characteristics of midwifery patients found that during the 1990s there was an increase in the 
number of white, educated women of higher socioeconomic status using midwifery services, and 
a decrease in the use of midwives by all other ethnic groups, suggesting that these woman are 
opting for midwife care rather than being forced to use midwives due to limited options 
(MacDorman & Declercq, 2011). In another study, the reasons given by women for using 
midwives were primarily safety, followed by the appeal of reducing the use of unnecessary 
medical intervention. Other top reasons included increased comfort, more control, and better 
birth outcomes (Lindeman et al., 2009). The anthropological literature on the emergence and 
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growth of the natural/home birth movement in the US provides context for the appearance and 
spread of this practice as a natural behavior (see Cheyney, 2010), and it is at this time that the 
earliest accounts of placentophagy are seen (Ober, 1973), and when similar movements toward 
more natural child rearing practices, such as breastfeeding, arise (Martucci, 2015).  
In addition to increased support for natural childbirth, ideas about food and health have 
also changed since the 1960s. An increase in the belief that our diets include many foods that are 
poorly matched with those which our bodies are designed to eat, or that are otherwise harmful 
(e.g., highly processed or pesticide-laden foods),  began during this time, and evidence of these 
beliefs that have persisted today can be seen in the popularity of books like Fast Food Nation 
and The Omnivore’s Dilemma, in diets that claim to prescribe ancestrally appropriate foods such 
as the “Paleolithic” diet, and in the growing popularity of organic foods. These examples 
illustrate the belief of adherents that foods can have magical and healing properties (Aarnio & 
Lindeman, 2004; Lindeman et al., 2009), and certain demographics are more likely to adhere to 
this belief, mainly white women with some college education (Lindeman et al., 2009). 
Unsurprisingly, the demographic profile of those likely to hold beliefs that food has healing 
properties is similar to that of the growing population of women opting for midwife-attended 
home birth, and that of women who reported their experiences with placentophagy in an internet-
based survey (Selander et al., 2013). This suggests that some people may be more likely to 
adhere to a lifestyle that incorporates various aspects of natural health, natural diet, and natural 
childbirth.  
Despite the above noted similarities in the natural health movement and the growing 
popularity of placentophagy, there are also differences between the two movements. 
Placentophagy for example, focuses on one specific aspect of the childbirth process, and is often 
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practiced by women who give birth in hospitals (Selander et al., 2013), suggesting that it may 
function primarily as an effort to elicit a desired effect, such as the relief or prevention of 
postpartum depression, which may be independent of an overall belief that natural health or 
natural birth practices are best. 
 
Human Placentophagy and Postpartum Health and Recovery 
Though the practice may have emerged out of the natural health and birth movements, ideas 
about placentophagy have shifted or expanded to include beliefs that placenta is a natural and 
beneficial form of maternal “medicine” (Bastien, 2004; Field, 1984; Janszen, 1980). Often the 
placenta is steamed, dehydrated, pulverized, and encapsulated to be taken as a postpartum 
supplement in the weeks following parturition, however, various preparation methods are 
employed ranging from ingestion of raw placental tissue to preparing the placenta in a cooked 
dish as part of a meal (Bastien, 2004; Janszen, 1980; Selander et al., 2013). Although no data 
exist to validate the claims of placentophagy advocates, one preliminary study in which women 
discussed their experience with postpartum placentophagy found that many of the women who 
had chosen to consume the placenta postpartum had done so because it was “natural”, would 
speed recovery from childbirth, prevent postnatal depression and blues, and improve milk 
production, among other benefits, and the majority of the women in the study not only reported 
benefits, but also rated the experience as a positive one that they would repeat after a future 
pregnancy (Selander et al., 2013).  
 
Postpartum affect. The 2013 survey of women who have engaged in placentophagy after the 
birth of at least one child suggests that the most common reason for women’s decision to ingest 
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their placenta is to prevent or alleviate postpartum depressive symptoms (Selander et al., 2013). 
Approximately 80% of women experience postpartum “blues” and 10-15% of women develop 
postpartum depression (Goeser, 2008). The exact etiology of this condition is unclear, although 
fluctuating hormone levels and postpartum nutritional deficiencies are suspected by some 
researchers to play a role in developing depressive symptoms and mood lability during the 
postnatal period (Apari & Rózsa, 2006; Bloch et al., 2003; Soares & Zitek, 2008). Studies have 
shown a relationship between low levels of certain hormones or nutrients and increased instance 
of depression. Evidence from intervention trials also indicates that some symptoms can be 
alleviated when low levels of hormones and nutrients are replenished. In a 1996 study, Gregoire 
and colleagues found that administration of estradiol over a 12 week period significantly 
improved depressive symptoms compared to a placebo in women with postpartum depression. 
Another study investigating the role of female sex steroids in postpartum depression etiology 
included women both with and without a history of postpartum depression. For both groups, 
endogenous gonadal steroid synthesis was suppressed and participants were administered 
estrogen and progesterone over 8 weeks, simulating pregnancy, followed by an abrupt 
withdrawal, simulating parturition. The authors found that 63% of women with a history of 
postpartum depression developed depressive symptoms while none of the controls experienced 
this change (Bloch et al., 2003).  
Other studies have correlated the levels of certain non-steroid hormones with rates of 
postpartum depression. Prolactin, a hormone involved in breast milk production, has been shown 
to be lower in women with postpartum depression. Women who breastfeed have lower rates of 
postpartum depression than those who do not, and because suckling stimulates prolactin 
production, it has been suggested that this hormone may also have a role in the disorder (Abou-
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Saleh et al., 1998). George and Wilson (1983) conducted a study examining endogenous ?-
endorphin and found that low levels postpartum correlate with depression, anxiety, and tension. 
In addition to evidence for a hormonal etiology of postpartum depression, there is some 
evidence for a relationship between nutrient deficiencies and depressive symptoms as well. 
Connections have been made between postpartum depression and decreased iron (Beard et al., 
2005), and low levels of folate and vitamin B12 (Bodnar & Wisner, 2005). Low levels of omega-
3 fatty acids have also been correlated with affective disorders (Parker et al., 2006; Rees et al., 
2005). For example, Hibbeln (2002) compared seafood consumption, DHA (an omega-3 fatty 
acid) levels in mothers’ milk, and rates of postpartum depression in 23 countries and found that 
lower seafood consumption and lower breast milk DHA levels were correlated with higher 
prevalence of postpartum depression. These studies suggest that depleted nutrients postpartum 
may also be related to the development of postpartum affective disorders. 
Because the placenta is known to retain certain hormones and nutrients after its delivery, 
placentophagy advocates suggest this as the ideal way to restore balance to levels of these 
substances postpartum and suggest that the behavior functions to stave off postnatal affective 
disorders, along with a variety of additional benefits. The placenta is known to transfer vitamins 
(Prasad et al., 1998; Smith et al., 1992), minerals (Smith et al., 1992), trace elements (de Moraes 
et al., 2011; Lorenzo Alonso et al., 2005; Smith et al., 1992), and other substances necessary for 
fetal growth such as fatty acids, amino acids, and glucose (Donnelly & Campling 2008; Jones et 
al., 2007; Prasad et al., 1998). The placenta is also responsible for the synthesis and secretion of 
a number of hormones across pregnancy such as progesterone, estrogens, androgens, human 
placental lactogen, human chorionic gonadotropin, placental growth hormone and corticotropin 
releasing hormone, oxytocin, and relaxin (Di Santo et al., 2003; Gude et al., 2004; Guibordenche 
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et al., 2009; Hall et al., 1977; Schmidt et al., 1984; Sugahara et al., 1985; Taylor & Lebovic, 
2007). Many of these substances have been measured in term human placental tissue, leading 
some to argue that the placenta is a viable source of hormones and nutrients needed by the 
recovering postpartum mother. Although questions remain about the ability of these substances 
to survive the temperatures associated with processing placental tissue to be ingested as a 
postpartum supplement, a 2000 study (Phuapradit et al.) evaluated the concentration of 
macronutrients, minerals, amino acids, and hormones in 30 heat dried human placentas (15 
female, 15 male) and found detectable concentrations of each substance reported. Of particular 
interest is the finding that all 4 hormones measured (estradiol, progesterone, testosterone, and 
growth hormone) were detected in these samples (although growth hormone was not detected in 
male placentas), as researchers have expressed doubt that hormones in particular would remain 
after processing (Kristal et al., 2012).   
 
Placentophagy and lactation. In addition to the relief and prevention of postpartum mood 
lability, placentophagy advocates report a number of other benefits attributed to the behavior, 
including improved lactation, improved recovery from childbirth and decreased fatigue 
(Selander, 2009). Despite an abundance of research on the immediate effects of placentophagy in 
rodent models, only a handful of studies have investigated the effects of placentophagy in human 
participants, or the use of placenta derivatives to address certain symptoms experienced by 
human females.  
Research in the early 1900’s conducted by Hammett and McNeile (1917a; 1917b) 
suggests that maternal ingestion of dehydrated placenta, given three times daily in 0.6 gram 
doses, may influence milk quality and infant growth compared to a lack of maternal placenta 
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supplementation, although these finding are not statistically significant (unpublished analysis of 
published results, 2013). In 1954, Soyková-Pachnervá et al., published a study in which women 
who were expected to have difficulty nursing were administered either dehydrated placenta or a 
dehydrated beef placebo within 2 days postpartum. The authors measured breast milk production 
and indicators of breast fullness and found that 86% of the women in the group given placenta 
experienced very good results (determined by increased breast size and milk production) 
compared to 33% of the women in the control group. These results indicate that placenta may 
contain substances that assist in improved lactation. This study, however, was not without flaws, 
as the measures of milk production were rather subjective and the study does not meet the 
standards of scientific rigor expected of clinical studies today.  
 
Placentophagy and fatigue. One other study using human subjects may provide insight into the 
health benefits of placenta. Although not focusing on placental ingestion, researchers in Korea 
conducted a study designed to identify whether Human Placental Extract (HPE) improves 
symptoms related to menopause (Kong et al., 2008). HPE, sold under the name Laennec, has 
been commercially available in Japan since the 1950s and is used to treat cirrhosis of the liver. In 
Korea, it has been available since 2003 and in addition to treating cirrhosis it is used to treat a 
variety of disorders including liver disease, fatigue and menopausal symptoms. Kong et al., 
(2008) conducted a single-blind, placebo-controlled trial in which either HPE or a saline placebo 
was administered subcutaneously to menopausal women across an 8 week span. Well-established 
menopausal and fatigue scales were used to measure improvements in each area, and the 
investigation identified statistically significant improvement in the treatment group compared to 
those who received the placebo, as well as increases in levels of estradiol across the study in the 
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group receiving HPE. This suggests that the placenta may contain properties that improve 
fatigue, one of the claims reported by women who have ingested their placentas.  
The above research collectively suggests a role for hormonal and nutritional deficiencies 
in the etiology of postnatal disturbances in affect as well as other complaints typically reported 
by postpartum mothers. Although ideas about placentophagy initially focused on the behavior as 
a natural part of childbirth, in recent years, advocates claim more specific health benefits related 
to the replenishment of these hormones and nutrients through placentophagy and its role in 
postpartum affect and recovery.    
 
Concerns over Therapeutic Use of Placenta and Maternal Safety 
Although placentophagy has increased in popularity since its emergence in the late 1960s/early 
1970s, and is touted by proponents as a safe and natural behavior that can positively impact the 
maternal postpartum experience, the safety of the practice have not been evaluated. While some 
research has been conducted to evaluate the reported benefits of the practice, as noted previously, 
these studies are few in number and are not without limitations. Additionally, no research to date 
has objectively evaluated the safety of human maternal placentophagy.  
In light of the lack of research and available information about not only the safety of 
placentophagy but also its efficacy, in recent studies both placentophagy researchers and medical 
practitioners have called for scientific investigation of placentophagy that rigorously evaluates 
the efficacy and safety of the practice (Cole, 2014; Coyle et al., 2015; Kristal et al., 2012; 
Marraccini & Gorman, 2015; Selander et al., 2013; Young & Benyshek, 2010; Young et al., 
2012). In addition to a call for research, concerns have been expressed about the potential risks 
associated with placentophagy. Because the placenta functions as a barrier between the mother 
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and fetus during pregnancy, it has been suggested that placentophagy may expose postpartum 
mothers to environmental contaminants and toxins such as heavy metals (Hayes, 2015; Young et 
al., 2012; Young et al., 2016), or other environmental pollutants such as pesticides (Young et al., 
2012), that have been retained by the organ. Marraccini & Gorman (2015) note that there are 
some circumstances where placentophagy may be contraindicated, such as cases where the 
placenta has been affected by meconium or bacterial infection, where mothers smoke, or where 
cord clamping is delayed. They also raise concerns that in cases where women opt for 
placentophagy to prevent or treat postpartum conditions, such as depression or nutritional 
deficiency, that these women may forgo conventional treatment with known efficacy in favor of 
placentophagy whose effects are unknown. Other concerns that have been raised are that 
placentophagy may expose the new mother or encapsulation provider to pathogens present in the 
placental tissue, and the potential for increased risk of the mother developing a 
thromboembolism as a result of increased estrogen provided by the placenta (Hayes, 2015).   
 
Summary 
Given the strong advocacy in support of placentophagy, with a limited amount of available 
research investigating the benefits of this behavior, it is important to evaluate the claims that 
proponents have made in support of this growing practice. Additionally, the risks of the behavior 
remain unknown, with no direct evidence to date to support the safety of this practice for 
mothers or infants. In order to address these gaps in the literature, this dissertations aims to 
address whether placentophagy is effective in improving postpartum affect and recovery, 
whether placentophagy affects postpartum maternal hormone levels, and to identify the hormonal 
and heavy metal content of dehydrated placenta capsules prepared as a postpartum supplement.  
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Chapter 3: Research Questions and Study Design 
 
Study Purpose and Aims  
As discussed in Chapter 2, the practice of human maternal placentophagy appears to have 
emerged in recent years among mothers in industrialized countries, despite the absence of the 
practice as a traditional cultural practice and with little support in the scientific literature for the 
purported positive effects. While a small amount of data has been collected regarding the 
physiological and behavioral effects of placentophagy in animals, research on human 
placentophagy is limited to a handful of experiments in the early and mid-twentieth century, and 
anecdotal evidence (Bastien, 2004; Field, 1985; Hammet & McNeile, 1917b; Janszen, 1980; 
Selander, 2009; Stein, 2009; Young & Benyshek, 2010). This lack of attention given to research 
on placentophagy in the literature is important to address, as the ingestion by a mother of her 
own dehydrated and encapsulated placenta is a seemingly growing practice that is promoted by 
advocates of its health benefits (Selander, 2009; Selander et al., 2013).  
This strong advocacy for the practice coupled with a limited amount of rigorous scientific 
research on the topic has led many placentophagy and maternal health researchers to call for 
research that addresses these claims and evaluates the effects of the practice on maternal 
postpartum affect and recovery (Cole, 2014; Coyle et al., 2015; Marraccini & Gorman, 2015; 
Selander et al., 2013; Young & Benyshek, 2010; Young et al., 2012). Additionally, the growing 
prevalence of the practice combined with a lack of empirical data to evaluate the safety of 
postpartum placenta supplementation raises questions about the content of both beneficial and 
potentially harmful substances that might be retained in processed and encapsulated human 
placenta. 
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The purpose of this dissertation study is to investigate the widely held beliefs of 
supporters that placentophagy improves postpartum affect and maternal boding, and that 
hormones retained by the placenta at parturition may be the mechanism by which these 
improvements occur. This study also aims to address questions by supporters and skeptics alike 
regarding the composition of beneficial hormones and nutrients, and potentially harmful 
environmental metals, in encapsulated placenta supplements, and whether these substances are 
preserved through the process of steaming and dehydrating the organ in preparation for 
encapsulation.  
 
Research Design 
In order to address this lack of research on human maternal placentophagy, a double-blind 
placebo-controlled trial was conducted which addresses the questions of whether the postpartum 
ingestion of a mother’s own dehydrated and encapsulated placenta can improve postpartum 
mood and recovery, whether hormonal or nutritional biomarkers are correlated with postpartum 
psychometric changes, and to examine the hormonal and nutritional composition of human 
placenta capsules.  
Participants in this study included postpartum women who had decided they would ingest 
their placenta after birth. Study participants were given either their own dehydrated and 
encapsulated placenta or a placebo supplement to take during the immediate postpartum period. 
Biological samples and psychometric data were collected in order to identify whether the women 
who ingested their placenta experienced positive changes in mood and improved recovery in 
relation to the control (placebo) group, and whether changes in the concentration of certain 
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hormones were correlated with any psychological or emotional changes perceived by the 
participants. 
The randomized, double-blind, placebo-controlled design was selected as it provides a 
way to evaluate the effects of postpartum supplementation with placenta capsules and evaluate 
whether the claims that there are benefits to placentophagy could be the result of a placebo 
effect. Because the participants in this study constitute a self-selected sample of women who had 
already decided to ingest placenta supplements postpartum, they presumably hold some degree 
of belief that the practice is beneficial at best, and neutral at worst. Given this sample, it is 
essential to include a control group who receives a placebo supplement in order to ensure that 
any positive effects experienced by participants in the experimental group include improvements 
beyond those experienced by participants in the control group. In order to reduce the possibility 
that the perceived effects of supplementation during the study are influenced by the participants’ 
knowledge of which supplement they are taking, a double-blind, randomized protocol was 
employed. This ensures that neither the participant nor the research team members who 
interacted with the participant throughout the study had prior knowledge of the participant’s 
group assignment, and therefore could not consciously or unconsciously influence the perceived 
effects of the participant throughout the study.  
 
Research Site 
All data were collected in Las Vegas, Nevada and surrounding cities in the Las Vegas area (the 
cities of Henderson and North Las Vegas, Nevada). Human maternal placentophagy has gained 
popularity among a sizeable group of women in the Las Vegas area, and the city is also home to 
the internet-based company, Placenta Benefits, LTD (PBi), which provides encapsulation 
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services, training for providers of this service, and information and resources for postpartum 
women. These factors make Las Vegas an ideal location to conduct placentophagy research and 
this facilitated the recruitment of women who were interested in this service.  
 
Research Questions 
In order to investigate the purported benefits and physiological effects of placentophagy, whether 
nutrients and hormones are retained in encapsulated placental tissue, and the potential risks of 
the practice due to environmental contamination of placenta capsules, this dissertation addresses 
the following research questions: 
1) Does placentophagy, in the form of dehydrated capsules, improve postpartum affect, 
energy and recovery in comparison to a vegetarian or beef placebo supplement? 
2) Are there differences within and between the experimental and control groups (receiving 
placenta and placebo supplements, respectively) in concentration of salivary and plasma 
hormones and micronutrients across meetings, and are hormone and micronutrient levels 
correlated to measures of postpartum affect, energy and recovery? 
3) What is the concentration of select hormones, micronutrients, and environmental metals 
in dehydrated and encapsulated human placenta?  
 
Summary 
This dissertation aims to address the limited data and scientific literature on the benefits of 
placentophagy for postpartum mothers, and answers the call of researchers for rigorous scientific 
evaluation of the claims of placentophagy supporters. It also aims to identify the hormonal, 
nutritional, and environmental metal content of processed placenta supplements that have been 
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steamed, dehydrated, pulverized, and encapsulated for ingestion. The study does this through a 
randomized, double-blind, placebo-controlled design, which compares the physiological and 
psychometric effects of placenta capsule supplements in comparison to a placebo supplement. 
The methods of data collection and analysis are described in detail in Chapter 4.  
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Chapter 4: Methods 
 
This chapter provides a detailed description of the methodology employed in this research study. 
This includes information about participant recruitment and inclusion criteria, meeting schedule, 
data and sample collection procedures, supplement preparation and dosing, and randomization 
and blinding procedures. The assessment tools utilized in this study are also described here. 
 
Participant Recruitment 
One area where placentophagy has flourished among a sizeable group of women is Las Vegas, 
Nevada. The Las Vegas based organization, Placenta Benefits, LTD (PBi), offers encapsulation 
services to mothers who wish to ingest their placenta, and provides a source of information and 
support network for these women (PlacentaBenefits.info). According to Jodi Selander, 
encapsulation provider and founder of PBi, she processes approximately 120 placentas annually 
for clients, and over 1,000 women have accessed encapsulation services in the Las Vegas area 
through her organization alone since 2006, with many who claim to have experienced substantial 
benefits (personal communication with Jodi Selander, 2016).  
Participants were recruited through PBi founder, Jodi Selander, via word of mouth, 
advertisement on the PBi blog and social networking websites, and through Selander’s 
connections with area midwives and physicians. Additional participants were recruited through 
word of mouth by women who had previously participated in the study and by midwives and 
physicians of previous participants.  
Healthy women over the age of 18 who were experiencing a normal pregnancy with no 
anticipated complications, and who had decided to ingest their placenta postpartum were 
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recruited for this study. Participants were not encouraged to engage in placentophagy during the 
course of recruitment, and the decision to engage in this behavior was made by all participants 
prior to enrollment in the study. Women who used drugs or drank alcohol at the time of 
enrollment, or who smoked cigarettes during pregnancy, were excluded from participating. 
Participants who had a chronic health condition or who were taking medication during 
pregnancy were asked to consult their medical practitioner regarding the safety of taking 
placenta capsules during the postpartum period. In order to participate in the study, they were 
asked to submit a form indicating that they had consulted their medical practitioner about 
placentophagy, and that their medical practitioner had not advised them against postpartum 
placenta supplementation. Participants who met the inclusion criteria for the study scheduled an 
initial meeting with a team of two research team members during the 36th week of pregnancy 
where they completed a background questionnaire with screening criteria. Participants who met 
the screening criteria were enrolled in the study.  
 
Data Collection 
A team of two graduate and four undergraduate student researchers assisted the author and co-
investigator Laura Gryder in meeting with participants, collecting demographic and 
psychometric data and biological samples, and entering and reviewing participant data in the 
study database. All student researchers were trained by the author in the study protocol and 
completed the required university training, including: Biomedical components of the 
Collaborative Institutional Training Initiative (CITI) for research with human subjects, Biosafety 
training, Bloodborne Pathogens training, Chemical Hygiene training, and Department of 
Transportation Infectious Substance Transportation training (this course was completed only by 
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research team members who were responsible for sample transportation). Placenta encapsulation 
was performed by certified encapsulation providers trained in the Placenta Benefits proprietary 
encapsulation method. Placenta encapsulation providers also completed the Biomedical 
components of the CITI training program, and were trained for their role in the study protocol by 
the author. In order to prevent potential participant discomfort and possible effects on hormone 
measures, all research team members for this study were female.  
Participation in the study occurred across four meetings with each participant from late 
pregnancy to the early postpartum period. Two female research team members were present at 
each meeting, which included questionnaire administration and biological sample collection. All 
meetings occurred either in the residence of the participant or at UNLV, at the discretion of the 
participant. This venue was flexible in order to accommodate the schedule and comfort of the 
participant. These meetings were typically scheduled to start between 8:00 – 11:00 am, however, 
in a handful of cases, meetings were scheduled either in the afternoon or evening in order to 
accommodate unforeseen scheduling constraints of the participant. Morning meetings were 
scheduled in order to reduce variation in results due to circadian fluctuations in hormonal 
concentration and the influence of daily events in psychometric questionnaire responses. 
Although participants were not asked to refrain from these behaviors, the time of last 
breastfeeding and last contact with the infant were recorded at each postpartum meeting, as these 
actions are known to elicit hormonal responses in the mother and could affect prolactin measures 
in this study.  
 
Meeting Schedule  
The first meeting occurred during the 36th week of pregnancy. This timeframe was selected in 
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order to gain a late pregnancy baseline for psychometric and biological measures at a time that 
also accommodates the somewhat unpredictable timing of birth. A pregnancy measurement is 
important to collect in order to control for psychometric and biological variables, as pregnancy 
measures for many variables are related to or can predict many of the postpartum outcomes (e.g., 
depression, anxiety, attachment, hormonal measures, etc.).  At this first meeting, a research team 
member reviewed the Informed Consent form and answered participant questions. The 
participant then completed a background questionnaire which collected basic demographic 
information, reproductive history, and screened for inclusion and exclusion criteria. Participants 
who met the inclusion criteria were given two questionnaires in order to evaluate a number of 
psychometric, social, and lifestyle variables. They also provided samples of saliva, urine, and 
blood at this meeting. Participants were given a copy of the Informed Consent form, and a 
postpartum resource sheet with information about local and online support groups and 
organizations.  
 The second meeting occurred between days 1 and 4 postpartum (within 96 hours of 
parturition). While a 48 hour postpartum timeframe is ideal for this measure, a 96 hour time 
window was selected because it allows for a postpartum baseline to be established for 
psychometric and biological measures while providing flexibility to meet with participants who 
gave birth in a hospital and had varying timeframes for postpartum release. At this meeting, the 
two questionnaires given at the initial meeting were administered, the length and weight of the 
neonate were measured, and samples of saliva, urine, blood, and PBi-processed placenta samples 
were collected. The placenta was prepared by the encapsulation provider during this early 
postpartum period and the participant was given a jar of capsules containing either her own 
dehydrated placenta or a placebo supplement to be taken during the remainder of the study. 
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Participants were instructed to begin taking their capsules after this meeting so that the data 
collected at this time was reflective of their baseline postpartum experiences and unaffected by 
the capsules.  
 The third meeting occurred between days 5 and 7 postpartum (120-168 hours 
postpartum). This timeframe was selected to provide an early measure of psychometric and 
biological markers once capsule supplementation had begun. Research also suggests that 
postpartum blues and negative affect peak around the fifth day postpartum (Buttner et al., 2015; 
O’Hara & Wisner, 2014) making this an important point in the postpartum timeline for 
investigating possible effects of placenta supplementation on postpartum affect. Because the 
prevention and relief of postpartum depression and blues is the primary benefit claimed by 
placentophagy advocates (Selander, 2009; Selander et al., 2013), this is an important aspect of 
postpartum recovery to address in this study, and was considered in the selection for this data 
collection time-point. At this meeting, the two questionnaires given during the first two meetings 
were administered, length and weight of the neonate were measured, and samples of saliva, 
urine, and blood were collected. Additionally, participants were asked to complete the Willett 
Food Frequency Questionnaire (Willett et al., 1985) in order to evaluate dietary iron intake.  
 The final meeting was held during the third week postpartum, which for this study, was 
considered to occur between days 21 and 27 postpartum. This timeframe was selected because 
the approximate duration of placenta supplementation recommended by Jodi Selander of 
Placenta Benefit, LTD (personal communication, 2011) is 3 weeks postpartum. Data collected 
during the third postpartum week provided a final measure of psychometric and biological 
markers after an extended course of supplementation, representative of a typical recommended 
duration. At this meeting, the two questionnaires from the previous meetings were administered, 
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length and weight of the neonate were measured, and samples of saliva, urine, blood, and hair 
were collected. At the conclusion of the meeting, participants were informed of their group 
assignment and debriefed, and those who were assigned to the control group were given a jar 
containing their placenta capsules. For an overview of samples and data collected at each 
meeting, see Table 4.1. 
 
Questionnaires 
The background questionnaire which was administered at the first meeting during pregnancy 
week 36 was administered to collect demographic information, reproductive history, and to 
evaluate the screening criteria (see Appendix A). Additionally, information about diet, 
supplement intake, and medications was collected. Although nutritional supplements and 
medication use could affect the measures addressed in this study, because many women take 
prenatal nutritional supplements or medication during pregnancy and postpartum at the 
recommendation of their health care provider, women who were taking these substances were 
not excluded from the study, however, information about supplements and medications being 
taken was recorded at each meeting. 
The assessment tools used in this study were selected based on the claims made by 
placentophagy advocates of the postpartum benefits of the practice (see Selander, 2009; Young 
& Benyshek, 2010), as well as the most frequently reported perceived effects of postpartum 
placenta ingestion as reported in a 2013 internet survey (Selander et al., 2013). Potential 
confounding variables that could impact these measures were also included in the questionnaires 
(e.g., sleep quality, relationship satisfaction, social support, etc.), and measures were taken 
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during pregnancy in order to control for the effects of these variables during pregnancy on 
postpartum measures.  
 
Table 4.1  
Data Collected at each Meeting 
Time Point Biological samples Collected Psychometric Data Collected 
Week 36 Gestation Blood 
Saliva 
Urine 
Demographic information 
Mood 
Anxiety 
Stress 
Sleep quality 
Fatigue/Energy 
Marital/relationship satisfaction 
Maternal-fetal attachment 
Social Support 
96 Hours Postpartum 
(Supplement administered after 
data collection) 
Blood 
Saliva 
Urine 
Placenta 
Demographic information 
Mood  
Anxiety 
Stress 
Sleep quality 
Fatigue/Energy 
Marital/relationship satisfaction 
Mother-infant bonding 
Social support 
Experiences with breastfeeding 
Day 5-7 Postpartum  
(120 – 168 hours postpartum) 
Blood  
Saliva 
Urine 
Demographic information 
Mood  
Anxiety 
Stress 
Sleep quality 
Fatigue/Energy 
Marital/relationship satisfaction 
Mother-infant bonding 
Social support 
Experiences with breastfeeding 
Experiences with supplement 
Week 3 Postpartum Blood 
Saliva 
Urine 
Hair  
Demographic information 
Mood  
Anxiety 
Stress 
Sleep quality 
Fatigue/Energy 
Marital/relationship satisfaction 
Mother-infant bonding 
Social support 
Experiences with breastfeeding 
Experiences with supplement 
49 
Two questionnaires were administered at each participant meeting. One questionnaire 
was comprised of assessment tools that are available in the published literature and have been 
previously used in populations of pregnant and postpartum women, as well as additional 
questions added by the author that were specifically designed to address the study aims. The 
questionnaires assess mood using the Edinburgh postnatal depression scale (EPDS), a well 
validated tool for assessing postpartum depression risk (Cox et al., 1987), the Kennerley Blues 
Questionnaire which evaluates the “baby blues” (Kennerley & Gath, 1989), and the Depression 
Anxiety Stress Subscale (Lovibond & Lovibond, 1995). Anxiety was assessed using the 
Depression Anxiety Stress Subscale (Lovibond & Lovibond 1995).  Sleep quality was evaluated 
using the Pittsburgh Sleep Quality Index (Buysse et al., 1989), and fatigue and energy through 
the Fatigue Assessment Scale (Michielsen et al., 2004). A slightly modified version of the 
Kansas Marital Satisfaction Scale was included to measure relationship satisfaction (Schumm et 
al., 1983) (the word “spouse” was modified to “partner” in order to accommodate participants 
who were in a relationship but not married to their partner). Social support was measured using 
the Multidimensional Scale of Perceived Social Support which evaluates 3 areas of support: 
significant other, friends, and family (Zimet et al., 1988). On the questionnaire administered 
during pregnancy, maternal-fetal attachment was measured using the Prenatal Attachment 
Inventory (Muller & Mercer, 1993) and during the postpartum meetings, maternal bonding to her 
infant was measured with the Mother-to-Infant Bonding Scale (Taylor et al., 2005). Additional 
questions were included in the questionnaires administered at the second, third, and fourth 
meetings which were designed to evaluate perceived changes in the items commonly identified 
by placentophagy supporters as being positively affected by the practice, including: energy, 
anxiety, stress, strength, sleep quality, libido, attachment to the infant, overall health, mood, 
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breast milk quality and quantity, postpartum bleeding, overall postpartum recovery, and an open-
ended question asking if any other changes had been experienced since the last meeting. The 
questionnaires administered during the third and fourth meetings (the two meetings after 
supplementation had begun) also asked whether the participant attributed the above changes to 
the supplement they were receiving during the study, and asked whether they believed they were 
taking placenta or placebo capsules and asked them to explain why (see Appendices B-D for 
questionnaires). 
The Symptom Checklist-90-Revised (SCL-90R) (Pearson Education, Inc.) was purchased 
with permission from Pearson Education, Inc. and is composed of 90 questions that ask the 
participant to rate their level of psychological distress in various categories. It takes 
approximately 10-15 minutes to complete, measuring nine dimensions of psychiatric symptoms 
including somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, 
hostility, phobic anxiety, paranoid ideation, and psychoticism. The SCL-90-R was administered 
at each meeting in addition to the previously described questionnaire in order to provide a 
sensitive measure for psychological changes between meetings.  
 
Biological Sample Collection 
Samples of blood, saliva, urine, hair and placenta were collected during the course of the study. 
Saliva, urine and blood were collected at all 4 meetings, placenta samples were collected at the 
second meeting, and a hair sample was collected at the final meeting. All samples were placed on 
ice in a cooler immediately upon collection and were transferred to a freezer at UNLV for long-
term storage at -40˚C awaiting analysis. 
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Approximately 2 mL of saliva was collected through unstimulated passive drool into 
polypropylene cryovials. Participants were asked to refrain from eating a meal or brushing their 
teeth for 1 hour and from drinking water for 10 minutes prior to saliva collection to prevent 
contamination and dilution of cortisol in the samples. Where possible, saliva was collected prior 
to completing the questionnaires and blood sample collection due to the possible effects of stress 
from responding to sensitive questions and from the finger stick required for the blood draw. 
Samples were frozen in the cryovials without additives and were stored between1-14 months 
prior to analysis.  
Approximately 20 mL of urine was collected by the participant into sterile urine 
specimen cups. Urine samples were transferred to polypropylene centrifuge tubes and were 
stored frozen without additives between 1-14 months prior to analysis. 
Approximately 600 μL of whole blood was collected through finger stick capillary blood 
collection into a polypropylene lithium heparin Multivette collection tube. Samples were 
centrifuged for 5 minutes at 2,000 x g and 20°C to extract plasma. The plasma was transferred to 
a microcentrifuge tube and stored frozen without additives between 1-14 months prior to 
analysis. 
 
Supplement Preparation and Storage 
Placebo capsules were prepared by the author at UNLV in accordance with Clark County food 
preparation standards, and prior to distribution to participants, capsules were stored at -20˚C in a 
locked freezer at UNLV. Lean organic beef was used to create the meat-based placebo capsules 
and Quorn brand soy-free vegetarian crumbled beef substitute was used to create the vegetarian 
placebo capsules. Organic beef was selected due to its visual similarity to placenta and in order 
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to reduce the potential for the introduction of hormones through the supplement. Quorn brand 
soy-free vegetarian crumbled beef substitute was selected as the vegetarian option for the 
placebo capsules due to its visual similarity to placenta, and in order to reduce the potential of 
introducing phytoestrogens that might be present in soy-based meat alternatives.  
Selander or one of her two assistants, Marcie Webb and Romina Lizaso, prepared the 
placenta capsules for this study in the participants’ homes using the Placenta Benefits proprietary 
procedure and in accordance with OSHA and EPA regulations. In the case of home births, the 
placenta was refrigerated in the participant’s home prior to processing, and for hospital births, 
the placenta was typically frozen on site and transferred to the participant’s home where it was 
thawed prior to processing. Each placenta was rinsed, stripped of membranes, steamed with a 
PlacentaBenefits LTD proprietary blend of herbs, dehydrated and pulverized prior to 
encapsulation. Upon completion of the encapsulation process, the placenta capsules were placed 
into a jar supplied to the encapsulation provider by the author that was identical to that of the 
placebo capsules. Capsules that were not immediately given to the participants (i.e., capsules 
belonging to control group participants) were stored at -20˚C in a locked freezer at UNLV until 
they were returned to the appropriate participant.  
 
Group Assignment and Blinding Procedures 
Group assignment was randomly selected using an internet-based randomization generator and 
each participant’s group assignment was sealed in an envelope labeled with their ID number. 
Group assignment envelopes were created to accommodate 60 participants prior to the 
commencement of data collection by the dissertation committee chair who had no role in data 
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collection or interaction with enrolled study participants, and who retained a master list of all 
participant group assignments.  
In order to ensure that both the participants and research team members were blinded to 
each participant’s group assignment during data collection, once the placenta had been processed 
the placenta encapsulation provider reviewed the dosage instructions for the capsules with the 
participant. Once the dosage instructions had been reviewed and the encapsulation provider had 
answered any questions the participant had, the provider was instructed to privately open a 
sealed envelope containing the group assignment for the participant, and to leave the appropriate 
jar of capsules for the participant. Once the group assignment had been revealed to the 
encapsulation professional, she had no direct contact with the participant thereafter. After the 
envelope containing the group assignment had been opened, the card listing the assignment was 
placed into a new envelope labeled with the participant ID number that she then sealed and 
placed into a Ziploc-type bag with the jar of capsules that was not left for the participant. This jar 
of capsules was sealed with a label that was marked with a unique alphanumeric ID code that the 
participant could easily recognize (i.e., the two digit date of her baby’s birth, followed by the 
first two letters of her street name, and ending with the last two digits of her phone number). This 
was done for easy verification upon return of the placenta capsules to control group participants 
at the end of the study. The Ziploc-type bag containing the group assignment envelope and jar of 
capsules was given to the author by the encapsulation provider to be transported to UNLV where 
it was stored in a locked freezer at -40˚C. For participants in the control group, the jar of their 
placenta capsules was returned to them at the end of the final meeting following the debriefing.  
 
Dosage Instructions 
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Dosage instructions were given by a member of the research team during the second meeting, 
and by the encapsulation professional after the capsules were prepared, and were also written on 
the supplement jar label. Participants were instructed to ingest two capsules (approximately 550 
mg per capsule) three times daily for the first 5 days in which capsules were taken 
(approximately the first week postpartum), two capsules twice daily from days 6 through 12, and 
two  capsules once daily from days 13 through completion of their participation in the study 
(approximately day 21). Ingestion of the supplements was the only aspect of their nutritional 
intake or behavior that participants were asked to alter for the study. 
 
Participant Compensation 
At the conclusion of participation, participants were given a gift card of their choice for either 
Target or Whole Foods in the amount of $80 ($20 per meeting session of participation). 
Additionally, upon completion of the third meeting, participants were provided with their choice 
of one of the following services: home cleaning service, meal delivery, or grocery delivery. 
Placenta encapsulation services were provided free of charge as a part of this study ($250). 
Participants who withdrew from the study were compensated on a prorated basis that 
corresponded to the point at which they withdrew. Participants who withdrew after the first 
meeting were compensated with a $20 gift card, and the participant who withdrew after the third 
meeting was compensated with a $60 gift card, the service she had chosen at the third meeting, 
and her placenta capsules were provided to her. The total value of participant compensation was 
approximately $425 per participant at the conclusion of the study.  
 
IRB Approval and Conflict of Interest 
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All study procedures were approved by the UNLV Institutional Review Board and the 
Institutional Biosafety Committee prior to initiation of the project. All participants were recruited 
through Jodi Selander and word of mouth through her network of local midwives and physicians, 
and those receiving supplements were limited to women who had already decided to practice 
placentophagy prior to enrollment in the study. No individuals who had not otherwise decided to 
ingest their placenta postpartum were asked or encouraged to do so in order to participate in any 
part of the study. As a placentophagy advocate and encapsulation provider, Jodi Selander’s 
services were employed in recruitment and for placenta encapsulation services, and Selander and 
her assistants were compensated at the retail rate for encapsulation services. Once the placenta 
encapsulation provider had been exposed to the group assignment for each participant, they 
ceased communication with the participant until the conclusion of their participation in the study, 
at which point, all data for the participant had been collected and her group assignment had been 
disclosed. Selander had no role in data collection or analysis. Data collection and entry was 
performed by Sharon Young and Laura Gryder with the assistance of research assistants Tiffany 
Alvarez, Jacqueline Casey, Elizabeth Chang, Winnie David, Kristen Herlosky, Heidi Manlove, 
Namritha Manoharan, and Caitlin Roske, and data analysis was performed by Sharon Young and 
Laura Gryder with the assistance of biostatistics consultant, Chad Cross. None of the research 
team members involved in the project design, data collection, or data analysis have any personal 
or financial conflict of interest that may have influenced the outcome of this study.  
 
Data Analysis 
Questionnaire scoring. Psychometric questionnaires were scored according to the 
instructions for each individual assessment instrument that comprised the questionnaire. A 
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spreadsheet was designed by the author to calculate scores for the individual assessment 
instruments, and all participant questionnaire responses were entered into this spreadsheet. The 
formulas in the spreadsheet were checked for errors by co-investigator Laura Gryder, and 
research assistant Winnie David, and all participant responses that were entered into the 
spreadsheet were checked for data entry errors by research assistant Kristen Herlosky. 
The Willett Food Frequency Questionnaire was scored by Laura Gryder in order to assess 
iron intake across the year prior to completion of the questionnaire. Participants’ dietary iron 
intake was categorized as either adequate, below the recommended dietary intake, or greater than 
the recommended dietary intake for pregnant and lactating women, per WHO guidelines. For a 
detailed description of Willett Food Frequency Questionnaire evaluation in this study, see 
Gryder, 2015.  
 
Analysis of plasma samples. Plasma samples were shipped overnight on dry ice to ZRT 
Laboratories (Beaverton, OR) for analysis of prolactin, transferrin, and ferritin using enzyme-
linked immunosorbent assay analysis (ELISA).  
 
Analysis of saliva samples. Saliva samples were shipped overnight on dry ice to ZRT 
Laboratories (Beaverton, OR) for analysis of 17 hormones: 11-deoxycortisol, 17-
hydroxyprogesterone, 7-ketodehydroepiandrosterone, aldosterone, allopregnanolone, 
androstenedione, corticosterone, cortisol, cortisone, dehydroepiandrosterone (DHEA), 5-alpha-
dihydrotestosterone (DHT), estradiol, estriol, estrone, melatonin, progesterone, and testosterone 
using used liquid chromatography tandem-mass spectrometry (LC-MS/MS). For a detailed 
description of saliva sample analysis, see McHale et al., (2015). Table 4.2 includes the lower 
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limit of quantification (LLOQ), range, and precision for each salivary anlayte (table courtesy of 
David Zava and David Kimball, ZRT Laboratory).   
 
Analysis of dehydrated placenta samples. Samples of dehydrated placenta prepared for 
encapsulation were analyzed to determine the concentrations of hormones, micronutrients, and 
environmental metals.  
  
Hormonal analysis. Approximately 1000 mg of dehydrated placenta sample from each 
participant was shipped overnight on dry ice to ZRT Laboratories (Beaverton, OR) for analysis 
of 17 hormones: 11-deoxycortisol, 17-hydroxyprogesterone, 7-ketodehydroepiandrosterone, 
aldosterone, allopregnanolone, androstenedione, corticosterone, cortisol, cortisone, DHEA, 
DHT, estradiol, estriol, estrone, melatonin, progesterone, and testosterone, using LC-MS/MS 
analysis. Samples of approximately 1000 mg each from 3 different batches of beef placebo and 3 
different batches of vegetarian placebo were also shipped on ice to ZRT Laboratories 
(Beaverton, OR) for analysis. Placebo samples were analyzed using the same procedure as the 
placenta samples for the 17 hormones listed above using. For a detailed description of placenta 
and placebo sample analysis methods, see Young et al., (2016a).  
 
Micronutrient and trace element analysis. Approximately 500 mg of dehydrated 
placenta sample from each participant was further pulverized using a diamonite mortar and 
pestle and analyzed using Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) analysis in 
the UNLV Geosciences Department Environmental Soil Analysis Laboratory. For a detailed 
description of the digestion and analysis procedure, see Young et al., (2016b). One sample 
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Table 4.2  
QA measures for salivary analytes 
Analyte LLOQ Range Precision 
Estrone (pg/mL) 0.4 0.4 - 510 8.7 - 13.7% 
Estradiol (pg/mL) 0.2 0.2 – 540 4.3 - 18.7% 
Estriol (pg/mL) 0.8 0.8 - 2100 2.9 - 18.9% 
Testosterone (pg/mL) 3.0 3.0 - 5100 3.0 - 18.1% 
Androstenedione (pg/mL) 5.0 5.0 - 2300 5.2 – 10.9% 
DHEA (pg/mL) 20.0 20.0 - 1900 4.1 - 15.2% 
DHT (pg/mL) 10.0 10.0 - 920 3.6 - 17.7% 
Progesterone (pg/mL) 5.0 5.0 - 10000 4.8 - 10.8% 
17OH-Progesterone (pg/mL) 5.0 5.0 - 630 3.9 - 13.8% 
11-Deoxycortisol (pg/mL) 5.0 5.0 - 410 6.8 - 16.6% 
Cortisol (ng/mL) 0.1 0.1 - 52 5.1 - 17.9% 
Cortisone (ng/mL) 0.1 0.1 - 81 4.1 - 14.9% 
Corticosterone (pg/mL) 5.0 5.0 - 1800 4.6 - 17.5% 
Aldosterone (pg/mL) 10.0 10.0 - 560 8.9 - 18.8% 
Melatonin (pg/mL) 2.0 2.0 - 10000 5.2 - 15.9% 
7-keto DHEA (pg/mL) 50.0 50 - 4700 6.9 - 19.7% 
Allopregnanolone (pg/mL) 10.0 10 - 2500 4.1 – 18.3% 
 
each of approximately 500 mg of beef and vegetarian placebo were also processed and analyzed 
as described above. Placenta and placebo samples were analyzed to identify concentrations of 
arsenic (As), cadmium (Cd), cobalt (Co), copper (Cu), iron (Fe), lead (Pb), manganese (Mn), 
mercury (Hg), molybdenum (Mo), rubidium (Rb), selenium (Se), strontium (Sr), uranium (U), 
and zinc (Zn).  
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Statistical analysis. All statistical analyses were conducted using SPSS version 19 
statistical analysis software (IBM). In cases where data points were missing, the value from the 
participant’s previous meeting for that measure was carried forward to fill in the missing value. 
All continuous data were analyzed using the Shapiro-Wilk statistic, and data that were not 
normally distributed were log transformed prior to analysis. Demographic variables were 
compared between groups using a t-test of independence for interval data, or a Chi-Square test of 
independence for ranked data, to identify differences between the treatment and control groups in 
these variables. 
Scores for selected psychometric assessment tools were analyzed using repeated-
measures ANOVA to identify changes both within participants and between the treatment and 
control groups across the postpartum period. The assessment tools reported here were selected 
because they represent a subset of the aspects of the postpartum period that are most often 
claimed by placentophagy advocates to be positively affected by placenta supplementation: 
postnatal depression, postpartum blues, overall affect, maternal attachment/bonding to the infant, 
and energy (fatigue). Measures of relationship satisfaction, sleep quality, and social support were 
also included in this analysis, as they are known to influence mood and affect. An alpha of 0.05 
was assumed for all tests. 
 Concentrations of select hormones were analyzed using repeated-measures ANOVA to 
identify changes both within participants and between the treatment and control groups across 
the postpartum period. The hormones addressed here include prolactin, estradiol, progesterone, 
17-hydroxyprogesterone, cortisol, testosterone, and melatonin. These analytes were selected 
based on their relationship to mood disturbances (e.g., sex steroid hormones, prolactin), lactation 
(e.g., prolactin, progesterone), energy (e.g., estradiol, progesterone), stress (e.g., cortisol), and 
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other areas of recovery that are claimed by placentophagy advocates to benefit from the practice. 
Pearson’s r correlation analysis was used to identify relationships between these hormones and 
psychometric measures.  
The concentration of 14 environmental metals and micronutrients, and 18 hormones in 
samples of participants’ dehydrated placenta prepared for encapsulation were included in this 
analysis. Pearson’s r correlation analysis was used to identify relationships between the 
concentration of hormones in the placenta samples and salivary and plasma hormone measures 
for participants in both the treatment and control groups. With the exception of iron, the 
environmental metals and micronutrients were not determined in the saliva or plasma samples 
and therefore, participant measures of these substances were not able to be compared to the 
concentrations in the placenta samples. The concentration of hormones and environmental metals 
was also determined in samples of the beef and vegetarian placebo supplements, and these 
concentrations were compared to salivary measures of these hormones in control participants to 
identify relationships between placebo supplements and salivary hormone and plasma iron 
measures.  
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Chapter 5: Results 
 
Overview  
This chapter presents the results of the analyses described in Chapter 4. The chapter begins with 
an overview of demographic characteristics and reproductive history of the participants in each 
group, and a comparison of demographic and reproductive differences between groups. The first 
research question, which addresses whether placentophagy, in the form of dehydrated capsules, 
improves postpartum affect, energy and recovery, is addressed by comparing changes in 
psychometric variables across time, and between groups. The second research question, which 
addresses whether there are differences in salivary and plasma hormone levels within and 
between participant groups, and whether hormone levels are correlated to changes in postpartum 
affect, energy and recovery, is addressed by evaluating changes in hormone concentration across 
time and between groups, and by identifying correlations between biological analytes and 
psychometric variables. This section also addresses relationships between concentrations of 
hormones in each participant’s dehydrated placenta capsule contents and plasma/salivary 
measures of the same hormone at each postpartum time point. Finally, the third research question 
which addresses the concentration of select hormones, micronutrients, and environmental metals 
in dehydrated and encapsulated human placenta, is answered in this sample by reporting the 
content of these substances in samples of dehydrated and encapsulated placenta collected from 
each participant.  
 
Demographic, Reproductive, and Birth Characteristics 
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Thirty-five women met the inclusion criteria for enrollment in the study and completed the first 
meeting during the 36th week of pregnancy (16 were assigned to the treatment group, and 19 
were assigned to the control group). Of these, nine participants withdrew or were excluded from 
the study (4 from the treatment group, and 5 from the control group), six after the first meeting (4 
treatment group, 2 control group), one after the third meeting (control group), and two after 
completing the study (control group). In three instances the participant unavailable for the second 
meeting with the research team; one was released from the hospital more than 96 hours after 
birth (control group), one participant’s placenta was released from the hospital more than 96 
hours after birth (treatment group), and one participant’s newborn was in the Neonatal Intensive 
Care Unit and she opted to withdraw from the study to stay with her daughter in the hospital 
(treatment group). In one instance the placenta was mistakenly discarded by the hospital and 
therefore unavailable for encapsulation (control group), in another case, the participant withdrew 
from the study after the first meeting due to feeling overwhelmed after the birth of her child 
(placenta group), and one participant withdrew from the study after the first meeting for 
undisclosed reasons (treatment group). The participant who withdrew from the study after the 
third meeting reported that she did so because she was experiencing mood swings and had 
concerns about her milk production (control group). Of the two participants who were excluded 
after completing the study, one was excluded due to receiving both placebo and placenta 
capsules during the study, making it impossible to evaluate whether her experiences were related 
to receiving the placenta or placebo supplement control group). The other participant was 
excluded because she was taking antidepressant medication during pregnancy and throughout the 
study period (control group). The remaining 26 participants completed the study, and including 
the participant who withdrew after the third meeting, the total number of participants who are 
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included in this analysis is 27, with 12 in the treatment (placenta) group and 15 in the control 
(placebo) group.  
 The mean participant age during the initial meeting in the 36th week of pregnancy was 
29.7 years (SD = 4.39), ranging from 21 to 38 years of age. The majority of women in the 
sample reported a household income over $50,000 (N = 16, 57.1%), with a median of $50,001 - 
$60,000 annually (n=15, 55.6%). This is approximately the same as the 2014 median household 
income in both Clark County, Nevada ($52,070), and the US ($53,482) according to the US 
Census Bureau (2015). The majority of participants identified as Caucasian (n=22; 78.6%), 4 
(14.8%) identified as Hispanic/Latina, and 1 (3.7%) identified as both American Indian/Alaska 
Native and Caucasian. Twenty-six of the participants (96.3%) reported that they were in a 
relationship with the father of their child that was born during the course of the study, and one 
reported that she was friends with the father of her child (3.7%). See table 5.1 for an overview of 
participant demographic characteristics. 
All participants reported taking a nutritional supplement of some type during pregnancy, 
and 25 (92.6%) reported taking a prenatal or multivitamin. Three (11.1%) participants reported 
consuming a specialized diet during pregnancy; two vegetarian / mostly vegetarian / vegan, and 
one mostly vegan and gluten free (a modified “Paleolithic Diet”). Dietary iron intake was 
evaluated using the Willett Food Frequency Questionnaire, which revealed that all participants 
were ingesting an adequate amount of dietary iron during pregnancy per the FDA guidelines for 
pregnant and postpartum women (see Gryder 2015 for a discussion of Willett Food Frequency 
scoring and analysis). 
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At the time of enrollment, the majority of participants in this sample were pregnant with 
their first child (n=15, 55.6%), although only 11 (40.7%) reported that this was their first 
pregnancy. Six reported one prior live birth (22.2%), 3 reported 2 previous births (11.1%), and 3 
reported 3 prior births (11.1%). The mean number of live births for participants in the treatment 
Table 5.1  
Participant Demographic Characteristics 
 
Treatment 
Group (N=12) 
Control Group 
(N=15) 
Total 
(N=27) 
Mean Age (years)* 32.1 ± 3.40 27.7 ± 4.20 29.7 ± 4.39 
Education     
Vocational/Technical School 0 1 (6.7%) 1 (3.7%) 
Some College 4 (33.3%) 7 (46.7%) 11 (40.7%) 
Bachelor's Degree 5 (41.7%) 3 (20%) 8 (29.6%) 
Master's Degree 2 (16.7%) 4 (26.7%) 6 (22.2%) 
Doctoral Degree 1 (8.3%) 0 (0%) 1 (3.7%) 
Ethnicity  (0%) (0%) (0%) 
American Indian/Alaska 
Native & Caucasian 
0 1 (6.7%) 1 (3.7%) 
Caucasian 11 (91.7%) 11 (73.3%) 22 (81.5%) 
Hispanic/Latina 1 (8.3%) 3 (20%) 4 (14.8%) 
Mean Household Size 2.92 ± 1.31 3.13 ± 1.19 3.04 ± 1.22 
Annual Household Income     
Declined to state 1 (8.3%) 0 (0%) 1 (3.7%) 
$20,001 - $30,000 1 (8.3%) 2 (13.3%) 3 (11.1%) 
$30,001 - $40,000 1 (8.3%) 4 (26.7%) 5 (18.5%) 
$40,001 - $50,000 0 2 (13.3%) 2 (7.4%) 
$50,001 - $60,000 1 (8.3%) 2 (13.3%) 3 (11.1%) 
$60,001 - $70,000 0 2 (13.3%) 2 (7.4%) 
$70,001 - $80,000 2 (16.7%) 0 (0%) 2 (7.4%) 
Over $80,000 6 (50%) 3 (20%) 9 (33.3%) 
Values reported as mean ± SD, or N (percentage of group) 
*Statistically significant difference between treatment and control groups (p < 0.01) 
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group at the time of the study was 1.8 (SD=1.05). See table 5.2 for an overview of participant 
reproductive and health history. 
Most participants gave birth at the hospital (n=21, 77.8%) with either a physician (n=19, 
70.4%), a midwife (n=1, 3.7%), or both (n=1, 3.7%), and 6 (22.2%) gave birth at home with a 
midwife. Two of the participants who gave birth at the hospital with a physician also reported 
that a doula was present for the birth. Eight participants (29.6%) reported experiencing birth 
complications, and 18 (66.7%) reported experiencing 1 or more medical interventions during the 
birth, including induced labor (n=13, 48.1%), pain medication administered (n=11, 40.7%), 
antibiotics administered (n=4, 14.8%), vacuum suction (n=2, 7.4%), cesarean-section (n=5, 
18.5%), other interventions (n=2, 7.4%). Two of the infants born during the study were born on 
their due date (7.4%), 11 were born before their due date (40.7%), and 14 were born after the due 
date (50.9%). The mean birth weight for infants born during the study is 125.57 ounces, and the 
majority of participants reported that they fed their infant exclusively through breastfeeding 
(n=21, 77.8%), while 6 (22.2%) reported a mixture of breast- and bottle-feeding, some noting 
that when they bottle fed, the infant was fed breast milk. See table 5.3 for an overview of 
characteristics of the births that occurred during the study.  
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Table 5.2  
Participant Reproductive and Health History 
 Treatment 
Group (N=12) 
Control Group 
(N=15) 
Total 
(N=27) 
Parity     
Mean number of live births 1.9 ± 1.24 1.4 ± 0.90 1.8 ± 1.05 
One Live Birth 7 (58.3%) 8 (53.3%) 15 (55.6%) 
Two Live Births 1 (8.3%) 6 (40%) 7 (25.9%) 
Three Live Births 2 (16.7%) 1 (6.7%) 3 (11.1%) 
Four Live Births 2 (16.7%) 1 (6.7%) 3 (11.1%) 
Planned Pregnancy     
Yes 7 (58.3%) 10 (66.7%) 17 (63%) 
No 5 (41.7%) 5 (33.3%) 10 (37%) 
Feelings Toward Pregnancy     
Very Unhappy 1 (8.3%) 0 1 (3.7%) 
Somewhat Unhappy 0 0 0 
Neither Happy nor Unhappy 2 (16.7%) 0 2 (7.4%) 
Somewhat Happy 3 (25%) 6 (40%) 9 (33.3%) 
Very Happy 6 (50%) 9 (60%) 15 (55.6%) 
Previous Depression    
Did not experience condition 9 (75%) 11 (73.3%) 20 (74.1%) 
Mild 1 (8.3%) 1 (6.7%) 1 (3.7%) 
Moderate 2 (16.7%) 3 (20%) 3 (11.1%) 
Previous Maternity Blues    
Did not experience condition 11 (91.7%) 12 (80%) 23 (85.2%) 
Mild 0 1 (6.7%) 1 (3.7%) 
Moderate 1 (8.3%) 2 (13.3%) 2 (7.4%) 
Previous PMDD    
Did not experience condition 12 (100%) 14 (93.3%) 26 (96.3%) 
Mild 0 1 (6.7%) 1 (3.7%) 
Previous Postnatal Depression    
Did not experience condition 10 (83.3%) 15 (100%) 25 (92.6%) 
Mild 0 0 0 
Moderate 2 (16.7%) 0 2 (7.4%) 
Previous Antenatal Depression    
Did not experience condition 10 (83.3%) 13 (86.7%) 23 (85.2%) 
Mild 0 2 (13.3%) 2 (7.4%) 
Moderate 2 (16.7%) 0 2 (7.4%) 
Special Dietary Practice    
Vegan/Vegetarian/Mostly Vegetarian 1 (8.3%) 1 (6.7%) 2 (7.4%) 
Gluten Free/”Paleolithic” Diet 1 (8.3%) 0 1 (3.7%) 
No Specialized Diet 10 (83.3%) 14 (93.3%) 24 (88.9%) 
Prenatal Supplements    
Prenatal or multivitamin 12 (100%) 13 (86.7%) 25 (92.6%) 
Iron supplement 2 (16.7%) 2 (13.3%) 4 (14.8%) 
Other vitamin, mineral, or herbal 
supplements 
5 (41.7%) 4 (26.7%) 9 (33.3%) 
Prenatal Medications    
Yes 5 (41.7%) 6 (40%) 11 (40.7%) 
No 7 (58.3%) 9 (60%) 16 (59.3%) 
Values reported as mean ± SD, or N (percentage of group) 
No statistically significant difference between treatment and control groups were found for birth 
characteristics 
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Table 5.3 
 Information about the birth experienced during the study 
 
Treatment 
Group (N=12) 
Control Group 
(N=15) 
Total 
(N=27) 
Birth Location    
Hospital with a physician 8 (66.7%) 11 (73.3%) 19 (70.4%) 
Hospital with a midwife 0 1 (6.7%) 1 (3.7%) 
Hospital with a physician & 
midwife 
0 1 (6.7%) 1 (3.7%) 
Home with a midwife 4 (33.3%) 2 (13.3%) 6 (22.2%) 
Birth Complications    
Yes 4 (33.3%) 4 (26.7%) 8 (29.6%) 
No 8 (66.7%) 11 (73.3%) 19 (70.4%) 
Medical Interventions    
Induced labor 4 (33.3%) 9 (60%) 13 (48.1%) 
Pain medication administered 4 (33.3%) 7 (46.7%) 11 (40.7%) 
Antibiotics administered 1 (8.3%) 3 (20%) 4 (14.8%) 
Vacuum suction 2 (16.7%) 0 (0%) 2 (7.4%) 
Cesarean-section 3 (25%) 2 (13.3%) 5 (18.5%) 
Other interventions 1 (8.3%) 1 (6.7%) 2 (7.4%) 
Days from Due Date    
Number born on due date 1 (8.3%) 1 (6.7%) 2 (7.4%) 
Number born before due date 6 (50%) 5 (33.3%) 11 (40.7%) 
Number born after due date 5 (41.7%) 9 (60%) 14 (51.9%) 
Mean number of days from due 
date 
-2.0 ± 7.6 0.67 ± 8.5 -0.63 ± 8.0 
Mean number of days early 7.5 ± 6.4 8.6 ± 7.8 8.0 ± 6.7 
Mean number of days late 4.2 ± 3.4 5.6 ± 3.6 5.1 ± 3.4 
Mean Birth Weight (ounces) 126.50 ± 18.41 124.83 ± 16.25 125.57 ± 16.92 
Feeding Method    
Breastfeeding only 9 (75%) 12 (80%) 21 (77.8%) 
Breast- and bottle-feeding  3 (25%) 3 (20%) 6 (22.2%) 
Values reported as mean ± SD, or N (percentage of group) 
No statistically significant difference between treatment and control groups were found for 
birth characteristics 
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Demographic, reproductive, and birth characteristics for treatment group participants. 
Twelve participants (44.4% of the sample) were randomly assigned to the treatment group which 
received their own dehydrated and encapsulated placenta as a postpartum supplement. The mean 
age of participants in the treatment group during the 36th week of pregnancy was 32.1 years (SD 
= 3.40), ranging from 26 to 37 years of age. The median income range for participants in the 
treatment group was over $80,000, and half of the women in this group reported a household 
income over $80,000 (n=6). Of the remaining 6 participants in this group, 2 (16.7%) reported an 
annual income between $70,001 - $80,001 (8.3%) reported between $50,001 - $60,000, 1 (8.3%) 
reported between $30,001 - $40,000, 1 (8.3%) reported between $20,001 - $30,000, and 1 (8.3%) 
did not report her annual household income. The median income of women in the treatment 
group of over $80,000 annually is higher than the 2014 median household income in both Clark 
County, Nevada ($52,070), and the US ($53,482) according to the US Census Bureau (2015). All 
but 1 participant in the treatment group identified as Caucasian (n=11; 91.7%), and 1 (8.3%) 
identified as Hispanic/Latina.  
At the time of enrollment, the majority of participants in this group were pregnant with 
their first child (n=7, 58.3%). One woman reported one prior live birth (8.3%), 2 reported 2 
previous births (16.7%), and 2 reported 3 prior births (16.7%). The mean number of live births 
for participants in the treatment group at the time of the study was 1.9 (SD=1.24). Seven (58.3%) 
participants reported that the current pregnancy was planned, and 5 (41.7%) reported that the 
pregnancy was not planned. The majority of participants in the treatment group reported that 
they were happy when they learned they were pregnant (n=9, 75.0%), o2 (16.7%) reported that 
they were neither happy nor unhappy, and 1 (8.3%) reported that she was very unhappy to learn 
about her pregnancy.  
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Most participants in this group gave birth at the hospital with a physician (n=8, 66.7%), 
and 4 (33.3%) gave birth at home with a midwife. Two of the participants who gave birth at the 
hospital with a physician also reported that a doula was present for the birth. One third of the 
participants in the treatment group (n=4) reported experiencing birth complications, and 7 
(58.3%) reported one or more medical interventions during the birth. These included 
administration of antibiotics (n=1, 8.3%) and pain medication (n=4, 33.3%), induced labor (n=4, 
33.3%), vacuum suctioning (n=2, 16.7%), cesarean section (n=3, 25.0%), or another intervention 
(n=1, 8.3%).  
 
Demographic, reproductive, and birth characteristics for control group participants. 
Fifteen participants (55.6% of the sample) were randomly assigned to the control group which 
received capsules containing dehydrated and encapsulated beef or vegetarian meat substitute as a 
postpartum placebo supplement. Twelve (80.0%) participants received the beef placebo capsules, 
and 3 (20.0%) received the vegetarian placebo capsules. The mean participant age during the 36th 
week of pregnancy was 27.7 years (SD = 4.39), ranging from 21 to 38 years of age. The majority 
of women in the control group reported an annual household income of $50,000 or less (n=8, 
53.5%), with a median of $40,001 - $50,000 annually. This is lower than 2014 median household 
income in both Clark County, Nevada ($52,070), and the US ($53,482) according to the US 
Census Bureau (2015). The majority of participants in the control group identified as Caucasian 
(n=11; 73.3%), 3 (20.0%) identified as Hispanic/Latina, and 1 (6.7%) identified as both 
American Indian/Alaska Native and Caucasian. 
At the time of enrollment, just over half of participants in the control group were 
pregnant with their first child (n=8, 53.3%). Five reported one prior live birth (33.3%), 1 reported 
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2 previous births (6.7%), and 1 reported 3 prior births (6.7%). The mean number of live births 
for participants in the control group at the time of the study was 1.67 (SD=0.90). Two thirds 
(n=10) of the control group participants reported that the current pregnancy was planned, and 5 
(33.3%) reported that the pregnancy was not planned. All participants in the control group 
reported that they were happy when they learned they were pregnant, with 6 (40.0%) reporting 
that they were somewhat happy, and 9 (60.0%) reporting that they were very happy. 
Most participants gave birth at the hospital (n=13, 86.7%) with either a physician (n=11, 
66.7%), a midwife (n=1, 6.7%), or both (n=1, 6.7%), and 2 (13.3%) gave birth at home with a 
midwife. About one fourth of the participants in the control group (n=4, 26.7%) reported 
experiencing birth complications, and 11 (73.3%) reported one or more medical interventions 
during the birth. These included administration of antibiotics (n=3, 20.0%) and pain medication 
(n=7, 46.7%), induced labor (n=9, 60.0%), cesarean section (n=2, 13.3%), or another 
intervention (n=1, 6.7%). 
  
Demographic and reproductive differences between groups. Between-group differences in 
education, ethnicity, and annual household income were evaluated using a Chi-Square test of 
independence, which revealed no significant difference between the treatment and control groups 
in education (X2 (4, N = 27) = 3.697, p =.449), ethnicity (X2 (42, N = 27) = 1.687, p =.430), or 
income (X2 (6, N = 27) = 9.066, p =.170). An independent t-test was used to evaluate between 
group differences in age and household size, and revealed no significant differences between 
groups in household size (t=-0.450; df=25; p=0.657), however, there was a significant difference 
between groups for age (t=2.904; df=25; p=.008). Women in the treatment group were 
significantly older than participants in the control group.  
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 Between-group differences in characteristics of the participants’ reproductive and health 
histories were evaluated using a Chi-Square test of independence. Analysis revealed no 
significant differences between groups in whether the pregnancy was planned (X2 (1, N = 27) = 
0.199, p = 0.656), their feelings about the pregnancy (X2 (3, N = 27) = 4.320, p = 0.229), history 
of depression (X2 (2, N = 27) = 0.068, p = 0.967), maternity blues (X2 (2, N = 27) = 1.057, p = 
0.590), premenstrual dysphoric disorder (PMDD) (X2 (1, N = 27) = 0.831, p = 0.382), postnatal 
depression (X2 (1, N = 27) = 2.700, p = 0.100), antenatal (pregnancy) depression (X2 (2, N = 27) 
= 4.109, p = 0.128), special dietary practices (X2 (2, N = 27) = 1.350, p = 0.509), and whether 
they took supplements during pregnancy (X2 (1, N = 27) = 0.142, p = 0.706). An independent t-
test was used to evaluate between group differences in parity, and revealed no significant 
differences between groups (t=0.607; df=25; p= 0.549). 
 Between-group differences in birth location, birth complications, medical interventions, 
and feeding method were evaluated using a Chi-Square test of independence, which revealed no 
significant difference between the treatment and control groups in any measures (birth location, 
X2 (3, N = 27) = 2.842, p = 0.417; birth complicaitons, X2 (1, N = 27) = 0.142, p = 0.706; 
medical interventions, X2 (1, N = 27) = 0.675, p = 0.411; feeding method, X2 (1, N = 27) = 0.096, 
p = 0.756). An independent t-test was used to evaluate between group differences in gestational 
age and birth weight, and revealed no significant differences between groups in either measure 
(gestational age, t = -0.851; df = 25; p = 0.403; birth weight, t = 0.250; df = 25; p = 0.805). 
 
Research Question 1 
 The first research question addresses whether placentophagy, in the form of dehydrated 
capsules, improves postpartum affect, energy and recovery. Repeated measures ANOVA 
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analysis was performed for measures of depressive symptoms, fatigue, maternal-infant bonding, 
and infant weight, in order to identify differences between groups in these measures, as well as 
changes in these measures across the 3 postpartum meetings. Missing values were replaced with 
the mean value of the group for the particular measure and time point for which the data point 
was missing (e.g., a missing depression score at the second postpartum meeting for a treatment 
group participant would have been replaced with the mean depression score of treatment group 
participants at the second postpartum meeting). Data that did not meet the normality assumption 
were log-transformed prior to repeated measures ANOVA analysis. Data that did not meet the 
normality assumption after log transformation were rank transformed prior to repeated measures 
ANOVA analysis. These variables were selected to evaluate 4 of the most commonly claimed 
benefits of placentophagy: relief or prevention of postpartum depressive symptoms, improved 
energy/decreased fatigue, improved maternal bonding with the infant, and increased breast milk 
production and/or quality. 
 
Postpartum depressive symptoms: Edinburgh Postnatal Depression Scale. In order to 
evaluate whether placentophagy, in the form of dehydrated capsules, improves postpartum affect, 
specifically postpartum depressive symptoms, data from the Edinburgh Postnatal Depression 
Scale (EPDS, Cox et al., 1987), administered across the study, were analyzed. Differences in 
postpartum depression score within-subjects and between groups was evaluated using repeated-
measures ANOVA across the three postpartum meetings. Several variables that are known 
predictors of postpartum depression were included in the model, including postpartum depressive 
symptoms during pregnancy (EPDS score during pregnancy), stress and anxiety during 
pregnancy (DASS21, Stress and Anxiety scores), social support (mean overall MSPSS score), 
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history of depression (self-reported), history of postpartum depression (self-reported), parity 
(self-reported), birth complications (self-reported), presence of breastfeeding (self-reported), and 
whether a C-section was performed (self-reported). Because scores on the DASS21 and MSPSS 
were not normally distributed, scores for all continuous variables were rank transformed prior to 
repeated-measures ANOVA analysis. Between-subjects analysis revealed no significant 
difference between groups in any control variables, therefore all control variables were removed, 
and the analysis was repeated on log transformed EPDS scores.  
Mauchly’s test indicated that the sphericity assumption had been violated (X2(2) = 7.536, 
p = 0.023), so the Greenhouse-Geisser correction was applied (ɛ = 0.788). Within-subjects 
analysis showed that there was not a significant main effect of time across the three postpartum 
meetings (F(2, 27) = 2.693, p = 0.092), indicating that EPDS score did not change significantly 
over time for both groups combined. There was, however, a significant interaction of time and 
condition (placebo vs. placenta) (F(2, 27) = 4.022, p = 0.034), indicating that depression scores 
for each group are changing over time in different ways. Bonferroni corrected post hoc tests 
show there were no statistically significant differences between meetings in EPDS score 
measures in the control group (postpartum meeting 1 to 2, p = 1.000; postpartum meeting 1 to 3, 
p = 0.500; postpartum meeting 2 to 3, p = 0.909), however, there was a significant decrease in 
depressive symptoms in the treatment group between postpartum meetings 1 and 2 (p = 0.012), 
but not between meetings 1 and 3 (p = 0.270), or 2 and 3 (p = 1.000). This means that 
participants receiving the placenta supplement experienced a decrease in depressive symptoms, 
as measured by EPDS score, from the first postpartum meeting (pre-supplementation) to the 
second postpartum meeting (post-supplementation), that did not occur in the control group. 
Between-subjects tests indicate that the variable condition was not significant (F(1, 27) = 1.469, 
74 
p = 0.237), indicating that overall, EPDS scores were the same for both groups when time is not 
considered. (See Figure 5.1).   
 
 
 
 
Energy: Fatigue Assessment Scale. Energy was evaluated using the Fatigue Assessment 
Scale (FAS) scale (Michielsen et al., 2004). Differences in FAS score within and between groups 
were evaluated using repeated-measures ANOVA across the three postpartum meetings with age, 
fatigue during pregnancy (FAS score during pregnancy), and sleep quality (PSQI overall score) 
included in the model because they could affect postpartum fatigue scores. Because scores on the 
FAS were not normally distributed, these scores were log10 transformed prior to repeated 
measures ANOVA analysis. Between-subjects analysis revealed no significant difference 
Figure 5.1. EPDS score estimated marginal means across postpartum 
meetings by condition.  
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between groups in the age and pregnancy fatigue control variables, therefore these 2 variables 
were removed, and the analysis was repeated with log10 transformed FAS scores, controlling for 
sleep quality.  
Within-subjects analysis showed that there was not a significant main effect of time 
across the three postpartum meetings (F(2, 27) = 1.336, p = 0.272), indicating that FAS score did 
not change significantly over time for both groups combined. There was, however, a significant 
interaction of time and condition (F(2, 27) = 4.473, p = 0.017), indicating that FAS scores 
changed over time for each group in different ways. Pairwise comparisons using the Bonferroni 
adjustment indicated that mean FAS score for both groups combined did not change significantly 
between any of the 3 postpartum meetings (p = 1.000). A one-way ANCOVA was conducted to 
identify between group differences in FAS score, controlling for sleep quality, at each individual 
postpartum meeting and revealed that the mean FAS score at the final postpartum meeting was 
significantly lower in the treatment group than in the control group (F(1, 24) = 5.788, p = 0.024). 
Between-subjects tests indicate that the control variable PSQI score was significantly related to 
FAS score (F(1, 27) = 26.877, p < 0.001). Analysis also revealed that the variable condition was 
not significant (F(1, 27) = 0.003, p = 0.958), indicating that overall, FAS scores were the same 
for both groups when time is not considered. (See Figure 5.2).  
 
Bonding and attachment: Mother-to-Infant Bonding Scale. Postpartum maternal bonding was 
evaluated using the Mother-to-infant Bonding (MIB) scale (Taylor et al., 2005). Differences in 
MIB score within-subjects and between groups were evaluated using repeated-measures 
ANOVA across the three postpartum meetings, including as control variables prenatal 
attachment (Prenatal Attachment Inventory, or PAI, score), social support (mean MSPSS score 
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during pregnancy and postpartum), birth complications (self-reported), presence of breastfeeding 
(self-reported), and whether a C-section was performed (self-reported). Because scores on the 
MIB and MSPSS were not normally distributed, scores for all continuous variables were rank 
transformed prior to repeated measures ANOVA analysis. Between-subjects analysis revealed no 
significant difference between groups in any control variables except prenatal attachment, 
therefore all other control variables were removed, and the analysis was repeated on log10 
transformed MIB scores, controlling for PAI score during pregnancy.  
Within-subjects analysis showed that there was not a significant main effect of time 
across the three postpartum meetings (F(2, 27) = 1.488, p = 0.236), indicating that MIB score did 
not change significantly over time for both groups combined. There also was not a significant 
interaction of time and condition (F(2, 27) = 4.652, p = 0.202), indicating that MIB score did not 
Figure 5.2 FAS score across postpartum meetings by condition 
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differ significantly between groups over time. Between-subjects tests show that the control 
variable PAI score is significantly related to MIB score (F(1, 27) = 26.877, p < 0.001), and that 
the variable condition is not significant (F(1, 27) = 2.095, p = 0.161), indicating that, overall, 
MIB scores were the same for both groups when time is not considered. A one-way ANCOVA 
was conducted to identify between group differences in MIB score, controlling for attachment 
score during pregnancy, at each individual postpartum meeting and revealed that the mean MIB 
score at the final postpartum meeting was significantly lower in the treatment group than in the 
control group (F(1, 24) = 5.666, p = 0.026), indicating higher maternal bonding in the treatment 
group than the control group at this time point. (See Figure 5.3). 
 
 
 
 
 
Figure 5.3 MIB score across postpartum meetings by condition (note 
that a higher score indicates lower bonding) 
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Infant weight. Because breast milk was not collected and production was not measured 
directly during this study, in order to address the claim that placentophagy increases breast milk 
production, infant birth weight was collected, and weights were taken at each of the 3 postpartum 
meetings as an indirect measure of breast milk quantity/quality. Difference in infant weight 
within and between groups was evaluated using repeated-measures ANOVA across the three 
postpartum meetings. Several variables that could influence infant weight were included in the 
model. These are: infant birth weight (reported by participant), whether the infant was breastfed 
or bottle and breastfed (self-reported), maternal height (self-reported), maternal weight (self-
reported and collected), number of days born before or after the due date (self-reported), whether 
there were complications during the birth (self-reported), parity (self-reported), and depressive 
symptoms (EPDS). Between-subjects analysis revealed no significant difference between groups 
in infant feeding method, maternal weight, number of days born from the due date, whether there 
were birth complications, and depressive symptoms, therefore these control variables were 
removed, and the analysis was repeated for infant weight, controlling for birth weight, maternal 
height, and parity.  
Mauchly’s test indicated that the sphericity assumption had been violated (X2(2) = 
11.347, p = 0.003), therefore the Greenhouse-Geisser correction was applied (ɛ = 0.713). Within-
subjects analysis showed that there was not a significant main effect of time across the three 
postpartum meetings (F(2, 27) = 0.015, p = 0.956), indicating that time is not a significant 
predictor of infant weight for both groups combined. There also was not a significant interaction 
of time and condition (F(2, 27) = 0.441, p = 0.581), indicating that infant weight did not differ 
significantly between groups over time. Between-subjects tests indicate that the control variables 
birth weight (F(1, 27) = 217.350, p < 0.001) and maternal height (F(1, 27) = 4.962, p = 0.036), 
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are both significantly related to infant weight. Analysis also revealed that the variable condition 
is not significant (F(1, 27) = 2.729, p = 0.112), indicating that overall, infant weights were the 
same for both groups when time is not considered. (See Figure 5.4). 
 
 
 
 
 
Research Question 2  
The second research question addresses whether there are differences in salivary and plasma 
hormone levels within and between participants, and whether hormone and micronutrient levels 
are correlated to changes in postpartum affect, energy and recovery. Repeated measures ANOVA 
analysis was performed for prolactin, progesterone, and estradiol to identify differences between 
groups in hormone measures, as well as changes in hormone measures across the 3 postpartum 
Figure 5.4 Infant weight (ounces) across postpartum meetings by 
condition 
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meetings, both within and between groups. Data that did not meet the normality assumption were 
log-transformed prior to repeated measures ANOVA analysis. Data that did not meet the 
normality assumption after log transformation were rank transformed prior to repeated measures 
ANOVA analysis.  
 Relationships between hormone measures (prolactin, estradiol, and progesterone) and 
psychometric variables (depressive symptoms, fatigue, and bonding) were evaluated using 
Spearman’s rank-order correlation analysis because the assumption of normality was not met for 
these data. To correct for inflated Type I error due to the number of correlation analyses 
conducted, relationships were considered significant at an alpha level of p <0.01 for all 
correlations analyses, however, non-significant relationships at an alpha level of p <0.05, may be 
of interest and are noted as well. 
These hormones were selected because they are noted by placentophagy advocates as 
potential candidates for the mechanism by which placentophagy elicits the purported effects, and 
because they are known to affect the variables addressed in section 5.3 above that are often 
claimed as benefits of placentophagy (e.g., effects of estradiol and progesterone on mood and 
energy, and effects of prolactin on bonding and breast milk production). Additionally, both 
estradiol and progesterone were found to be present in the dehydrated placenta capsule samples 
in higher concentrations than most of the other hormones evaluated (see Table 5.4 below), and in 
concentrations that may possibly elicit physiological effects, making them good candidates for a 
role in the reported benefits of placentophagy. 
 
Prolactin. Differences in plasma prolactin within-subjects and between groups were 
evaluated using repeated-measures ANOVA across the three postpartum meetings. The 
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following variables that may impact prolactin measures were included in the analysis: plasma 
prolactin during pregnancy, whether the infant is breastfed (self-reported), number of hours 
postpartum at time of sample collection, and number of minutes since the infant was last fed at 
the time of samples collection. Because prolactin values were not normally distributed, they were 
log10 transformed prior to repeated-measures ANOVA analysis. Between-subjects analysis 
revealed no significant difference between groups in whether the infant is breastfed, number of 
hours postpartum at time of sample collection, and number of minutes since the infant was last 
fed at the time of samples collection, therefore these control variables were removed, and the 
analysis was repeated for log 10 transformed prolactin concentration, controlling for plasma 
prolactin during pregnancy. 
Mauchly’s test indicated that the sphericity assumption was violated (X2(2) = 21.153, p < 
0.001), so the Greenhouse-Geisser correction was applied (ɛ = 0.624). Within-subjects analysis 
showed that there was not a significant main effect of time across the three postpartum meetings 
(F(2, 27) = 0.221, p = 0.696), indicating that plasma prolactin did not change significantly over 
time for both groups combined. There were also non-significant interactions of time and 
condition (F(2, 27) = 0.523, p = 0.514), and time and plasma prolactin during pregnancy (F(2, 
27) = 0.481, p = 0.535) indicating that condition and plasma prolactin during pregnancy did not 
interact with time to predict postpartum prolactin levels. Between-subjects tests show that the 
variable condition is not significant (F(1, 27) = 1.561, p = 0.224), indicating that, overall, 
prolactin levels were the same for both groups when time is not considered. Analysis also 
showed that the control variable pregnancy prolactin level is significantly related to postpartum 
plasma prolactin levels (F(1, 27) = 5.685, p = 0.025). (See Figure 5.5).  
Spearman's rank-order correlation was used to determine the relationship between 
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participants’ plasma prolactin level and maternal attachment/bonding (PAI/MIB Scores) at each 
of the four meetings. There was no significant relationship between plasma prolactin and 
PAI/MIB score during pregnancy (rs(25) = 0.280, p = 0.157), or at any of the 3 postpartum time 
points (first postpartum meeting: rs(25) = 0.000, p = 0.999; second postpartum meeting: rs(25) = 
-0.172, p = 0.392; third postpartum meeting: rs(25) = 0.900, p = 0.656). Correlations between 
plasma prolactin and attachment/bonding were evaluated within each group (treatment and 
control), and revealed no significant correlations within either group at any time point.  
Spearman's rank-order correlation analysis was also run to determine the relationship 
between participants’ plasma prolactin level and postpartum depressive symptoms (EPDS score) 
at each of the four meetings. There was no significant relationship between prolactin and EPDS 
score during pregnancy (rs(25) = 0.094, p = 0.641), or at any of the 3 postpartum time points 
(first postpartum meeting: rs(25) = -0.403, p = 0.037; second postpartum meeting: rs(25) = -
0.025, p = 0.902; third postpartum meeting: rs(25) = -0.088, p = 0.661). Correlations between 
plasma prolactin and EPDS score were evaluated within each group (treatment and control) as 
well, and revealed no significant correlations within either group at any time point. 
 
Progesterone. Differences in salivary progesterone within-subjects and between groups 
were evaluated using repeated-measures ANOVA across the three postpartum meetings. The 
following variables that may impact progesterone measures were included in the analysis: 
salivary progesterone during pregnancy, maternal age, and the number of hours postpartum at 
time of sample collection. Because progesterone values were not normally distributed, all 
continuous variables were rank transformed prior to repeated-measures ANOVA analysis. 
Between-subjects analysis revealed no significant difference between groups in maternal 
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age and pregnancy progesterone values, however there was a significant effect of the number of 
hours postpartum at time of the second postpartum meeting, therefore the control variables 
maternal age and pregnancy progesterone levels were removed, and the analysis was repeated for 
progesterone, controlling for the number of hours postpartum at the second postpartum meeting. 
Within-subjects analysis showed that there was a significant main effect of time across 
the three postpartum meetings (F(2, 27) = 22.658, p < 0.001), indicating that salivary 
progesterone concentrations changed significantly over time for both groups combined. Pairwise 
comparisons using the Bonferroni adjustment indicated that mean overall progesterone 
concentrations decreased significantly from the first to second (p < 0.001), and first to third 
postpartum meetings (p < 0.001), but not from the second to third postpartum meeting (p = 
Figure 5.5 Plasma prolactin concentration across postpartum 
meetings by condition 
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1.000). There was a significant interaction of time and hours postpartum at the second 
postpartum meeting (F(2, 27) = 10.343, p < 0.001) indicating that hours postpartum at the second 
meeting interacted with time to predict postpartum salivary progesterone levels. There were a 
non-significant interaction of time and condition (F(2, 27) = 1.772, p = 0.181) indicating that 
condition did not interact with time to predict postpartum salivary progesterone levels. Between-
subjects tests show that the variable condition is not significant (F(1, 27) = 2.761, p = 0.110), 
indicating that, overall, progesterone levels were the same for both groups when time is not 
considered. Analysis also showed that the control variable, hours postpartum at meeting 2, is 
significantly related to postpartum salivary progesterone levels (F(1, 27) = 9.180, p = 0.006). 
(See Figure 5.6). 
 Spearman's rank-order correlation was used to determine the relationship between 
participants’ salivary progesterone levels and depressive symptoms (EPDS) at each of the four 
meetings. There was no significant relationship between salivary progesterone levels and EPDS 
score during pregnancy (rs(25) = 0.280, p = 0.157), or at any of the 3 postpartum time points 
(first postpartum meeting: rs(25) = 0.000, p = 0.999; second postpartum meeting: rs(25) = -0.172, 
p = 0.392; third postpartum meeting: rs(25) = 0.900, p = 0.656). Correlations between salivary 
progesterone and EPDS score were evaluated within each group (treatment and control), and 
revealed no significant correlations within either group at any time point.  
Spearman's rank-order correlation analysis was also run to determine the relationship 
between participants’ salivary progesterone levels and attachment/bonding (MIB score) at each 
of the four meetings. There was no significant relationship between progesterone and MIB score 
during pregnancy (rs(25) = 0.094, p = 0.641), or at the first and third postpartum time points 
(first postpartum meeting: rs(25) = -0.403, p = 0.037; third postpartum meeting: rs(25) = -0.088, 
85 
p = 0.661), however, there was a moderate positive correlation between salivary progesterone 
and MIB score at the second postpartum meeting (rs(25) = 0.494, p = 0.009). Correlations 
between salivary progesterone levels and MIB score were evaluated within each group 
(treatment and control) as well, and revealed no significant correlations within either group at 
any time point, although there was a moderate positive correlation between progesterone and 
bonding at the second postpartum meeting in the control group only that was not statistically 
significant at an alpha level of p < 0.01, but is worth noting (rs(25) = 0.589, p = 0.021).  
Spearman's rank-order correlation analysis was also run to determine the relationship 
between participants’ salivary progesterone levels and energy/fatigue (FAS score) at each of the 
four meetings. There was no significant relationship between progesterone and FAS score during 
pregnancy (rs(25) = 0.167, p = 0.405), or at any of the 3 postpartum time points (first postpartum 
meeting: rs(25) = 0.144, p = 0.474; second postpartum meeting: rs(25) = 0.093, p = 0.646; third 
postpartum meeting: rs(25) = 0.083, p = 0.682). Correlations between salivary progesterone 
levels and FAS score were evaluated within each group as well, and revealed no significant 
correlations within either group at any time point. 
 
Estradiol. Differences in salivary estradiol within-subjects and between groups were 
evaluated using repeated-measures ANOVA across the three postpartum meetings. The 
following variables that may impact estradiol measures were included in the analysis: salivary 
estradiol during pregnancy, maternal age, the time of sample collection, and the number of hours 
postpartum at time of sample collection. Because estradiol values were not normally distributed, 
all continuous variables were rank transformed prior to repeated-measures ANOVA analysis. 
Between-subjects analysis revealed no significant between-subjects effects of any control 
86 
 
 
variables, therefore the control variables were removed, and the analysis was repeated for rank 
transformed estradiol values. 
Within-subjects analysis showed that there was a significant main effect of time across 
the three postpartum meetings (F(2, 27) = 24.107, p < 0.001), indicating that salivary estradiol 
concentrations changed significantly over time for both groups combined. Pairwise comparisons 
using the Bonferroni adjustment indicated that mean overall estradiol concentrations decreased 
significantly from the first to second (p < 0.001), and first to third postpartum meetings (p < 
0.001), but not from the second to third postpartum meeting (p = 1.000). There was a non-
significant interaction of time and condition (F(2, 27) = 1.434, p = 0.248) indicating condition 
did not interact with time to predict postpartum salivary estradiol levels. Between-subjects tests 
revealed that the variable condition is not significant (F(1, 27) = 0.089, p = 0.768), indicating 
Figure 5.6 Salivary progesterone concentration across postpartum 
meetings by condition 
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that overall, estradiol levels were the same for both groups when time is not considered. (See 
Figure 5.7). 
Spearman's rank-order correlation was used to determine the relationship between 
participants’ salivary estradiol levels and depressive symptoms (EPDS) at each of the four 
meetings. There was a moderate negative correlation between salivary estradiol levels and EPDS 
score during pregnancy (rs(25) = -0.487, p = 0.010), but not at any of the 3 postpartum time 
points (first postpartum meeting: rs(25) = 0.182, p = 0.364; second postpartum meeting: rs(25) = 
-0.069, p = 0.773; third postpartum meeting: rs(25) = 0.117, p = 0.562). Correlations between
salivary estradiol and EPDS score were evaluated within each group (treatment and control), and 
revealed a strong negative correlation between estradiol and EPDS score during pregnancy in the 
control group only (rs(25) = -0.849, p < 0.001), and no other significant correlations within either 
group at any time point.  
Spearman's rank-order correlation analysis was also run to determine the relationship 
between participants’ salivary estradiol levels and energy/fatigue (FAS score) at each of the four 
meetings. There was no significant relationship between progesterone and FAS score during 
pregnancy (rs(25) = -0.133, p = 0.510), or at any of the 3 postpartum time points (first 
postpartum meeting: rs(25) = 0.125, p = 0.534; second postpartum meeting: rs(25) = 0.125, p =
0.534; third postpartum meeting: rs(25) = 0.201, p = 0.315). Correlations between salivary 
progesterone levels and FAS score were evaluated within each group as well, and revealed no 
significant correlations within either group at any time point. 
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Research Question 3 
The third research question addresses the content of hormones, micronutrients, and 
environmental metals in dehydrated and encapsulated placenta. Concentrations of these 
substances were evaluated in 28 dehydrated placenta samples, as well samples of the beef and 
vegetarian placebo contents as a comparison. The placenta samples analyzed here include 
samples from two participants whose data was excluded from the analyses described in sections 
5.3 and 5.4, as the reasons they were excluded from those analyses are not sufficient to exclude 
theses data here. Additionally, no placenta sample was collected from one participant whose data 
were included previously, therefore the hormonal and nutritional contents of her placenta 
capsules could not be include here.  
Figure 5.7 Salivary estradiol concentration across postpartum 
meetings by condition
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Hormonal content of encapsulated placenta. The concentration of 17 hormones was 
evaluated in 28 samples of dehydrated placenta prepared for encapsulation, and in 3 samples of 
beef and 3 samples of vegetarian placebo contents. These include: 11-deoxycortisol, 17-
hydroxyprogesterone, 7-keto DHEA, aldosterone, allopregnanolone, androstenedione, 
corticosterone, cortisol, cortisone, DHEA, DHT, estradiol, estriol, estrone, melatonin, 
progesterone, and testosterone. Spearman's rank-order correlation analysis was also run to 
determine the relationship between hormone concentrations in prepared placenta and 
participants’ salivary hormone concentrations post-supplementation at Meetings 3 and 4 for 
estradiol and progesterone. Prolactin values in placenta and participant plasma could not be 
compared as prolactin was not measured in the placenta samples.  
Fifteen of the 17 hormones were detected in all 28 placenta samples. Melatonin was 
detected in only one third of the placenta samples (n = 9, 33.3%), and DHT was not detected in 
any of the 28 samples, indicating that in these samples these hormones were either not present, or 
were present in concentrations that were below the limit of detection for this analysis. Mean, 
range, and standard deviation for each analyte in placenta capsule contents, and beef and 
vegetarian placebo contents are reported in Table 5.4. Mean concentrations of each hormone in 
each type of capsule (placenta, beef placebo, and vegetarian placebo) for the three capsule doses 
administered during this study (6 capsules, 4 capsules, and 2 capsules) are reported in Appendix 
B, Table 5.4. 
Estradiol. Spearman's rank-order correlation analysis was run to determine the 
relationship between the estradiol concentration of the placenta capsules and salivary estradiol 
levels at the second (meeting 3) and third (meeting 4) postpartum meetings (post-
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supplementation). Analysis revealed no significant relationship between salivary estradiol and 
estradiol in placenta samples for the treatment group at meeting 3 (rs(12) = 0.637, p = 0.026), 
and at meeting 4 (rs(12) = -0.208, p = 0.517). In order to address whether any relationships 
between placental and salivary hormone levels can be attributed to relationships between 
circulating and placental hormone concentrations in general, Spearman’s rank-order correlation 
analysis was also conducted for the control group. Analysis also revealed that there was not a 
significant correlation between placental and salivary estradiol in the control group at either 
meeting (meeting 3, rs(15) = -0.080, p = 0.786; meeting 4, rs(15) = 0.165, p = 0.556). Although 
analysis revealed no significant relationship between placental and salivary estradiol post-
supplementation in either group, there was a strong, positive correlation (rs(12) = 0.637, p =
0.026) at the third meeting between estradiol in the placenta capsules and salivary estradiol for 
the treatment group only that is worth noting, although it is not significant at an alpha level of p
<0.01. 
Progesterone. Spearman's rank-order correlation analysis was run to determine the 
relationship between the progesterone concentration of the placenta capsules and salivary 
progesterone levels at the second (meeting 3) and third (meeting 4) postpartum meetings (post-
supplementation). Analysis revealed no significant relationship between salivary progesterone 
and progesterone in placenta capsules for the treatment group at meeting 3 (rs(12) = -0.091, p =
0.778), and at meeting 4 (rs(12) = -0.134, p = 0.677). In order to address whether any 
relationships between placental and salivary hormone levels can be attributed to relationships 
between circulating and placental hormone concentrations in general, Spearman’s rank-order 
correlation analysis was also conducted for the control group. Analysis also revealed that there
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was not a significant correlation between placenta capsule and salivary progesterone in the 
control group at either meeting (meeting 3, rs(15) = 0.127, p = 0.535; meeting 4, rs(15) = 0.281, 
p = 0.156). 
Environmental metal and micronutrient content of encapsulated placenta. In order 
to investigate the concentration of beneficial micronutrients and potentially harmful 
environmental metals in processed placenta capsules, 28 samples of dehydrated placenta 
prepared for encapsulation were analyzed using inductively coupled plasma mass spectrometry 
analysis (ICP-MS). The concentration of 14 elements was evaluated, including arsenic (As), 
cobalt (Co), copper (Cu), iron (Fe), lead (Pb), manganese (Mn), mercury (Hg), molybdenum 
(Mo), rubidium (Rb), selenium (Se), strontium (Sr), and zinc (Zn). Thirteen of the 14 elements 
evaluated were detected in all 28 placenta samples. The element that was not detected in all 
samples, Hg, was detected in 24 (85.7%) of the 28 samples, indicating that it was either not 
present or was present in concentrations that were below the limit of detection using ICP-MS 
analysis in 4 of the samples. Seven (50.0%) of the elements had a mean concentration below 0.1 
parts per million (ppm), including As, Cd, Co, Pb, Hg, Mo, and U. Mean, range, and standard 
deviation for each analyte in placenta capsule contents are reported in Table 5.6 (Appendix C). 
Iron is the most highly concentrated element in the dehydrated placenta samples (664.38 
ppm), followed by Zn (54.63 ppm), Rb (8.03 ppm), Cu (5.58 ppm), Sr (1.51 ppm), and Se (1.51 
ppm). Conversely, the environmental metals that are of the greatest health concern, especially for 
postpartum women who may be breastfeeding, are seen in very low concentrations (e.g., As, Cd, 
Pb, Hg, and U), and all below 0.1 ppm. Mean concentrations for each analyte in each type of 
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capsules (placenta, beef placebo, and vegetarian placebo) for the three capsule doses 
administered during this study (6 capsules, 4 capsules, and 2 capsules) are reported in table 5.7. 
Summary 
This chapter presents results of a subset of the current project intended to address the most 
widely claimed effects of placentophagy, and the longstanding question of the hormonal and 
nutritional composition of dehydrated placenta supplements. Analysis revealed a significant 
effect of placentophagy on postpartum mood and energy, but not on maternal bonding or infant 
weight. Further analysis revealed that although there were significant changes in some salivary 
and plasma hormone levels over time, no significant differences in postpartum hormone 
concentrations between groups were revealed, and there were no significant relationships 
between plasma and salivary hormone measures and depressive symptoms, energy, or maternal 
bonding.  
Concentrations of hormones, trace micronutrients, and environmental metals were 
evaluated in placenta and placebo capsule contents, and analysis revealed no significant 
relationship between concentration of hormones in the placenta and participants’ salivary 
hormone levels with the exception of salivary estradiol during pregnancy in the control group 
only. The next chapter provides discussion and interpretation of these findings, limitations of the 
study, and future recommendations.  
Footnotes: 
1 Improved iron rebound is a commonly reported benefit of placentophagy supporters, and iron deficiency 
and iron deficiency anemia have been reported in women with postpartum depressive symptoms. Three 
iron measures were collected as a part of this study, however they are not included in the present analysis. 
The effects of placentophagy on these iron measures is reported in detail in Gryder, 2015. 
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Chapter 6: Discussion 
This chapter provides a discussion of the results presented in the previous chapter. This includes 
a review and interpretation of each measure evaluated to address the research questions 
presented in Chapter 3, as well as the limitations of the study.  
Research Question 1
Does placentophagy, in the form of dehydrated capsules, improve postpartum affect, energy and 
recovery in comparison to a vegetarian or beef placebo supplement? 
Postpartum depression. Postpartum depressive symptoms were evaluated using the 
Edinburgh Postnatal Depression Scale (EPDS; Cox et al., 1987) and although there was no 
significant difference between groups in depression score overall, there was a significant 
interaction of time and condition that predicted trends in EPDS score. As illustrated in figure 5.1, 
participants receiving the placenta supplement experienced a significant decrease in depressive 
symptoms between the first and second postpartum meetings (pre-supplementation to early post-
supplementation), followed by a non-significant increase in symptoms form the second to final 
postpartum meetings. Control group participants, however, experienced a slight non-significant 
increase in depressive symptoms overall across the postpartum period.  
Previous research on placentophagy among mothers in industrialized countries suggests 
that the primary benefit women claim as a result of ingesting placenta postpartum is the relief or 
prevention of postpartum depressive symptoms (Selander et al., 2013). Research on postpartum 
affect has shown that postnatal blues manifests early in the postpartum period, with many 
researchers identifying a peak in symptoms around day 5 postpartum (Henshaw, 2003) 
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(approximately the time of the second postpartum participant meeting in this study), and resolves
within a few days (Robertson et al., 2004). Unlike postnatal blues, postpartum depression 
typically manifests within 6 weeks postpartum and has a longer duration (Robertson et al., 2004). 
Given these sensitive time frames for postnatal affective lability, if placentophagy is effective in 
mitigating some of these changes, we would expect to see significantly lower post-
supplementation postpartum depression scores in the treatment group compared to the control 
group, significant post-supplementation decreases in depressive symptoms in the treatment group 
in comparison to the control group, or both. While the results did not show significantly lower 
EPDS scores in the treatment group at any postpartum time point, they did indicate that the 
treatment group experienced a significant decrease in depressive symptoms from the first 
postpartum meeting (within 96 hours postpartum) to the second (between days 5-7 postpartum). 
The EPDS score did show a statistically insignificant increase in this group, however, from the 
second to final postpartum meeting (week 3 postpartum).  
It is worth noting that the dose of placenta or placebo capsules taken across the 
postpartum period in this study decreased over time, from 6 capsules daily on days 1-4 of 
supplementation, to 4 capsules daily on days 5-12 of supplementation, to 2 capsules daily for the 
remainder of participation in the study. If the decrease in EPDS score in the early postpartum 
period did in fact result from taking the placenta supplement, it is possible that this decrease in 
depressive symptoms, followed by the subsequent increase in symptoms, was influenced by the 
decreased dose of capsules over time, as participants were taking 6 capsules daily at the second 
postpartum meeting, and only 2 daily at the final meeting. It is also possible that other factors are 
responsible for the difference between groups in the change in depressive symptoms immediately 
post-supplementation. For example, one participant in the treatment group noted that she 
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experienced an improvement in mood when she started taking the capsules, but noticed an 
increase in feelings of depression when the dose decreased. She noted that this timing also 
coincided with her mother leaving after having stayed with her for the first week postpartum, 
suggesting that this could have affected her mood. Because many experiences during pregnancy 
and the postpartum period could potentially effect postpartum depressive symptoms, especially 
social support and a history of depression, these measures were included as possible controls in 
the statistical model for this study, decreasing the likelihood that one of these factors was 
responsible for the between groups difference in change in depressive symptoms. 
 
Fatigue. In order to address the effects of placentophagy on postpartum fatigue, scores 
on the Fatigue Assessment Scale (Michielsen et al., 2004) were evaluated, controlling for 
postpartum sleep quality. While there was no significant difference between groups for FAS 
score overall during the postpartum period, there was a significant interaction of time and 
condition on FAS score, indicating that condition interacted with time to predict trends in FAS 
score. Figure 5.2 illustrates the different trends in FAS score between women in the treatment 
and control groups, with participants in the placenta group experiencing a slight, non-significant 
decrease in fatigue score over time, and the control group experiencing a slight, non-significant 
decrease in fatigue between the second and third postpartum meetings, followed by a non-
significant increase in FAS score between the last two meetings. Additionally, although not 
significantly different between groups, treatment group participants entered the postpartum 
period with a higher mean FAS score than the control group, and completed the study with a 
significantly lower final FAS score. Thus, it appears the women receiving the placenta 
supplement experienced decreased fatigue while women receiving the placebo supplement 
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experienced increased fatigue across the study period, which would be expected if placenta 
supplements do in fact improve postpartum energy as claimed by placentophagy supporters.  
Because sleep quality is negatively related to fatigue score, the difference in postpartum 
changes in fatigue between groups could be related to sleep quality, which may or may not have 
been impacted by the type of supplement received. This analysis controlled for sleep quality, 
however, making this an unlikely source for the differences seen here. Another suspected cause 
for the reported increase in energy/decrease in fatigue among women who ingest placenta 
postpartum is the presumed iron content in placenta supplements (and in placenta in general). 
Given the inverse relationship between iron and fatigue, and the benefits for reducing fatigue 
through iron supplementation that are reported in the scientific literature (Patterson et al., 2001; 
Vaucher et al., 2012; Verdon et al., 2003), it is possible that differences in iron levels between 
groups may be responsible for the different trends in FAS score between groups seen here. 
Although between group differences and changes in iron across the study were not evaluated for 
this dissertation, Gryder (2015) assessed three different measures of iron status across the 
postpartum period in women from the sample of participants in this study and found no 
significant difference between groups in iron measures across the study. Rather, Gryder found 
that although iron measures in the treatment group were slightly lower than those of the control 
group, they changed across the study in parallel ways, and there were no significant differences 
between groups with respect to iron deficiency at any time point in the study, or in sources of 
heme and non-heme iron between groups. Given that placentophagy did not impact participant 
iron status across the study period, it is unlikely that iron received through the placental 
supplements had a positive impact on fatigue scores in the treatment group here. Additionally, 
analysis of the micronutrient content of the placenta capsules in this study revealed only a 
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modest amount of iron in the placenta supplements – even at the highest dose administered 
during the study, making iron from the placenta capsules themselves an unlikely source of 
improvements in fatigue.  
Although the effects of placentophagy on fatigue have not previously been evaluated 
empirically, a Korean study in which injections of human placental extract or a saline placebo 
were administered to perimenopausal women found that women who received injections of 
placental extract had decreased fatigue compared to those who received the saline placebo 
injection (Kong et al., 2008). These results are consistent with the findings of the effects of 
postpartum placenta supplementation presented here.   
 
Bonding. There was neither a significant overall change over time, nor a significant 
difference between groups in overall maternal bonding score as measured by the Mother-to-
Infant Bonding Scale (Taylor et al., 2005). The treatment group experienced a slight, non-
significant increase in bonding score (indicating decreased bonding with their infant) followed 
by a non-significant decrease across the postpartum period, while the control group exhibited an 
overall non-significant increase. At the final postpartum meeting, however, the mean bonding 
score in the treatment group was significantly lower than that of the control group, indicating that 
the treatment group had higher maternal bonding at the end of the study. Although improved 
maternal bonding with the infant is often reported as a benefit of placentophagy, this claim was 
not fully supported by the current findings given that the change in bonding score did not 
decrease significantly in the treatment group, or increase significantly in the control group. This 
suggests that improved mother-to-infant bonding reported by women who have ingested placenta 
may be due to a placebo effect. It is also possible that bonding scale used in this study did not 
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capture nuanced differences between participants in feelings of bonding toward their infant. In 
both groups, participants reported overall very low scores on the bonding scale. 
 Given the participants who composed the sample in this study were highly self-selecting 
with regard to parenting style, as women who engage in placentophagy may be predisposed to 
express higher maternal infant bonding in general due to an increased likelihood of embracing 
“attachment parenting” practices (Benyshek & Young, 2015; Williams, 2014), it is possible that 
maternal bonding was elevated in these participants overall. If this is the case, the lack of 
significant changes in bonding score between groups across the postpartum study period may 
have resulted from these mothers being more highly bonded with their infants than would be 
expected in a representative sample.  
 
Infant Weight. Infant weight was evaluated as a proxy for breast milk production, and in 
both the treatment and control groups, infant weight increased over the 3 postpartum meetings in 
similar ways, however this increase was not significant. There was also no significant difference 
in infant weight between the two groups. These results suggest that infant weight is not affected 
by postpartum supplementation with placenta capsules.  
 Although early research on the effects of dehydrated placenta on infant growth and breast 
milk production reported larger infant weight gains and greater breast milk production in women 
taking placenta powder, these results were not statistically significant (Hammett & McNeile, 
1917a; 1917b), or were measured subjectively making the results difficult to interpret (Soykova-
Pachnerova et al., 1954). The results of the present study are consistent with those reported in the 
early 1900s medical literature. 
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Research Question 2 
Are there differences within and between the experimental and control groups (receiving 
placenta and placebo supplements, respectively) in concentration of salivary and plasma 
hormones across meetings, and are hormone levels correlated to measures of postpartum affect, 
energy and recovery? 
 
Prolactin. Plasma prolactin levels in both the treatment and control groups decreased 
overall across the 3 postpartum meetings, however, this decrease did not change significantly 
over time, or between groups. This can be seen in figure 5.5, which illustrates that although 
prolactin appears to decline over time, both groups exhibit similar decreases with the lines in the 
figure running nearly parallel to one another. 
 There were also no significant correlations between plasma prolactin levels and 
postpartum depressive symptoms (EPDS score), or maternal attachment/bonding (PAI/MIB 
score) for the overall sample, the treatment group, or the control group. This suggests that in this 
study, pregnancy and postpartum plasma prolactin levels were not related to the presence of 
depressive symptoms, or maternal bonding.  
 Although the presence or absence of breastfeeding and the time of last infant feeding bout 
were accounted for in this analysis, it is possible that these factors may have affected the 
prolactin measures in his study. There is a positive correlation between breastfeeding and 
prolactin levels, therefore differences between groups in breastfeeding practices could have 
influenced prolactin levels in the study participants. Because these factors were controlled for 
statistically, however, it is unlikely that they are responsible for the lack of difference in 
prolactin levels or trends in the change in prolactin levels between groups.  
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Progesterone. Salivary progesterone concentrations declined significantly overall across 
the 3 postpartum meetings, however, the control group experienced a small, non-significant 
increase in progesterone between the second and final postpartum meetings, while progesterone 
levels in the treatment group continued to decline. There was also a significant interaction 
between time and number of hours postpartum at the second meeting (first postpartum meeting), 
showing that the timing of this meeting impacted salivary progesterone levels. This is consistent 
with what is expected given the 96 hour window in which participants met with researchers for 
the second time, and the known postpartum decline in progesterone that occurs over the first few 
days after parturition (Taylor & Lebovic, 2007). Although there was a significant change over 
time in salivary progesterone measures, this decline was not significantly different overall 
between the treatment and control groups. Although no literature exists on effects of 
placentophagy on hormone measures in human, research on the hormonal effects of placenta 
ingestion has been conducted in rodent modes. This research has shown that compared to rats 
who were prevented from eating their placenta postpartum, those who did ingest the organ had 
lower progesterone levels on the sixth and eighth days postpartum (Blank & Friesen, 1980). 
Another study conducted by Grota and Eik-Nes (1967) found the opposite in rats that were 
prevented from consuming the placenta. In this study, decreased levels of progesterone were 
found on the fourth day of lactation in rats that were prevented from ingesting the placenta 
compared to those allowed to consume the organ. Unlike the results reported in the rodent 
literature, postpartum endocrine changes in the human participants in both groups for this 
dissertation study showed similarly decreased progesterone levels between days 5 and 7 
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postpartum, with no significant difference in salivary progesterone measures between groups at 
this time point.  
 There were also no significant correlations between salivary progesterone concentrations 
and depressive symptoms (EPDS score), maternal attachment/bonding (PAI/MIB scores), and 
fatigue (FAS score), during pregnancy or at any of the postpartum meetings, with the exception 
of a moderate positive correlation between salivary progesterone and MIB score at the second 
postpartum meeting overall that was significant. This indicates that overall, as progesterone 
concentrations increased, maternal bonding decreased (increased bonding scores reflect 
decreased bonding with the MIB scale). When these relationships were investigated in the 
treatment and control groups separately, the treatment group did not exhibit a significant 
relationship between progesterone concentration and bonding, however the control group 
exhibited a moderate positive correlation between bonding score and progesterone levels at the 
second postpartum meeting that, although not significant, was interesting given the p-value of 
0.021, and may warrant future investigation. This possible correlation is in contrast to previous 
research on the endocrinology of maternal attachment that has shown a relationship between the 
ratio of plasma estradiol to progesterone during pregnancy and postpartum maternal attachment, 
but not between postpartum progesterone and attachment (Fleming et al., 1997). While these 
results could suggest a possible relationship between increased progesterone and decreased 
maternal bonding that results from a lack of placentophagy, this could also be an artifact of the 
endocrinology of human lactation. Given that progesterone has an inhibitory effect on prolactin’s 
action on mammary tissue, and may therefore impact lactation (Goodman, 2003), the inverse 
relationship between progesterone and bonding seen in the current study could be an artifact of 
the relationship between lactation and maternal feelings of bonding (Labbok, 2001).  
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Estradiol. Postpartum concentrations of salivary estradiol showed an overall significant 
decrease across the 3 postpartum meetings, specifically from the first to second, and first to third 
postpartum meetings, however, there was not a significant difference in mean overall estradiol 
concentrations between groups. This means that although estradiol concentrations decreased over 
time, they changed in similar ways in both groups. The rapid decline of estradiol across the first 
few days postpartum that was seen in the present study is consistent with the return of estradiol 
to prepartum levels within a few days of parturition that has been documented in the medical 
literature (Taylor & Lebovic, 2007). Although no prior research has evaluated the effects of 
placentophagy on postpartum estradiol, the previously mentioned study in which injections of 
human placental extract or a saline placebo were administered to perimenopausal women found 
that women who received placenta injections had increased estradiol levels compared to those 
who received a saline placebo injection (Kong et al., 2008). The results of the current study are 
not consistent with these findings, and did not find a relationship between placenta 
supplementation and estradiol levels. 
 Salivary estradiol and EPDS score during pregnancy were moderately negatively 
correlated in the overall sample, and after evaluating each group separately, this correlation 
remained in the control group, but not in the treatment group. This suggests that in control group 
participants, lower estradiol levels were related to increased depressive symptoms during 
pregnancy. Previous research on depression has suggested a role for decreases in estradiol in the 
manifestation of postpartum depressive symptoms (Bloch et al., 2000), and late pregnancy 
estradiol levels have also been shown to be lower in women with depression than in women who 
were not depressed (O’Hara et al., 1991).   
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Research Question 3 
What is the concentration of select hormones, micronutrients, and environmental metals in 
dehydrated and encapsulated human placenta?  
 
Hormonal content of encapsulated placenta. Analysis of the hormone concentrations 
in samples of 28 dehydrated placenta capsules revealed low concentrations for most of the 
analytes, with one hormone (DHT) below the limit of detection in every sample (see table 5.4). 
A number of factors affect the bioavailability and bioactivity of hormones (Fotherby, 1996), such 
as the route of exposure, individual lifestyle factors, and interactions between different 
hormones, making it difficult to know whether the hormones evaluated in these placenta samples 
are present in sufficient concentrations to elicit a physiological response. With this caveat in 
mind, the estrogens and progestogens are of particular interest here, given their concentrations at 
levels that may potentially be high enough to have physiological effects when administered in 
the highest dose of capsules taken by study participants.  
 The mean amount of each hormone (in μg) in each of the three doses and for each type of 
supplement administered in this study are reported in table 5.5. In comparison to the beef and 
vegetarian placebo contents, the dehydrated placenta supplement contained higher mean amounts 
of every hormone that was detected (all hormones except DHT). This is not surprising 
considering the critical role the placenta plays during pregnancy in endocrine function. The beef 
placebo capsules contained detectable concentrations of 10 hormones, albeit at much lower 
concentrations, and most of these were present in the beef placebo capsules in higher amounts 
than what was seen in the vegetarian placebo capsules, with the exception of allopregnanolone 
and progesterone which were slightly higher in the vegetarian placebo contents than the beef. 
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 Previous research by Phuapradit and colleagues (2000) investigated the concentration of 
various substances in heat dried placentas from 15 male and 15 female births in Thailand. 
Among these substances were 3 hormones evaluated here, estradiol, progesterone, and 
testosterone. While their results similarly showed that all 3 steroids were retained in heat dried 
placental tissue, the concentrations were much lower than those found in this study, with the 
placental tissue analyzed in this study containing approximately 11.5 times the amount of 
estradiol, 83 times the amount of progesterone, and 1.5 times the amount of testosterone found in 
the heat dried placentas analyzed by Phuapradit and colleagues (2000).  These differences in 
results could be due to geographical differences between placenta donors, differences in lifestyle 
characteristics such as diet or smoking, the preparation method used to dehydrate and process the 
placentas for analysis, or the analysis method employed.  
 Because proponents of placentophagy claim that the hormones and nutrients in placenta 
capsules are helpful in replenishing these substances that have been lost during parturition, and 
in providing these substances while the body returns to typical pre-pregnancy endocrine 
function, relationships between concentrations of estradiol and progesterone in the placenta 
capsules were compared to post-supplementation salivary measures of these analytes. In the 
present study, there was no significant relationship between placental and salivary concentrations 
of progesterone at either of the 2 time points after participants had begun supplementation, for 
either the treatment or control group. This suggests that the progesterone content of the capsules 
that the participants took during the study did not have a direct impact on women’s salivary 
progesterone.  
 Estradiol concentrations in the dehydrated samples was also compared to salivary 
estradiol measures at the two post-supplementation meetings. As with progesterone, there was no 
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significant relationship between the two measures for either the treatment or control group at 
either of the 2 post-supplementation time points. There was, however, a strong positive 
correlation between the two salivary hormone measures at the first post-supplementation meeting 
(meeting 3) among treatment group participants that, while not statistically significant (p = 
0.026), may be worth future investigation. Although the effects of oral intake of placenta 
supplements on estradiol levels has not been previously investigated, as discussed earlier, 
research with perimenopausal women receiving injections of human placental extract showed an 
increase in estradiol among these women, suggesting a relationship between the hormone in 
placental extract and circulating levels.  
 
Micronutrient and environmental metal content of encapsulated placenta. Analysis 
of the concentration of micronutrients and environmental metals in placenta capsules contents 
from 28 placentas collected during this study revealed modest concentration of potentially 
beneficial micronutrients (i.e., iron, selenium, copper, and zinc), and negligible concentrations of 
potentially harmful elements (i.e., arsenic, cadmium, mercury, lead, and uranium).  
The results of the elemental analysis presented here are somewhat consistent with the 
results of the study mentioned above that was conducted in Thailand where researchers measured 
concentrations of iron, zinc, copper, and manganese (among other minerals) in heat dried human 
placenta (Phuapradit et al., 2000) – the only other study to date, to my knowledge, to evaluate the 
concentration of nutrients in heat dried placental tissue. In the 30 placentas analyzed, the authors 
found a similar concentration of zinc as found in samples from this dissertation study, however, 
the samples analyzed in this study contained approximately two thirds the concentration of iron 
and manganese, and only about one tenth of the concentration of copper that was found by 
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Phuapradit and colleagues (2000). While the actual concentrations of each of these 4 analytes 
vary between studies, in both cases, iron is by far the most highly concentrated element, followed 
by zinc, then copper, and lastly, manganese.  
Of greatest interest to placentophagy advocates are the micronutrients in dehydrated 
placenta capsules that have been suggested as a potential source of the purported benefits of the 
practice, particularly iron due to its inverse relationship with depression (Beard et al., 2005; 
Benton & Donohoe, 1999; Corwin et al., 2003) and fatigue (Patterson et al., 2001; Vaucher et al., 
2012; Verdon et al., 2003), and because iron is typically lost through bleeding during parturition. 
Despite the belief by placentophagy advocates that placenta supplements provide a rich source of 
nutrients to the postpartum mother, the mean concentration of the essential micronutrients iron, 
selenium, zinc, and copper in this sample are modest to negligible, with a 6 capsule dose of 
placenta supplements accounting for approximately 24% (2.192 mg), 7.1% (0.005 mg), 1.5% 
(0.180 mg), and 1.4% (0.018 mg) of the recommended daily intake for lactating women of iron, 
selenium, zinc, and copper respectively (see Table 5.7). Although unlikely to account for 
substantive changes in postpartum affect, health, or recovery, these results suggest that placenta 
capsules may provide a modest but beneficial source of additional micronutrients for postpartum 
mothers. It is important to note, however, that the concentrations of these substances found in 
this study may not provide a sufficient source of postpartum nutrients on their own.  
 In addition to evaluating the beneficial substances present in placenta capsules, 
placentophagy researchers have raised concerns about potentially harmful substances, such as 
toxic environmental metals that may be retained in dehydrated placenta supplements (Hayes, 
2015; Young et al., 2012; Young et al., 2016). The results presented here for the potentially 
harmful toxic elements arsenic, cadmium, lead, mercury, and uranium, as well those with no 
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established health benefit such as cobalt, rubidium, and strontium, suggest that these substances 
in dehydrated placenta are present in concentrations that do not raise concern. In the maximum 
daily dose of placenta supplement administered during this study (approximately 3300 mg), all 
but rubidium (0.026 ± 0.006 ppm) and strontium (0.014 ± 0.013 ppm) were measured in 
concentrations below 0.001 ppm, and all were well below the oral upper tolerable limits (UL) or 
minimal risk levels (MRL) established by the CDC (note that no UL or MRL is available for 
lead, elemental mercury, or rubidium) (ATSDR, 2015a, 2015b; also see Young et al., 2016b).  
  
Summary of hormone and element content of placenta capsules. Given the results for 
the 14 elements evaluated in these placenta samples, it appears that placenta supplements may 
provide only a modest source of potentially beneficial micronutrients, and a negligible source of 
potentially toxic elements. It is important to note that although these results show that the toxic 
elements evaluated here are not present in high concentrations, this analysis does not include 
other potentially harmful substances that may be retained by the placenta and present in the 
capsules, such as pesticides and other environmental pollutants.  
Because the placenta samples evaluated in this study were prepared by steaming, 
dehydrating, and pulverizing the organ, following the proprietary method of a single 
encapsulation provider, Placenta Benefits, LTD, it is possible that other preparation methods 
would result in different concentrations of hormones and elements in the resulting preparation 
(e.g., raw tissue, tissue cooked into a dish, or placenta that is dehydrated without prior steaming). 
Additionally, the dehydrated placenta samples collected in this study were limited to those of 
healthy women in the Las Vegas area who did not smoke cigarettes or drink alcohol during 
pregnancy, and many of whom were of higher socioeconomic status and were taking prenatal 
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nutritional supplements. As a result, these findings may not be broadly applicable across the US 
and other industrialized countries where women are engaging in this practice. Lifestyle factors 
such as diet, socioeconomic status, geographical location, medication use, and 
drug/cigarette/alcohol use can affect endocrine function as well as exposure to and uptake of 
different elements, which could lead to different concentrations of hormones and elements in the 
placenta capsules of women outside of this study.  
 
 Limitations 
There are several limitations to the dissertation study presented here. Due to the nature of this 
study, participants were recruited through convenience sampling and from a population of 
women who had decided prior to enrollment in the study that they would be ingesting their 
placenta postpartum, thus the participants included here represent a biased sample. Because of 
this, the women in this study were highly motivated and believed that placenta offers postpartum 
benefits. Additionally, the women included in this study were all healthy, non-smokers who did 
not use recreational drugs or drink alcohol during pregnancy and were generally college 
educated, of higher socioeconomic status, and presumably adequately nourished. Other 
personality traits and parenting strategies mentioned previously that may be more prevalent in 
this self-selecting sample of women who elected to engage in placentophagy (e.g., attachment 
parenting strategies, use of doulas and lactation consultants, etc.) may also have impacted the 
outcomes measured in this study. While this may represent a typical mother who would opt to 
engage in placentophagy, this does not necessarily represent the demographic of the average 
pregnant woman in the US or other industrialized countries. These results, therefore, may not 
apply to women outside of this small sample of women in the Las Vegas area. The sample size in 
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this study, while sufficient to evaluate the questions addressed here, is also small and therefore 
less statistically powerful. Given this, a larger samples size may have allowed for more precise 
results. 
 Due to the inherently unpredictable nature of childbirth and the early postpartum period, 
many aspects of data collection were difficult to control. Ideally, each participant would have 
met with the research team after the same number of days postpartum, and at the same time of 
day. Although a standardized meeting scheduled was adhered to as closely as possible, this of 
course, was not feasible due to a number of factors such as the timing of the participant’s release 
from the hospital. The data collection setting was also different for each participant, as all 
postpartum meetings occurred at the participant’s residence. Because of this, environmental 
factors such as other people’s presence and household distractions during the meeting were 
unable to be controlled. These and other circumstances that would have been difficult to control 
by design, such as timing of breastfeeding and contact with the infant, may have impacted the 
data collected in this study, particularly the hormones that were evaluated, as hormone levels can 
be very sensitive to context (e.g., circadian fluctuations, stressful situations, physical stimuli, 
etc.).  
Because little scientific research has been conducted on placentophagy, the measures 
collected in this study, and the data collection schedule were designed through the consideration 
of women’s self-reported experiences and in consultation with the founder of a local 
encapsulation provider service. Due to this limitation, the study design reflects one of many ways 
that placentophagy could be practiced, and the data collection timeline may have missed 
potentially important differences that could have occurred outside of the data collection 
windows. An additional limitation of this study is that the placenta supplement provided to 
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participants was processed using the proprietary method of Placenta Benefits, LTD, which 
process the placenta through steaming, dehydrated, and pulverizing the organ prior to 
encapsulation. While a 2013 study (Selander et al.) suggests that dehydrated and encapsulated 
placenta is the most common method of placentophagy, the capsules in this study represent only 
one of several methods of placenta preparation. Beyond this, within this type of preparation, 
there is no guarantee that each encapsulation provider is preparing the placenta in the same way. 
For example, some encapsulation providers, such as Placenta Benefits, LTD, will steam or cook 
the placenta prior to dehydration while others will dehydrate the raw organ without prior 
cooking. Given that some substances that may be present in placental tissue are more heat-stable 
than others, this difference in preparation method may produce differences in outcomes.  
Additionally, the dosage of capsules administered in this study may not reflect that which 
is prescribed by other encapsulation providers. The dosage recommendations here were 
established through discussions with Jodi Selander of Placenta Benefits, LTD, based on the 
typical recommendation of this organization. Many encapsulation providers, including Selander, 
however, will instruct their clients to start with this recommended dosage and to adjust it as they 
see fit based upon their body’s response to the dose. Finally, in addition to providing placenta 
capsules themselves, some encapsulation providers will also offer tinctures and even the 
steaming broth to some clients, which could provide additional sources of placental 
supplementation not accounted for in this study.  
Looking carefully at the data collected in this study, there were also limitations to the 
measures used to evaluate some of the claims of placentophagy, specifically the use of infant 
weight as a proxy measure for breast milk production. While this has been used in previous 
medical research to address this question (Hammett & McNeile, 1917a), it is not the ideal 
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measure to identify differences in breastmilk production. While difficult to collect, a more 
precise method would have involved collecting pre- and post-feeding infant weights, and weights 
of remaining breast milk (through pumping) produced throughout the day at specified time 
points (see Dewey et al., 1991). These values combined would give a more accurate and direct 
value for breast milk production than infant weight alone. This particular methodology would 
have created undue burden on participants in this study and was thus not employed here.  
 Finally, the data collected during the course of this project far exceeds the scope of the 
data presented in this dissertation, therefore the effects of placentophagy on several other 
measures collected remain to be evaluated. Because of this, other aspects of the practice, and 
potential confounding variables may not have been accounted for in the dissertation analysis 
presented here.  
 
Summary  
In light of the limitations described above, and the limited scope of this dissertation, the results 
presented here can nonetheless shed light on some of the most pressing questions on the topic of 
human maternal placentophagy – namely, what are the physiological and psychological effects 
of the behavior and how does processing placental tissue for ingestion affect the concentration of 
potentially beneficial (and harmful) substances in the organ? The results of this dissertation 
suggest that while many of the claims evaluated in this project were not supported, postpartum 
supplementation with steamed and dehydrated placenta capsules may elicit some emotional and 
physiological changes that may not otherwise manifest in postpartum mothers. This includes a 
slight decrease in depressive symptoms in the early postpartum period (within the first week after 
parturition), improvements in fatigue over the first few weeks postpartum, and significantly 
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higher maternal bonding at approximately 3 weeks postpartum. Additionally, this research shows 
that many hormones and nutrients are retained in the placenta after it has been processed for 
encapsulation, something that skeptics have questioned about the possible efficacy of placenta 
supplements. 
 While some small effects were noted in this study in the treatment group that were not 
seen in control group participants, many of the claims evaluated were not supported. These 
include claims that placentophagy positively impacts maternal bonding, breastmilk production, 
and some postpartum hormone levels. While these experiences claimed by placentophagy 
supporters may be the result of a placebo effect, they may also be related to a very important 
aspect of human postpartum behavior – social support. While the capsules themselves may not 
have inherently beneficial properties for the postpartum mother, they bring with them an 
encapsulation provider, – and in the case of this study, two researchers – who is there with the 
mother during a time when social support is critical. Given the higher prevalence of natural and 
home birth practices and midwife and doula assisted births is expected among mothers who 
engage in placentophagy (Selander et al, 2013, the opportunity for additional social support 
surrounding parturition may be greater than that of the larger US population. The presence of, 
and support offered by an individual who is there to provide a service specifically for the mother, 
may provide emotional benefits as well. When I began data collection for this study, I was 
prepared for the participants to see these early postpartum meetings as an inconvenience, but to 
my surprise, they often seemed happy to see us and excited to talk about their birth story. 
Perhaps this additional social contact provided during the early postpartum period offers 
emotional support needed during this time. 
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 This chapter reviewed the results presented in the previous chapter, and provided 
interpretations for these results in the context of what is currently known about the effects of 
placentophagy, and presented the limitations of the present study. The next chapter provides a 
summary of the dissertation, including a discussion of the significance, and potential future 
directions of this research. 
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Chapter 7: Conclusions 
 
Summary of the Dissertation 
This dissertation provides an overview of the current state of research on human maternal 
placentophagy, a review of the existing literature on the topic, a description of the methods 
employed to empirically test claims made about the growing practice of human maternal 
placentophagy in postpartum mothers, and a discussion of the results of this investigation.  
This research study found that while women taking placenta capsules experienced a 
decrease in depressive symptoms within the first week postpartum, and decreased fatigue across 
the early postpartum period that were not experienced by women taking the placebo capsules, 
support was not found for other benefits that reportedly result from placentophagy such as 
improved maternal bonding, and increased breastmilk production. This dissertation study also 
found that although changes in levels of the hormones prolactin, estradiol, and progesterone were 
similar in both groups across the postpartum study period, women taking the placenta capsules 
had lower salivary progesterone at the final meeting during the third week postpartum than those 
taking the placebo capsules, suggesting a possible role for placenta supplements in decreasing 
progesterone levels.  
 In addition to the psychological and physiological effects noted, this study also found that 
placenta capsules prepared from placental tissue that has been steamed, dehydrated, and 
pulverized, does in fact retain detectable concentrations of many hormones and micronutrients. 
This dissertation also revealed that concentrations of potentially harmful environmental 
elements, when detected, were very low and present in concentrations that are well below 
established safety thresholds.  
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Significance and Implications 
While placentophagy has been well studied in experimental animal models, there has been a lack 
of extensive research on the topic in human mothers. Because the popularity of the practice 
appears to be growing among mothers in industrialized countries, questions about the efficacy 
and objectively measurable effects of placentophagy, in addition to the potential risks of the 
practice, leave these women with little data to inform their decision to ingest their placenta 
during this sensitive postpartum period. This dissertation study represents a first step in 
addressing claims that placentophagy provides benefits for postpartum maternal affect, fatigue, 
and general postpartum recovery, as well as evaluating whether potentially beneficial or harmful 
substances can be found in placenta capsules.  
In addition to contributing to the scientific literature on human maternal placentophagy, 
postpartum emotional and physiological changes, and human behavior in general, this research 
provides information about the effects of placentophagy on postpartum affect and recovery that 
can be useful for pregnant and postpartum women who are considering placentophagy. The 
results presented here can equip women and their health care providers with scientific data on the 
practice and aid them in making an informed decision about placentophagy, rather than relying 
on anecdotal evidence and data extrapolated from animal models. It is clear from the passionate 
support by advocates and the anecdotal reports in the literature that many women who engage in 
this practice experience benefits that they attribute to placentophagy. The findings presented here 
neither strongly support nor refute some of the most regularly cited purported benefits of 
placentophagy for postpartum health and recovery. Nor do the findings of the current rule out the 
possibility that many of the effects of placentophagy reported by women who have engaged in 
the practice are, at least in part, the result of a placebo effect. This is not to say that if 
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placentophagy elicits a placebo effect it is not a beneficial option for postpartum mothers, as 
placebo effects are widely recognized for their therapeutic value. 
 
Future Research 
As the practice of human maternal placentophagy continues to grow in popularity, it will become 
increasingly important to evaluate the claims that placentophagy provides postpartum benefits to 
the mother, as well as the potential risks of the practice. This dissertation encompasses only a 
fraction of the research that is needed to adequately address questions of the efficacy and safety 
of placentophagy, and future research is critical in addressing these questions.  
One area of additional exploration that would nicely complement this study is an 
investigation into additional measures of postpartum affect, health, and recovery not addressed in 
this study (e.g., stress, anxiety, postpartum hemorrhage, etc.), and the relationship between other 
hormones and nutrients found in dehydrated capsules and women’s postpartum experience. 
Furthermore, because accounts of contemporary placentophagy are relatively recent and the 
practice has only begun to gain popularity among more “mainstream” mothers over the last 
decade or so, no data exist on the potential long term effects of the practice for the mother or her 
offspring. This is an important area of research that warrants future investigation. Additional 
areas of future placentophagy research include detailed ethnography on the practice to identify 
women’s motivations, beliefs about, and experiences with placentophagy. Given that this 
practice has become increasingly popular despite a lack of support in the scientific literature or 
from medical practitioners, investigations into women’s decision-making process about health 
related issues during this reproductively sensitive time are also important. Another area ripe for 
scientific investigation is toxicological research to identify whether environmental contaminants 
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in other social, economic, and ecological contexts (including additional toxins not addressed 
here), are present in various preparations of human placenta, and if so, the resulting health effects 
of placentophagy in such circumstances. Finally, given the ubiquity of maternal placentophagy 
among eutherian mammals – including our closest primate relatives –  investigations into 
evolutionary explanations for the disappearance of the behavior in our species are clearly 
warranted.  
This dissertation contributes to a small but growing literature on the topic of human 
maternal placentophagy, and helps inform discussions about the potential benefits, and risks of 
engaging in this practice during the postpartum period. While further research is certainly 
necessary to advance our knowledge in this area, the information presented here lays an 
important foundation for future studies on the effects of human maternal placentophagy, and can 
inform future scientific investigation of the practice. 
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Appendix A: Table 2.1 
Table 2.1  
Recorded Placentophagy in Non-Human Primate Species (from Young et al., 2012) 
Family Species Captive/Wild References 
Cheirogaleidae Lesser Mouse Lemur (Microcebus Murinus) Captive in Hayssen et al., 1993 
Lemuridae Black lemurs (Lemur macaco macaco) Captive in Hayssen et al., 1993 
 Ringtailed lemurs (Lemur catta) Free-ranging Sauther, 1991 
 Ruffed lemurs (Varecia variegata) Captive in Hayssen et al., 1993 
Indriidae Malagasy prosimians (Propithecus verreauxi) Free-ranging Richard, 1976 
 Sifaka (Propithecus verreauxi coquereli) Captive in Hayssen et al., 1993 
Lorisidae Slender loris (Loris tardigradus lydekkerianus) Captive 
in Hayssen et al., 1993; 
Kadam & Swayamprabha, 
1980 
Galagidae Lesser Bushbaby (Galago senegalensis moholi) Captive in Hayssen et al., 1993 
Callitrichidae Common marmoset (Calthrix jacchus jacclius) Captive 
in Hayssen et al., 1993; 
Stevenson, 1976 
 Cotton-top tamarin (Saguinus oedipus) Captive Price, 1990 
 Red-bellied tamarin (Saguinus labiatus) Captive Pryce, Abbott, Hodges & 
Martin, 1988 
Callimiconidae Goeldi's monkey (Callimico goeldii) Captive in Hayssen et al., 1993 
Cebidae Squirrel monkeys (Saimiri sciurea) Captive in Hayssen et al., 1993; Hopf, 
1967; Takeshita, 1961 
Aotidae Owl monkey (Aotus trivirgatus) Captive in Hayssen et al., 1993 
Cercopithecidae Gelada baboon (Theropitehcus gelada) Wild Dunbar & Dunbar, 1974 
 Japanese macaque (Macaca fuscata) Wild Thomsen & Soltis, 2000 
 Japanese macaque (Macaca fuscata) Free-ranging Turner et al., 2010 
 Japanese macaque (Mucaca fuscata) Captive Negayama, Negayama 
&Kondo, 1986 
 Java macaque (Macaca fascicularis) Captive 
Kemps & Timmermans, 
1982; Timmermans & 
Vossen, 1996 
 Mona monkey (Cercopithecus mona) Captive Takeshita, 1961 
 Olive baboon (Papio anubis) Feral Nash, 1974 
 Patas monkeys (Erythrocebus patas) Captive Hemmalin & Loy, 1989 
 Proboscis monkeys (Nasalis larvatus) Wild Gorzitze, 1996 
 Rhesus monkey (Macacus rhesus) Captive 
Adachi, Saito & Tanioka, 
1982; Brandt & Mitchell, 
1973; Tinklepaugh & 
Hartman, 1930 
 Stumptail macaques (Maeaea aretoides) Captive Gouzoules, 1974 
 Toque macaque (Macaca sinica) Wild Ratnayeke & Dittus, 1989 
 Yellow baboon (Papio cynocephalus) Wild Condit & Smith, 1994 
Atelidae Black and gold howler monkeys (Alouatta caraya) Wild 
Peker, Kowalewski, Pave & 
Zunino, 2009 
 Howler Monkeys (Alouatta seniculu) Free-ranging Sekulic, 1982 
 Howler monkeys (Alouatta seniculus) Free-ranging Sekulic, 1982 
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 Mantled howling monkey (Alouatta palliata) Wild 
Moreno, Salas & Glander, 
1991 
 Mexican mantled howler monkeys (Alouatta palliata) Semi-free-ranging Dias, 2005 
 Red-handed howler monkey (Alouatta belzebul ) Free-ranging Camargo & Ferrari, 2007 
Hyolbatidae Gibbon (Hyolbates) Captive Hooton, 1946 
 Muller's Bornean gibbon (Hylobates lar mulleri) Captive in Hayssen et al., 1993 
 Pileated gobbon (Hylobates lar pileatus)  in Hayssen et al., 1993 
Pongidae Bonobo (Pan paniscus) Captive Bloser & Savage-Rumbaugh, 
1989; in Hayssen et al., 1993 
 Chimpanzee (Pan troglodytes schweinfurthii) Free-ranging 
Goodall & Athumani, 1980: 
in Hayssen et al., 1993 
 Chimpanzee (Pan troglodytes) Captive Elder & Yerkes, 1936 
 Lowland gorilla (Gorilla gorilla gorilla) Captive Beck, 1984; in Hayssen et al., 
1993 
 Mountain gorilla (Gorilla gorilla beringei) Wild Stewart, 1977; Stewart, 1984 
 Orangutan (Pongo poygmaeus) Captive in Hayssen et al., 1993 
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Appendix B: Table 5.4 
 
Table 5.4  
Mean concentration of 17 hormones in samples of dehydrated placenta, beef, and vegetarian meat 
substitute 
Capsule 
Contents 
Hormone 
Number 
of Detects 
Concentration Range 
(ng/g) 
Concentration 
Means ± SD (ng/g) 
Placenta 
(N=28) 
11-Deoxycortisol 28 15.180 – 121.092 52.305 ± 4.16 
17-hydroxyprogesterone 28 82.762 – 1105.969 265.611 ± 37.45 
7-keto DHEA 28 9.027 – 47.864 22.208 ± 1.899 
Aldosterone 28 0.179 – 2.993 1.274 ± 0.151 
Allopregnanolone 28 37.898 – 181.745 111.147 ± 7.817 
Androstenedione 28 97.501 – 1134.326 365.95 ± 40.002 
Corticosterone 28 2.183 – 59.345 15.237 ± 2.432 
Cortisol 28 9.829 – 205.696 85 ± 0.01 
Cortisone 28 356.662 – 2171.952 1196 ± 0.074 
DHEA 28 35.353 – 288.729 84.795 ± 9.67 
DHT 0 <LOD <LOD 
Estradiol 28 44.612 – 172.959 103.46 ± 6.321 
Estriol 28 453.480 – 926.433 752.187 ± 23.047 
Estrone 28 172.527 – 582.218 343.472 ± 18.757 
Melatonin 9 0.163 – 0.494 0.14 ± 0.026 
Progesterone 28 4307.218 – 15508.879 11314.029 ± 393.895 
Testosterone 28 5.078 – 119.290 30.503 ± 4.275 
Capsule 
Contents 
Hormone 
Number 
of Detects 
Concentration Range 
(ng/g) 
Concentration 
Means ± SD (ng/g) 
Beef 
(N=3) 
11-Deoxycortisol 3 0.181 - 0.950 0.668 ± 0.423 
17-hydroxyprogesterone 2 0.008 - 0.128 0.053 ± 0.065 
7-keto DHEA 0 <LOD <LOD 
Aldosterone 0 <LOD <LOD 
Allopregnanolone 0 <LOD <LOD 
Androstenedione 3 0.089 - 0.273 0.182 ± 0.092 
Corticosterone 3 0.529 - 2.651 1.411 ± 1.105 
Cortisol 3 9.189 - 19.071 13.373 ± 5.112 
Cortisone 3 1.714 - 3.178 2.370 ± 0.744 
DHEA 3 0.573 - 0.945 0.726 ± 0.195 
DHT 0 <LOD <LOD 
Estradiol 0 <LOD <LOD 
Estriol 0 <LOD <LOD 
Estrone 0 <LOD <LOD 
Melatonin 3 0.020 - 0.030 0.026 ± 0.005 
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Progesterone 3 0.338 - 1.627 0.972 ± 0.645 
Testosterone 3 0.026 - 0.041 0.032 ± 0.007 
Capsule 
Contents 
Hormone 
Number 
of Detects 
Concentration Range 
(ng/g) 
Concentration 
Means ± SD (ng/g) 
Vegetarian 
Meat 
Substitute 
(N=3) 
11-Deoxycortisol 0 <LOD <LOD 
17-hydroxyprogesterone 0 <LOD <LOD 
7-keto DHEA 0 <LOD <LOD 
Aldosterone 0 <LOD <LOD 
Allopregnanolone 3 3.593 - 7.874 5.599 ± 2.153 
Androstenedione 3 0.197 - 0.292 0.246 ± 0.048 
Corticosterone 0 <LOD <LOD 
Cortisol 0 <LOD <LOD 
Cortisone 0 <LOD <LOD 
DHEA 0 <LOD <LOD 
DHT 0 <LOD <LOD 
Estradiol 0 <LOD <LOD 
Estriol 0 <LOD <LOD 
Estrone 0 <LOD <LOD 
Melatonin 0 <LOD <LOD 
Progesterone 3 3.189 - 5.105 3.997 ± 0.993 
Testosterone 0 <LOD <LOD 
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Appendix C: Table 5.6 
 
Table 5.6  
Mean concentration of 14 elements in samples of dehydrated placenta, beef, and 
vegetarian meat substitute 
Capsule 
Contents 
Element 
Number 
of Detects 
Number 
<LOD 
Concentration 
Range (ppm) 
Concentration 
Means ± SD (ppm) 
Placenta 
(N=28) 
As 28 0 0.02 - 0.07 0.032 ± 0.013 
Cd 28 0 0.01 - 0.04 0.02 ± 0.006 
Co 28 0 0.01 - 0.19 0.035 ± 0.033 
Cu 28 0 3.30 - 7.81 5.583 ± 1.139 
Fe 28 0 440.86 - 1185.18 664.382 ± 161.398 
Pb 28 0 0.01 - 0.1 0.048 ± 0.023 
Mn 28 0 0.33 - 1.95 0.749 ± 0.444 
Hg 24 4 0 - 0.05 0.012 ± 0.013 
Mo 28 0 0.02 - 0.04 0.029 ± 0.004 
Rb 28 0 4.23 - 12.14 8.029 ± 1.931 
Se 28 0 1.16 - 2.48 1.509 ± 0.271 
Sr 28 0 0.73 - 24.21 4.47 ± 4.223 
U 28 0 0 - 0.03 0.009 ± 0.006 
Zn 28 0 40.65 - 63.59 54.635 ± 5.602 
Capsule 
Contents 
Hormone 
Number 
of Detects 
Number 
<LOD 
Concentration 
Range (ppm) 
Concentration 
(ppm) 
Beef 
(N=1) 
As 1 0 N/A 0.021 
Cd 1 0 N/A 0.001 
Co 1 0 N/A 0.007 
Cu 1 0 N/A 3.662 
Fe 1 0 N/A 92.884 
Pb 1 0 N/A 0.004 
Mn 1 0 N/A 0.297 
Hg 1 0 N/A <0.010 
Mo 1 0 N/A 0.022 
Rb 1 0 N/A 20.583 
Se 1 0 N/A 0.218 
Sr 1 0 N/A 0.233 
U 1 0 N/A 0.006 
Zn 1 0 N/A 170.201 
Capsule 
Contents 
Hormone 
Number 
of Detects 
Number 
<LOD 
Concentration 
Range (ppm) 
Concentration 
(ppm) 
Vegetarian 
Meat 
Substitute 
(N=1) 
As 1 0 N/A 0.014 
Cd 1 0 N/A 0.002 
Co 1 0 N/A 0.011 
Cu 1 0 N/A 13.260 
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Fe 1 0 N/A 15.382 
Pb 1 0 N/A 0.017 
Mn 1 0 N/A 136.840 
Hg 1 0 N/A <0.010 
Mo 1 0 N/A 0.091 
Rb 1 0 N/A 0.968 
Se 1 0 N/A 0.121 
Sr 1 0 N/A 4.523 
U 1 0 N/A 0.013 
Zn 1 0 N/A 203.427 
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Appendix D: Background Information and Meeting 1 Questionnaire  
 
An Investigation of the Effects of Human Maternal Placentophagy in Postpartum Maternal Health and Recovery 
University of Nevada, Las Vegas 
Please answer the following questions as accurately as possible  
Age: _____   Height: _____ ft ______ in  Weight: _____ lbs 
With which ethnicity do you most closely identify?  
__ American Indian/Alaska Native   __ Caucasian    __ Middle Eastern  
__ Asian     __ Hispanic/Latina   __ Other __________________  
__ African American    __ Hawaiian/Pacific Islander  
What is the highest level of education you have completed?  
__ Grammar School   __ Bachelor’s degree  __ Doctoral degree  
__ High School or equivalent __ Master’s degree   __ Professional degree (MD, JD, etc.)  
__ Some college    __ Vocational/technical school  
Which of the following income groups includes your total annual family income:  
__ Under $10,000   __ $30,001—$40,000   __ $60,001—$70,000  
__ $10,000—$20,000   __ $40,001—$50,000   __ $70,001—$80,000  
__ $20,001—$30,000  __ $50,001—$60,000  __ Over $80,000  
Please indicate your marital status: 
__ Single, never married  __ Married or domestic partnership 
__ Separated __ In a committed relationship, not cohabiting 
__ Divorced __ Widowed 
 
Total number of people in the household: _____  
Zip Code: _______________ 
Are you currently employed outside of the home?  Yes  No 
Do you currently consume alcoholic beverages?   Yes   No  
 If yes, how often (circle one)? daily frequently occasionally  rarely 
Do you currently smoke cigarettes?  Yes   No  
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Was your current pregnancy planned?  Yes  No 
Thinking back to just before you became pregnant, when would you say that you wanted to be pregnant 
(circle one)?  Sooner  Later  At that time  Never 
When you first realized you were pregnant, what was your reaction (circle one)? 
Very Happy Somewhat Happy Neither Happy nor Unhappy Somewhat Unhappy Very Unhappy 
In the 3 months before your most recent pregnancy, did you take a multivitamin containing folic acid or a 
folic acid supplement?  
No  Rarely  Occasionally   Almost everyday  Daily 
Is this your first pregnancy? Yes  No 
If this is not your first pregnancy, how many times have you given live birth? _____  
How old are your children? ________________________________________________ 
Did you have complications with any of your pregnancies?   Yes   No    
If yes, please explain briefly: 
_____________________________________________________________________________________
_____________________________________________________________________________________ 
Have you ever ingested placenta, in any form, after any of your pregnancies?  Yes No 
If yes, after which pregnancy did you ingest placenta? __________________________________ 
 Did you experience any effects that you attributed to placentophagy?  Yes No 
Please describe: 
________________________________________________________________________ 
 ________________________________________________________________________ 
 ________________________________________________________________________ 
Do you have any chronic health conditions?   Yes  No 
If yes, please describe them here: 
________________________________________________________________________ 
 ________________________________________________________________________ 
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Please mark any of the following conditions that you have experienced, and indicate the severity and 
whether the condition was diagnosed by a medical professional: 
___ Depression Mild  Moderate Severe ___ Diagnosed  
___ 
Antenatal (pregnancy) 
depression 
Mild  Moderate Severe ___ Diagnosed  
___ Postnatal depression Mild  Moderate Severe ___ Diagnosed  
___ Maternity blues Mild  Moderate Severe ___ Diagnosed  
___ 
Premenstrual dysphoric 
disorder (PMDD) Mild  Moderate Severe 
___ Diagnosed  
___ Anxiety Mild  Moderate Severe ___ Diagnosed  
___ Bipolar disorder Mild  Moderate Severe ___ Diagnosed  
___ Schizophrenia Mild  Moderate Severe ___ Diagnosed  
___ Anemia Mild  Moderate Severe ___ Diagnosed  
___ Insomnia/sleep disorder Mild  Moderate Severe ___ Diagnosed  
___ Thyroid disorder Mild  Moderate Severe ___ Diagnosed  
___ Endocrine disorder Mild  Moderate Severe ___ Diagnosed  
___ 
Reproductive disorder 
(e.g., PCOS, 
endometriosis) 
Mild  Moderate Severe ___ Diagnosed  
 
Are you currently consuming a special diet (e.g., vegan, vegetarian, etc.)?  Yes   No  
If yes, please explain: 
______________________________________________________________________________ 
Did your diet changed after learning that you were pregnant? Yes  No 
If yes, please explain how? 
________________________________________________________________________ 
 ________________________________________________________________________ 
 ________________________________________________________________________ 
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How much has your diet changed since pre-pregnancy (circle one)? 
  drastically  moderately  minimally  none 
Are you currently taking any medication?   Yes   No  
If yes, please list the medication you are taking: 
________________________________________________________________________ 
 ________________________________________________________________________ 
 ________________________________________________________________________ 
Are you currently taking any nutritional supplements (including multivitamins):  Yes  No  
If yes, please list them here, and indicate the brand and dose: 
________________________________________________________________________ 
 ________________________________________________________________________ 
 ________________________________________________________________________ 
What is the starting date of your last menstrual period (MM/DD/YY)?  _____/_____/_____    
What is your projected due date (MM/DD/YY)?  _____/_____/_____    
Where do you plan to give birth?  
__ In a hospital with a physician   __ At home     
__ In a hospital with a midwife   __ At a birthing center    
__ Other  Please describe: ______________________________________________________ 
When did you decide that you wanted to ingest your placenta after giving birth (MM/YY)?     ____/____ 
Why did you decide that you wanted to ingest your placenta after giving birth?  
_____________________________________________________________________________________
_____________________________________________________________________________________ 
Section 1: Edinburgh Postnatal Depression Scale 
Section 2: Kennerley Blues Questionnaire 
Section 3: DASS21 
Section 4: Pittsburgh Sleep Quality Index 
Section 5: Fatigue Assessment Scale 
Section 6: Kansas Marital Satisfaction Scale 
Section 7: Prenatal Attachment Inventory 
Section 8: Multidimensional Scale of Perceived Social Support 
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Appendix E: Meeting 2 Questionnaire  
 
An Investigation of the Effects of Human Maternal Placentophagy in Postpartum Maternal Health and Recovery 
University of Nevada, Las Vegas 
Please answer the following questions as accurately as possible  
Please list your height: _____ ft ______ in  and weight: _____ lbs 
Do you currently consume alcoholic beverages?  Yes   No  
 If yes, how often? daily  frequently  occasionally  rarely 
Do you currently smoke cigarettes?   Yes   No  
Are you currently consuming a special diet (e.g., vegan, vegetarian, etc.)?   Yes  
 No  
If yes, please explain: 
________________________________________________________________________ 
Are you currently taking any medication?   Yes   No  
If yes, please list the medication you are taking: 
________________________________________________________________________ 
 ________________________________________________________________________ 
 ________________________________________________________________________ 
Are you currently taking any nutritional supplements (including multivitamins):  Yes  No  
If yes, please list them here, and indicate the brand and dose:  
________________________________________________________________________ 
 ________________________________________________________________________ 
 ________________________________________________________________________ 
When did you give birth to your most recent child?   
Date:  _____/_____/_____  Time: __________  am pm  
Where did you give birth?  
__ In a hospital with a physician  __ At home     
__ In a hospital with a midwife   __ At a birthing center    
__ Other  Please describe: ______________________________________________ 
How much did your child weigh at birth?  ________lbs ________oz 
Did you receive any medical interventions during the birth (e.g., episiotomy, epidural, induced labor, 
etc.)?  Yes  No 
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If yes, please explain: 
________________________________________________________________________ 
 ________________________________________________________________________ 
 ________________________________________________________________________ 
Were there any complications during the birth?   Yes   No    
If yes, please explain briefly: 
________________________________________________________________________ 
 ________________________________________________________________________ 
 
Section 1: Edinburgh Postnatal Depression Scale 
Section 2: Kennerley Blues Questionnaire 
Section 3: DASS21 
Section 4: Pittsburgh Sleep Quality Index 
Section 5: Fatigue Assessment Scale 
Section 6: Kansas Marital Satisfaction Scale 
Section 7: Mother-to-Infant Bonding Scale 
Section 8: Multidimensional Scale of Perceived Social Support 
Section 9: In the chart below, please indicate how each item has changed since the last few weeks of 
pregnancy.  
 
Improved 
Stayed the 
Same Worsened 
Energy □ □ □ 
Anxiety □ □ □ 
Stress □ □ □ 
Strength □ □ □ 
Sleep quality □ □ □ 
Libido □ □ □ 
Attachment to your baby □ □ □ 
Overall health □ □ □ 
Overall mood □ □ □ 
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Appendix F: Meetings 3 and 4 Questionnaire  
 
An Investigation of the Effects of Human Maternal Placentophagy in Postpartum Maternal Health and Recovery 
University of Nevada, Las Vegas 
Please answer the following questions as accurately as possible  
Please list your height: _____ ft ______ in  and weight: _____ lbs 
Do you currently consume alcoholic beverages?   Yes   No  
 If yes, how often? daily  frequently  occasionally  rarely 
Do you currently smoke cigarettes?   Yes   No  
Are you currently consuming a special diet (e.g., vegan, vegetarian, etc.)?  Yes   No  
If yes, please explain: 
________________________________________________________________________ 
Are you currently taking any medication?   Yes   No  
If yes, please list the medication you are taking: 
________________________________________________________________________ 
 ________________________________________________________________________ 
 ________________________________________________________________________ 
Are you currently taking any nutritional supplements (including multivitamins):     Yes        No  
If yes, please list them here, and indicate the brand and dose: 
________________________________________________________________________ 
 ________________________________________________________________________ 
 ________________________________________________________________________ 
Section 1: Edinburgh Postnatal Depression Scale 
Section 2: Kennerley Blues Questionnaire 
Section 3: DASS21 
Section 4: Pittsburgh Sleep Quality Index 
Section 5: Fatigue Assessment Scale 
Section 6: Kansas Marital Satisfaction Scale 
Section 7: Mother-to-Infant Bonding Scale 
Section 8: Multidimensional Scale of Perceived Social Support 
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Section 9: In the chart below, please indicate how each item has changed since the day your youngest 
child was born, and whether you think these changes occurred as a result of taking the placenta or placebo 
supplement provided you in this study  
 Improved 
Stayed the 
same Worsened 
Result of taking supplement? 
   Yes             No         Not Sure 
Energy □ □ □ □ □ □ 
Breast milk quality □ □ □ □ □ □ 
Breast milk quantity □ □ □ □ □ □ 
Postpartum bleeding □ □ □ □ □ □ 
Anxiety □ □ □ □ □ □ 
Stress □ □ □ □ □ □ 
Strength □ □ □ □ □ □ 
Sleep quality □ □ □ □ □ □ 
Libido □ □ □ □ □ □ 
Bonding with your infant □ □ □ □ □ □ 
Overall health □ □ □ □ □ □ 
Overall mood □ □ □ □ □ □ 
General recovery □ □ □ □ □ □ 
 
Did you experience any other changes not listed here?  Yes  No 
If yes, please describe them here: 
______________________________________________________________________________ 
 ______________________________________________________________________________ 
 ______________________________________________________________________________ 
Do you think you received your placenta or a placebo?  Placenta Placebo 
Why? ________________________________________________________________________ 
 _____________________________________________________________________________ 
 _____________________________________________________________________________ 
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Professional Paper: In search of human placentophagy: a cross cultural survey of 
human placenta consumption, disposal and beliefs. 
   
2003-2005 B.S. Anthropology, Magna Cum Laude, University of California, Riverside, CA  
Senior Thesis: A comparison of Homo floresiensis to pygmy mammals and 
modern human dwarfs to determine the possibility of a dwarf species. 
 
2000-2003 General Education, Chaffey Community College, Rancho Cucamonga, CA 
  
RESEARCH SPECIALIZATIONS AND INTERESTS 
 
I am a biomedical anthropologist interested in evolutionary perspectives on health and disease. 
My research has focused on female reproductive health and the practice of human maternal 
placentophagy in cross-cultural and evolutionary context. My research interests include 
biocultural anthropology, human reproductive ecology, women’s health, human placentophagy, 
nutrition and diet, and evolutionary medicine. 
 
PROFESSIONAL EXPERIENCE 
 
2015-Present Program Manager, Office of Undergraduate Research, University of Nevada, Las 
Vegas 
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2014-2015  Part Time Instructor of Anthropology, Department of Anthropology, University 
of Nevada, Las Vegas 
 
2014-2015 Graduate and Professional Student Body President, Graduate Assistant, Graduate 
College, University of Nevada, Las Vegas 
 
2013-2014 Research Assistant, Harry Reid Center for Environmental Studies and Department 
of Geoscience, University of Nevada, Las Vegas 
 
2012 Instructor, Summer Advanced Gifted Education (SAGE) Program, Honors 
College, University of Nevada, Las Vegas 
 
2008-2012 Graduate Research Assistant, Graduate Teaching Assistant, and Part Time 
Instructor, Anthropology Department, University of Nevada, Las Vegas. 
  
2008 Graduate Research Assistant, Women’s Studies Department, University of 
Nevada, Las Vegas. January - May 
 
2005-2007 Long Term Substitute Teacher, Summit Intermediate School, Etiwanda School 
District, Etiwanda, California 
 
TEACHING EXPERIENCE 
 
2010-2014 Instructor, Department of Anthropology, University of Nevada, Las Vegas  
? Introduction to Physical Anthropology 
? Introduction to Cultural Anthropology 
? Anthropology of Women an d Men  (co-instructed with Alyssa Crittenden) 
? Physical Anthropology Laboratory 
 
2012 Instructor, Summer Advanced Gifted Education (SAGE), Honors College, 
University of Nevada, Las Vegas  
? People, Plants, and Animals 
 
2008-2012 Teaching Assistant, Department of Anthropology, University of Nevada, Las 
Vegas 
? Introduction to Cultural Anthropology  
? Introduction to Physical Anthropology 
? Introduction to World Archaeology 
? Peoples and Cultures of Native North America 
? Peoples and Cultures of Ancient Near East 
? Nutritional Anthropology 
 
RESEARCH EXPERIENCE 
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2008-Present Primary student investigator for ongoing research on human maternal 
placentophagy, including laboratory-based placental tissue analysis, internet-
based survey, experimental research with human participants, cross-cultural 
analysis using database and ethnographic literature sources, and double-blind 
placebo-controlled investigation of the effects of postpartum placenta capsule 
supplementation 
2010-2014 Research assistant for laboratory-based experimental immunotoxicology research 
investigating the health effects of toxic substances and environmental 
contaminants using rodent models and human subjects 
2010 Questionnaire administration and collection of salivary samples for hormonal 
analysis for human sexuality research  
2005 Student researcher for literature-based senior thesis project in which limb 
proportions from H. floresiensis were compared to those of H. erectus and 
modern human dwarfs to identify whether it more closely resembles an insular 
erectine dwarf or modern human dwarf. 
2002 Crew member for the excavation of the Historic Fallis Brothers Building in 
Ontario, California. Involved in excavation, artifact analysis and writing the field 
report. Principal Investigator, Michael Fong, Chaffey Community College. 
GRANTS AND AWARDS
2015 Graduate and Professional Student Association Merit Award, GPSA at University 
of Nevada, Las Vegas ($300.00) 
2014 Graduate and Professional Student Association Research Grant, GPSA at 
University of Nevada, Las Vegas ($1,250.00) 
2014 University of Nevada, Las Vegas Graduate and Professional Student Association 
Research Forum Social Sciences Platform Presentation Competition, First Place 
Prize, UNLV GPSA, Las Vegas, NV ($200.00) 
2013 Graduate and Professional Student Association Service Award, GPSA at 
University of Nevada, Las Vegas ($300.00)  
2012-2014 UNLV Foundation Board of Trustees Research Fellowship, Graduate College at 
University of Nevada, Las Vegas ($60,000.00) 
2011 Alumni Association Sterling Award, Graduate College at University of Nevada, 
Las Vegas ($5,000.00) 
2011 Dean’s Graduate Student Stipend Award, College of Liberal Arts, University of 
Nevada, Las Vegas ($2,000.00) 
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2010 Graduate and Professional Student Association Travel Grant, GPSA at University 
of Nevada, Las Vegas ($690.00) 
2010 Patricia L. Rocchio Memorial Scholarship Fund for Anthropology, Department of 
Anthropology, University of Nevada, Las Vegas ($400.00) 
2010 Graduate and Professional Student Association Travel Grant, GPSA at University 
of Nevada, Las Vegas ($580.00) 
2009 Eleanor F. Edwards and Max Olswang Scholarship Fund for Anthropology –
Archaeology, Department of Anthropology, University of Nevada, Las Vegas 
($350.00) 
2009 University of Nevada, Las Vegas Graduate and Professional Student Association 
Research Forum Social Sciences Poster Competition, Second Place Prize, UNLV 
GPSA, Las Vegas, NV ($125.00) 
2009 Graduate and Professional Student Association Research Grant, GPSA at 
University of Nevada, Las Vegas ($750.00) 
2005 Senior Thesis Research Grant, Office of Undergraduate Research at the 
University of California, Riverside ($400.00) 
2005 Mary G. and Rawley J. Miller Scholarship for Academic Achievement, 
Department of Anthropology, Chaffey Community College, Rancho Cucamonga, 
CA ($5,000.00) 
2003-2005 Dean’s List, University of California, Riverside, CA
2002-2003 Dean’s List, Chaffey Community College, Rancho Cucamonga, CA
PUBLICATIONS
Peer Reviewed Journal Articles: 
In Press Gryder K., Young S.M., Zava D., Kimball D., Cross C., and Benyshek D.C. 
Effects of Human Maternal Placentophagy on Maternal Postpartum Iron-Status:  
A Randomized, Double Blind, Placebo Controlled Pilot Study. Submitted to 
Journal of Midwifery and Women’s Health.
2016 Young S.M., Gryder K., Zava D., Kimball D., and Benyshek D.C. Presence and 
Concentration of 17 Hormones in Human Placenta Processed for Encapsulation 
and Consumption. Prepared for submission to Placenta 43:86-89.
2016 Young, S.M., Gryder, L.K., David, W.D., Teng, Y., Gerstenberger, S., and 
Benyshek, D.C. Human Placenta Processed for Encapsulation Contains Modest 
Concentrations of Fourteen Trace Minerals and Elements. Nutrition Research
36(8):872-878.
160
2016 DeWitt, J. Buck, B., Goossens, D., Hu, Q., Chow, R., David, W.B, Young, S.M.,
Teng, Y., Leetham-Spencer, M., Murphy, L., Pollard, J., McLaurin, B., Gerads, 
R., Keil, D. Health effects following subacute exposure to geogenic dusts from 
arsenic-rich sediment at the Nellis Dunes Recreation Area, Las Vegas, NV.
Toxicology and Applied Toxicology 304: 79-89.
2013 Selander, J., Cantor, A., Young, S.M., and Benyshek, D.C. Human Maternal 
Placentophagy: A Pilot Study Examining Postnatal Experiences with Placenta 
Consumption. Ecology of Food and Nutrition, 52(2): 93-115.
2012 Young, S.M., Benyshek, D.C., and Lienard, P. The conspicuous absence of 
placenta consumption in human postpartum females: The fire hypothesis. Ecology 
of Food and Nutrition, 51(3): 198-217. 
2011 Gray, P.B., and Young, S.M. A cross-cultural perspective on human-pet 
dynamics. Anthrozoos, 24(1): 17-30. 
2010 Young, S.M., and Benyshek D.C. In search of human placentophagy: a cross 
cultural survey of human placenta consumption, disposal and beliefs. Ecology of 
Food and Nutrition, 49(6): 467-484.
Book Chapters 
2013 Escasa, M., Young, S.M. and Gray, P.B. Now or later: Peripartum shifts in 
female sociosexuality. In Evolution’s Empress: How Females Shape Human 
Adaptation, Fisher, M., Garcia, J., Sokol Chang, R., Strout, S.L., eds. Oxford 
University Press: Oxford, UK. 
Non-Refereed Publications and Government Reports: 
2014 Buck, B., Goossens, D., McLaurin, B., Teng, Y., Pollard, J., Taylor, W., Young, 
S., David, W., and Gerads, R. Chapter 5: Arsenic and other analytes in the Nellis 
Dunes Recreation Area: occurrence, distribution, and origin. In: Nellis Dunes 
Recreation Area: Dust Exposure and Human Health Risk Assessment, B.J. Buck, 
D. Keil, D. Goossens, J. DeWitt, and B. McLaurin (Eds.), Final Report to Bureau 
of Land Management for Task Agreement Number L11AC20058. September 
2014, pp. 101-165.
2014 Keil, D.K, DeWitt, J., Spencer, M., Murphy, L., David, W., Chow, R., Young, S.,
Hu, Q., Eggers, M., Gerads, R., Goossens, D., and Buck, B. Chapter 10: 
Immunotoxicological and neurotoxicological effects of subacute exposure to CBN 
1 dust samples. In: Nellis Dunes Recreation Area: Dust Exposure and Human 
Health Risk Assessment, B.J. Buck, D. Keil, D. Goossens, J. DeWitt, and B. 
McLaurin (Eds.), Final Report to Bureau of Land Management for Task 
Agreement Number L11AC20058. September 2014, pp. 233-276.
2014 Keil, D.K, DeWitt, J., Hu, Q., David, W., Chow, R., Young, S., Spencer, M., 
Murphy, L., Teng, Y., Goossens, D., and Buck, B. Chapter 11:
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Immunotoxicological and neurotoxicological effects of subacute exposure to CBN 
2 dust samples. In: Nellis Dunes Recreation Area: Dust Exposure and Human 
Health Risk Assessment, B.J. Buck, D. Keil, D. Goossens, J. DeWitt, and B. 
McLaurin (Eds.), Final Report to Bureau of Land Management for Task 
Agreement Number L11AC20058. September 2014, pp. 277-294.
2014 Keil, D.K., DeWitt, J., Goossens, D., Hu, Q., Spencer, M., Murphy, L., David, 
W., Eggers, M., Chow, R., Young, S., Teng, Y., and Buck, B. Chapter 15: 
Immunotoxicological and neurotoxicological effects of subacute exposure to CBN 
6 dust samples. In: Nellis Dunes Recreation Area: Dust Exposure and Human 
Health Risk Assessment, B.J. Buck, D. Keil, D. Goossens, J. DeWitt, and B. 
McLaurin (Eds.), Final Report to Bureau of Land Management for Task 
Agreement Number L11AC20058. September 2014, pp. 343-358. 
2014 Keil, D.K, Goossens, D., Buck, B., DeWitt, J., Teng, Y., David, W., Chow, R., 
and Young, S. Chapter 19: Dust exposure during ORV recreation in the Nellis 
Dunes recreation Area: human exposure pilot study. In: Nellis Dunes Recreation 
Area: Dust Exposure and Human Health Risk Assessment, B.J. Buck, D. Keil, D. 
Goossens, J. DeWitt, and B. McLaurin (Eds.), Final Report to Bureau of Land 
Management for Task Agreement Number L11AC20058. September 2014, pp. 
413-433.
2010 ???????????????ssens, D., McLaurin, B., Soukup, D., Keil, D., Teng, Y., Sudowe, 
R., Proper, S., Peden-Adams, M., Ayala, N., Berger-Ritchie, J., Lebahn, S., 
Young, S., Baron, D., and Roman, A. Measuring Dust Emissions, Chemistry, and 
Mineralogy to Assess, Predict, and Manage Natural and Disturbed Land Surfaces, 
Nellis Dunes Recreation Area, Nevada. In: Research on Arid Soils in Southern 
Nevada: Dust Emissions, Petrocalcic Genesis, Petrogypsic Soils, and Biological 
Soil Crusts, ?????????, D. Merkler, and S. Thai (Eds.), Fieldtrip Guidebook for 
Western Regional Cooperative Soil Survey, Western Society of Soil 
Science/Western Society of Crop Science Joint Conference, Las Vegas, Nevada: 
June 21-24, 2010, pp. 5-33. 
2010 Keil, D.E., Proper, S., Peden-Adams, M., Ayala, N., Berger-Ritchie, J., Lebahn, 
S., Young, S., Buck, B., Goossens, D., Soukup, D., Sudowe, R., Teng, Y., Baron, 
D. Immunotoxicological Health Effects of Acute Exposure to Dust Samples 
Collected from Nellis Dunes Recreational Area. In: Research on Arid Soils in 
Southern Nevada: Dust Emissions, Petrocalcic Genesis, Petrogypsic Soils, and
Biological Soil Crusts, ?????????, D. Merkler, and S. Thai (Eds.), Fieldtrip 
Guidebook for Western Regional Cooperative Soil Survey, Western Society of 
Soil Science/Western Society of Crop Science Joint Conference, Las Vegas, 
Nevada: June 21-24, 2010, pp. 27-33. 
Articles and Works in prep and under review:
In Prep Benyshek, D.C., and Young, S.M. Consuming the Placenta: The Evolutionary 
Foundations of Placentophagy. Cambridge University Press: Cambridge, UK. 
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ORGANIZED SYMPOSIA
2011 Co-organizer of an invited symposium: Mothers, Children and Others: 
Anthropological Perspectives on Health at the Margins Southwestern 
Anthropological Association Annual Conference, May 5th – 8th, Reno, NV. 
2010 Co-organizer of a Society for Food and Nutrition (SAFN) and Biological 
Anthropology Society (BAS) jointly sponsored invited symposium: Human 
Consumption of ‘Afterbirth’ (Maternal Placentophagy): A ‘Natural’ and 
Beneficial Practice? 109th Annual meeting of the American Anthropological 
Association, November 17th – 21st, New Orleans, LA.   
PRESENTATIONS AND INVITED TALKS
Professional Conferences and Academic Forums
2015 Young, S.M. Strange Medicine: The Effects of Placenta Supplements on 
Postpartum Affect and Recovery 114th Annual Meeting of the American 
Anthropological Association, Denver, CO, November 19th – 22nd (invited talk) 
2014 Benyshek, D.C., and Young, S.M. The emerging trend of human maternal 
placentophagy: can placenta consumption enhance mother-infant bonding? 113th
Annual Meeting of the American Anthropological Association, Washington, 
D.C., December 3rd – 7th (invited talk) 
2014 Buck, B., Keil, D., Goossens, D., DeWitt, J., Warren, A., Simon, T., McLaurin, 
B., Teng, Y., David, W., Morman, S., Eggers, M., Leetham-Spencer, M., Murphy, 
L., and Young, S. Human Health Risk Assessment of Mineral Dust Exposure, 
Nellis Dunes Recreation Area, NV, USA 2014 International Annual Meeting of 
the Soil Science Society of America, Long Beach, CA, November 2nd – 5th
(presented by Brenda Buck) 
2014 Young, S.M., and Benyshek, D.C. Assessing the risks of maternal placentophagy: 
An analysis of environmental metals in human placenta capsules 82nd Meeting of 
the American Association of Physical Anthropology, Calgary, Alberta, Canada, 
April 9th – 12th, poster presentation 
2014 Gryder, L., Young, S.M., Liénard, P., and Benyshek, D.C. Exploring the human 
exception to maternal placentophagy among mammals: Assessing the visual and 
olfactory aversion to human placental tissue 82nd Meeting of the American 
Association of Physical Anthropology, Calgary, Alberta, Canada, April 9th – 12th,
poster presentation (presented by Laura Gryder) 
2014 Leetham-Spencer, M., DeWitt, J.C., Peden-Adams, M.M., Chow, R.M., David, 
W.B., Murphy, L.T., Jensen, M., Walters, N., Gryder, L., Buck, BJ., Goossens, 
D., Teng, Y., Young, S., and Keil, D.E. Immunotoxicity Profile following 
Exposure to Geological Dust Samples Collected from Nellis Dunes Recreational 
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Area Map Unit CBN2: Median Grain Size 4.5 μm 53rd Annual Meeting of the 
Society of Toxicology, Phoenix, AZ,  March 24th-27th, poster presentation 
(presented by Mallory Leetham-Spencer) 
2014 Murphy, L.T., David, W.B., Chow, R.M., Spencer, M., Jensen, M., Buck, B.J., 
Goossens, D., Teng, Y., Gryder, L., Young, S., Walters, N., Keil, D.E., Peden-
Adams, M.M., and Dewitt, J.C. Immunotoxicity Profile following Exposure to Silt 
Deposit Dust Samples from Nellis Dunes Recreational Area, Clark County, 
Nevada 53rd Annual Meeting of the Society of Toxicology, Phoenix, AZ,  March 
24th-27th, poster presentation (presented by Lacey Murphy) 
2012 Young, S.M., Escasa, M., and Gray, P.B. Shifts in female Sociosexuality during 
the Peripartum Period 24th Annual Meeting of the Human Behavior and 
Evolution Society, Albuquerque, NM, June 13th – 17th
2012 Young, S.M., Selander, J., Cantor, A., and Benyshek, D.C. Maternal Experiences 
with Postnatal Placentophagy Society for Cross Cultural Research Annual 
Conference, Las Vegas, NV, February 22nd-25th  
Session Chair, Women, Children, and Health: Selected Topics 
2011 Young, S.M. Human Placenta as Maternal Medicine: Are there Risks to 
Consider? Southwestern Anthropological Association Conference, Reno, NV, 
May 5th -8th
2011 Gray, P.B., Escasa, M. and Young, S.M. Peripartum Shifts in Female 
Sociosexuality American Association of Physical Anthropology Meetings, 
Minneapolis, MN, April 12th-16th
2011 Young, S.M., and Gray, P.B. Human Pet Relationships in Cross-Cultural 
Perspective University of Nevada, Las Vegas Graduate and Professional Student 
Association Research Forum, Las Vegas, NV, March 6th – 10th, poster 
presentation 
2011 Proper, S.P., Peden-Adams, M., Ayala, N., Berger-Ritchie, J., Lebahn, S., Young, 
S., Buck, B., Goossens, D., Soukup, D., Sudowe, R., Teng, Y., Baron, D., 
Harkema, J.R. and Keil, D.E. Health Effects Due to Acute Exposure of Dust
Samples Collected from Nellis Dunes Recreational Area 50th Annual Meeting of 
the Society of Toxicology, Washington D.C., March 6th – 10th, poster presentation 
(presented by Steve Proper)
2011
2010
Peden-Adams, M., Berger-Ritchie, J., Young, S., Ayala, N., and Keil, D. The 
Role of T-cell IL-2 and Macrophage IL-10 Production in PFOS-Induced Humoral 
Immunosupression Society of Toxicology Annual Meeting, Washiungton D.C., 
March 2011, poster presentation (presented by Margie Peden-Adams) 
Young, S.M., Cantor, A., Liénard, P., and Benyshek, D.C. Revulsion or Appeal? 
A Blind Test of the Visual and Olfactory Cues of Human Placental Tissue
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American Anthropological Association Conference, New Orleans, LA, November 
17th -21st
2010 Benyshek, D.C., Young, S.M., and Selander, J. Eating the Placenta: How do the 
Nutritional and Hormonal Profiles of Unprepared Human Placental Tissue 
Compare with Processed Human placental Capsules? American Anthropological 
Association Conference, New Orleans, LA, November 17th -21st (presented by 
Daniel C. Benyshek) 
2010 Selander, J., Cantor, A., Young, S.M., and Benyshek, D.C. Human Maternal 
Placentophagy: Benefits for Postpartum Mothers American Anthropological 
Association Conference, New Orleans, LA, November 17th -21st (presented by 
Jodi Selander) 
2010 Liénard, P., Young, S.M., and Benyshek, D.C. Disgust, Habit, or…? The 
‘Evolution’ of an Avoidance American Anthropological Association Conference, 
New Orleans, LA, November 17th -21st (presented by Pierre Liénard)
2010 Escasa, M., Young, S.M., and Gray, P.B. Peripartum Shifts in Female 
Sociosexuality American Anthropological Association Conference, New Orleans, 
LA, November 17th -21st, poster presentation, (presented by Michelle Escasa) 
2010 Young, S.M., and Gray, P.B. Pets in Cross-Cultural Perspective Human 
Behavior and Evolution Society Conference, Eugene, OR, June 16th – 20th, poster 
presentation 
2010 Young, S.M., and Benyshek, D.C. Human Placenta: From Biohazard to Food 
and Medicine for Mom Society for the Anthropology of Food and Nutrition 
Conference, Bloomington, IN, June 2nd -5th
2010 Gray, P.B., and Young, S.M. A Cross-Cultural Perspective on Human-Pet 
Dynamics American Association of Physical Anthropologists annual meeting, 
Albuquerque, NM, April 14th -17th (presented by Peter B. Gray) 
2009 Young, S.M., and Benyshek, D.C. Human Placentophagy: Maladaptive or 
Misplaced Cultural Taboo? Human Behavior and Evolution Society Conference, 
Fullerton, CA, May 27th - 31st, poster presentation 
2009 Young, S.M., and Benyshek, D.C. Human Placentophagy: Maladaptive or 
Misplaced Cultural Taboo? Southwestern Anthropological Association 
Conference, Las Vegas, NV, April 30th – May 3rd.
2009 Young, S.M., and Benyshek, D.C. Placentophagy: A Universal Human Taboo
University of Nevada, Las Vegas Graduate and Professional Student Association 
Research Forum, Las Vegas, NV, March 28th, awarded second place prize in 
poster competition 
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2005 Young, S.M. Were the Hobbits really human? A comparison of H.floresiensis to
pygmy mammals and modern human dwarfs to determine the possibility of a 
dwarf species. James C. Young Colloquium, Riverside, CA, February, and 
Southwestern Anthropological Association Conference, San Jose, CA, April 28th - 
30th.
SERVICE
Professional
2012 Member, Graduate Student Events Committee, and Student volunteer for the 
Society for Cross Cultural Research, 41st Annual Meeting, Las Vegas, NV 
2011 Ad hoc reviewer, Ecology of Food and Nutrition 
University 
2015-Present Member, UNLV Top Tier Student Success Subcommittee 
2014- 2015 Vice Chair and UNLV GPSA Representative, Nevada Student Alliance of the 
Nevada System of Higher Education 
2014- 2015 President, UNLV Graduate & Professional Student Association 
2014- 2015 Member, UNLV Tier One Steering Committee, and Student Achievement 
Subcommittee 
2014- 2015 Chair, UNLV Graduate & Professional Student Association Bylaws Committee 
2014- 2015 Chair, UNLV Graduate & Professional Student Association Ad hoc Student 
Health Insurance Committee 
2014- 2015 Member, UNLV President’s Advisory Council  
2014- 2015 Ex officio Member, UNLV Alumni Association Board of Directors 
2014 Member, UNLV Parking Advisory Committee 
2014 Student Presenter, UNLV Graduate & Professional Student Association 
Workshop, Polishing Your Presentation Skills & Preparing an Excellent Poster
2013-2015 Member, UNLV Student Health Insurance Committee 
2013-2015 Presidential Student Ambassador 
2013-2014 Member, Nevada Regents’ Academic Advisor Award Selection Committee
2013 Member, Selection Committee for UNLV Graduate College Associate Dean for 
Academic Affairs 
2013 Member, Selection Committee for UNLV Vice President for Research and 
Economic Development 
2013 Member, UNLV Student Academic Misconduct Policy Review Task Force 
2013 Commencement Student Marshal 
2012-2014 Vice President, UNLV Graduate & Professional Student Association, May 2012- 
January 2014, Acting President, September – November 2012 
2012-2014 Chair, UNLV Graduate & Professional Student Association Sponsorship 
Committee 
2012-2014 Chair, UNLV Graduate & Professional Student Association Research Forum 
2012-present Member, UNLV Graduate & Professional Student Association Government 
Relations Committee 
2012-present  Member, UNLV Graduate College Professional Development Committee  
2012-present Member, UNLV Graduate College Faculty and Student Issues Committee 
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2012-2013 Member, UNLV Foundation Distinguished Teaching Award Selection Committee 
2012-2013 Co-organizer, UNLV Graduate & Professional Student Association sponsored 
Graduate Student Research Brown Bag Series 
2012 Member, Graduate & Professional Student Commencement Speaker Selection 
Committee 
2011 College of Liberal Arts Representative, UNLV Graduate & Professional Student 
Association Summer Council 
2010-2012 Anthropology Department Representative, UNLV Graduate & Professional 
Student Association Council 
2010-2012 Member, UNLV Graduate & Professional Student Association Grants Committee 
2010-2012 Member, UNLV Graduate & Professional Student Association research Forum 
Committee 
2010-present Member, UNLV Student Conduct Hearing Board 
Departmental 
2014 Student Presenter, Lambda Alpha Honor Society Workshop, Building Your CV
2014 Judge for Undergraduate Student Poster Presentations, UNLV Anthropology 
Research Forum  
2013-2014 Student Coordinator, UNLV Anthropology Department Graduate Student Peer 
Mentoring Program  
2013 Chair, Judging Committee, UNLV Anthropology Research Forum. Judge for 
Graduate Student Poster Presentations 
2013 Student Presenter, Lambda Alpha Honor Society Workshop, Grants and Other 
Funding: What, Where, When?  
2012-2013 Laboratory Volunteer, Anthropology Department Open House, Metabolism, 
Anthropometry and Nutrition Laboratory 
2009-2012 Secretary and Treasurer, UNLV Chapter of Lambda Alpha National 
Anthropology Honor Society 
2009 Student Presenter, UNLV Anthropology Society Brown Bag Presentation, Human 
Placentophagy
2008-2010 Member, UNLV Hormones and Disease Group Fundraising Committee, and 
2009-2010 Newsletter Editor 
Community Outreach 
2015 Invited Speaker, The Mobile Lab: Doing Biomedical Anthropology in the Field,
Dawson College Bound Program Anthropology Course, Alexander Dawson 
School, Las Vegas, NV, July 
2015 Invited Speaker, The Past, Present, and Future of Placentophagy Research,
PlacentaCON, Las Vegas, NV, March 
2014 Invited Speaker, Doing Fieldwork in Biomedical Anthropology, Dawson College 
Bound Anthropology Course, Alexander Dawson School, Las Vegas, NV, July 
2012 Guest Lecture, How Diet Changed Human History, Trinity International School, 
Las Vegas, NV, September 
2011 UNLV Anthropology Department representative, Career Day, Mannion Middle 
School , Henderson, NV, December 
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2011 Guest Lecture, An Overview of Anthropology, Trinity International School, Las 
Vegas, NV, September  
ACADEMIC AND PROFESSIONAL MEMBERSHIP
American Association of Physical Anthropologists (AAPA) 
American Anthropological Association (AAA) 
Evolutionary Anthropology Society (EAS) 
Biological Anthropology Society (BAS) 
Lambda Alpha Honor Society, UNLV, Las Vegas, NV 
MEDIA COVERAGE OF RESEARCH
Fox Channel 5 Local News 
Fox News National 
KNPR, State of Nevada 
Las Vegas Sun 
UNLV Magazine 
